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ABSTRACT 
 
Zebrafish as a model for analysis of signaling pathways 
involved in cell growth, proliferation and development 
 
Ceren Sucularlı 
Ph.D. in Molecular Biology and Genetics 
Supervisor: Assist. Prof. Dr. Özlen Konu 
January 2011 
 
Zebrafish is an emerging and promising model organism to study 
cancer formation, organogenesis, development, cell signaling, and drug 
screening applications. Cellular signaling driven by E2F and TOR proteins 
regulate cell proliferation, growth and development; yet expression of E2F 
targets and downstream effectors of TOR inhibition have not been studied in 
zebrafish in detail. In this study, we first demonstrated the conservation of E2F 
target ortholog expression in zebrafish in response to serum; second our results 
revealed significant changes in the zebrafish fibroblast cells (ZF4) at the whole 
transcriptome level upon treatment with rapamycin, an inhibitor of TOR; and 
third we phenotypically screened zebrafish embryos in vivo when exposed to 
different doses of rapamycin. Our studies showed that as in mammalian cells, 
ZF4 cells entered into a quiescent state at G1/S phase in the cell cycle, which 
was reversed by serum stimulation. We showed that serum response of selected 
E2F target gene orthologs, namely pcna, mybl2, tyms, mcm7 and ctgf, were 
conserved between zebrafish and mammals. Using microarray analysis, we 
demonstrated that rapamycin modulated expression of a large number of genes 
in ZF4 cells with functions ranging from cell cycle to protein synthesis. Similar 
to previous findings in mammals, rapamycin treatment downregulated 
expression of proteasomal subunits in zebrafish. Our findings in zebrafish also 
implicated a moderate increase in expression of ribosomal subunits; this 
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finding warrants further comparison with mammalian studies. qRT-PCR 
studies confirmed dkk1b, pah, dcc, cyp26b1 and wif1 as being significantly 
differentially expressed under rapamycin treatment using a time-course 
experiment. In zebrafish embryos, in vivo exposure to rapamycin caused a 
significant dose-dependent developmental delay and in particular prominent 
reductions in formation of pigments and cartilage, tissues known to be derived 
from embryonic neural crest cells. Our study implicates a potential role for 
TOR in the neural crest formation, differentiation or migration in zebrafish. 
Our study also clearly establish ZF4 cells as a model to further study signaling 
pathways involved in cell proliferation, growth and development. 
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ÖZET 
 
Hücre büyümesi, çoğalması ve gelişiminde rol alan sinyal 
yolaklarının analizi için Zebrabalığı modeli 
 
Ceren Sucularlı 
Doktora Tezi, Moleküler Biyoloji ve Genetik Bölümü 
Tez Yöneticisi: Yard. Doç. Dr. Özlen Konu 
Ocak 2011 
 
Zebrabalığı, kanser ve organ oluşumunun incelenmesi, gelişim, hücre 
sinyal yolak analizi ve son zamanlarda da ilaç taramaları için kullanılan, ümit 
vadeden bir model organizmadır. E2F ve TOR proteinleri tarafından yürütülen 
hücresel sinyaller, hücre çoğalması, büyüme ve gelişimini kontrol ederler; 
ancak zebrabalığında E2F hedef proteinlerinin ifadeleri ve TOR 
inhibisyonunun yolağın alt bileşenleri üzerindeki etkileri, detaylı olarak daha 
önce çalışılmamıştır. Bu çalışmada, ilk önce E2F hedef ortologlarının 
ifadelerinin zebrabalığındaki evrimsel korunumu gösterildi; ikinci olarak 
çalışmalarımız, bir TOR inhibitörü olan rapamisine maruz bırakılan zebrabalığı 
fibroblast hücre hattında (ZF4) transkriptom düzeyindeki önemli değişiklikleri 
ortaya çıkardı; üçüncü olarak farklı dozlarda rapamisine maruz bırakılan 
zebrabalığı embryoları in vivo olarak incelendi. Çalışmalarımız, ZF4 
hücrelerinin, serum yokluğunda, memeli hücrelerinde olduğu gibi hücre 
döngüsünün G1/S fazında durgun hale geçtiğini, ve serum eklenmesi ile bu 
durumun tersine döndüğünü göstermektedir. Seçilen E2F hedef gen 
ortologlarının (pcna, mybl2, tyms, mcm7 ve ctgf) seruma verdikleri yanıtların 
zebrabalığı ve memeliler arasında korunmuşluğunu da bulgulamaktayız. 
Mikrdizin analizi ile, ZF4 hücrelerinde rapamisin tarafından  kontrol edilen ve 
foksiyonları hücre döngüsünden protein sentezine kadar çeşitlenen çok sayıda 
gen olduğunu gösterdik. Daha önce memelilerde belgelenen bulgulara benzer 
şekilde, rapamisin, proteasomal alt ünitelerin ifadelerini zebrabalığında da 
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geriletti. Bulgularımız ayrıca ribosomal alt ünitelerin ifadelerininde az miktarda 
artış olduğunu göstermekte olup bu bulgunun memeli çalışmaları ile 
karşılaştırılması öngörülmektedir. qRT-PCR çalışmalarımız ile dkk1b, pah, 
dcc, cyp26b1 ve wif1’ın ifadelerinin zamana bağlı olarak rapamisin uygulaması 
ile istatistiksel olarak anlamlı bir şekilde değiştiği doğrulanmıştır. Zebrabalığı 
embryolarında in vivo rapamisin uygulaması gelişimde doza bağlı olarak 
gerçekleşen bir gerilemeye ve özellikle embryonik nöral krest hücrelerinden 
geliştiği bilinen pigment ve kıkırdak hücrelerinde belirgin azalmalara neden 
olmuştur. Çalışmalarımız, TOR’un nöral krest oluşumu, farklılaşması veya 
göçünde potansiyel bir etkisi olduğuna işaret etmektedir. Sonuç olarak 
çalışmalarımız, zebrabalığını, hücre çoğalması, büyümesi ve gelişimde rol alan 
sinyal yolaklarını çalışmak için önemli bir model olarak ortaya çıkarmaktadır. 
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Chapter 1. INTRODUCTION 
 
 
1.1 Zebrafish as model organism 
 
 
1.1.1 Zebrafish embryo 
 
 The zebrafish has been used as a valuable model in molecular biology studies 
because of its ease of maintenance and molecular conservation with higher organisms 
(Barbazuk et al., 2000). A healthy female fish may lay hundreds of eggs; the embryos 
are easy to visualize and manipulate because they are large in size, transparent and 
have a short generation time (Wixon, 2000). The mutant zebrafish strains are available 
to explore the genes required for the development in large scale genetic screens 
(Driever et al., 1996). Zebrafish is a convenient model to also study organogenesis by 
visualizing mutations affecting specific organs; such as kidney (Chen et al., 1996; 
Drummond et al., 1998), heart, and cardiovascular system, liver and intestine (Chen et 
al., 1996; Pack et al., 1996).  
 
 More recently, the zebrafish has been used as a model organism in cancer. The 
tumor formation in zebrafish may develop naturally (Smolowitz et al., 2002), upon 
treatment with chemicals (Feitsma and Cuppen, 2008) or by xenotransplantation (Lee 
et al., 2005; Nicoli et al., 2007). The conservation between human and zebrafish 
tumors was shown at the molecular level by high-throughput transcriptome analysis 
(Lam et al., 2006; Ung et al., 2009).  The short development time and the existence of 
mutant strains also make zebrafish as an important and rising model for drug 
screening (Taylor et al., 2010; Wang et al., 2010).  
 
The zebrafish has also emerged as a valuable model organism to study 
craniofacial cartilage development and pigment pattern formation (Barrallo-Gimeno et 
al., 2004; Ellies et al., 1997; Parichy, 2006; Yelick and Schilling, 2002). Zebrafish 
have the similar craniofacial elements with higher vertabrate counterparts. In zebrafish 
the pharyngeal skeleton, jaw and branchial arches, arise from the cranial neural crest 
cells that develop from dorsal and lateral regions of the neural ectoderm then migrate 
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to pre-determined locations (Yelick and Schilling, 2002). Pigment cells are also 
derived from neural crest cells, except for the retinal pigment epithelium, which is 
derived from the neural epithelium (Dupin and Le Douarin, 2003). In mammals neural 
crest cells give rise to only one type of pigment cell, melanocytes. However, in 
zebrafish, pigments consist of black melanophores, yellow xanthophores and silver 
iridophores (Hirata et al., 2003; Parichy, 2006). Melanophores become visible around 
25 hpf in the retinal epithelium of zebrafish embryo and migrate to anterior of the 
trunk and the posterior of the head. Xanthophores become visible at the posterior of 
the head as yellow marks. Iridophores appear on the eye as silver spots. Xanthophore 
and iridophores start to appear during hatching period (Kelsh et al., 1996). 
 
Zebrafish has been used to understand the cellular signaling components of the 
regulatory pathways of development and disease, such as Wnt, TGF-β, TOR, PTK, 
and BMP and FGF signaling (Kan et al., 2009; Kim et al., 1999; Lemeer et al., 2007; 
Makky et al., 2007; Pyati et al., 2005; Shin et al., 2007). Since it is simple to generate 
transgenic fish, in vitro findings can easily be extended to in vivo fish models. One 
example of this is the identification of the PTK signaling profiles with zebrafish 
peptide arrays and discovery of functions with the zebrafish embryos using knock 
down of PTKs with morpholinos (Lemeer et al., 2007). Another example combines 
findings from human cell lines with an in vivo zebrafish model. The activation by 
polycystin of Wnt signaling, whose mutations caused autosomal dominant polycystic 
kidney disease, was shown in human embryonic kidney cells then the inhibition of 
GSK-3β by polycystin and its effect on phenotype have been shown in zebrafish 
embryos (Kim et al., 1999). The similarity of mammalian and zebrafish liver 
generation and the role of WNT, BMP and FGF signaling in liver regeneration have 
also been shown in a zebrafish model with expression studies and by generating 
transgenic zebrafish (Kan et al., 2009). The first in vivo presentation of the 
requirement of BMP and FGF signaling for hepatic specification was shown in 
zebrafish (Shin et al., 2007).  The activation of Wnt signaling in neural crest 
development also was identified in zebrafish embryos by monitoring the neural crest 
induction at different time points in transgenic fish, expressing Wnt inhibitor, Tcf 
(Lewis et al., 2004).  
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1.1.2 Zebrafish cell line, ZF4 
 
Zebrafish embryonic fibroblast cell line, ZF4, was generated from 1 day-old 
zebrafish embryo for use in gene expression studies (ATCC, CRL-2050; (Driever and 
Rangini, 1993)). The ZF4 cells have been used to compare overlapping segments of 
zebrafish and mouse cell chromosomes (Ekker et al., 1996), to investigate the effect of 
heat and cold shock on zebrafish heat shock proteins (Airaksinen et al., 2003), to 
identify the function of the genes, such as ATM (Garg et al., 2004), lamin B2 (Gruber 
et al., 2005), Tip-1 (Besser et al., 2007), XBP-1(Hu et al., 2007), TNF-alpha (Roca et 
al., 2008) and to assess the effects of chemical treatments on gene expression (Long et 
al., 2011). The effect of serum replenishment for 6 h after 24 h serum starvation on 
global gene expression of zebrafish has also been investigated using ZF4 and PAC2 
cells (He et al., 2006); however, the molecular response of ZF4 cells to 24  and 48 h 
serum starvation and 24 h replenishment has not been identified in this study.  
Accordingly, ZF4 cells provide ample opportunity to compare cell signaling 
components with humans with respect to sequence and expression.  
 
 
1.2 Serum starvation/replenishment in molecular biology studies 
 
Tissue culture cells require addition of serum to the culture media. Serum provides 
growth factors, nutrients, vitamins and amino acids that are lacking in the plain media 
of the tissue culture cells (Gstraunthaler, 2003). Insufficiency of these factors in the 
culture conditions affects the growth of the cells and causes a reversible cell cycle 
arrest (quiescence) (Demidenko and Blagosklonny, 2008). Lack of serum in the 
culture media also affects the number of the proliferating cells. In a study with normal 
human fibroblasts, the decrease in the cell number was observed in the cells cultured 
with serum free media. The number of the cells continued to decrease as the time of 
the treatment increased (0 to 10 days) (Nakatani et al., 2008). However, the duration 
of the treatment of serum starvation should be assessed carefully, since serum 
starvation may induce apoptosis (Kues et al., 2000). 
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Serum starvation is an appropriate model to study cell cycle progression, since 
serum starvation arrests cells at G0/G1 phase of the cell cycle (Bettuzzi et al., 1999; 
Goissis et al., 2007; Khammanit et al., 2008; Kues et al., 2000; Vackova et al., 2003). 
Previous studies with fibroblast cell lines from various species, such as human, 
porcine and canine showed that serum starvation (24 h to 5 day) causes an increase in 
the cell number at G0/G1 phase, while it decreases cells entering the S and G2/M 
phases of the cell cycle (Bettuzzi et al., 1999; Goissis et al., 2007; Khammanit et al., 
2008; Kues et al., 2000; Vackova et al., 2003). These changes in cell cycle distribution 
of cells may be reversible; serum replenishment may restore the effects of serum 
deprivation while the duration of starvation is critical to generate reversible growth 
arrest (Bettuzzi et al., 1999; Kues et al., 2000). 
 
The growth factor depletion exerts its effect on transcription (please see section 
1.3) and translation of the genes which are regulatory for G1 to S phase progression 
(Brunn et al., 1997; Hidalgo and Rowinsky, 2000).  
 
The transcription of several genes required for G1 to S phase transition are 
regulated by the E2F transcription factor family (Linhart et al., 2005). The role of 
E2F1 transcription factor in S phase progression has been shown in quiescent cells: 
overexpression of E2F1 facilitates the S phase entry in growth arrested cells (Johnson 
et al., 1993). In serum starved and then replenished human T98G neuroblastoma cells 
the increase in E2F1 mRNA expression was observed at the transition from G1 to S 
phase (Kherrouche et al., 2006).  
 
The translation of the genes required for the progression of G1 to S phase is 
mediated by the mTOR pathway (Hidalgo and Rowinsky, 2000). mTOR (mechanistic 
Target of Rapamycin) pathway is responsive to the changes in growth factors and 
nutrients (Edinger and Thompson, 2002). Thus treating cells with no serum inactivates 
TOR and causes a decrease in phosphorylation of S6, which is also observed in 
rapamycin treatment (Demidenko and Blagosklonny, 2008). Starvation also causes a 
decrease in phosphorylation of S6 (Demidenko and Blagosklonny, 2008). Rapamycin 
treatment has a similar affect with serum starvation on the phosphorylation of 4E-
BP1, which is phosphorylated by mTOR, in HEK 293 cells (Gingras et al., 1998). 
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1.3 E2F signaling 
 
The E2F transcription factors are important regulators of G1/S phase of the cell 
cycle. The regulatory regions of E2F target genes have been conserved in a wide 
range of species, including fruitfly, zebrafish, fugu, green spotted puffer fish, chicken, 
rat, mouse, dog and human (Duronio et al., 1995; Linhart et al., 2005). 
 
The E2F/DP transcription factor complex is a major downstream target of the 
pRB tumor-suppressor pathway. The E2F/DP heterodimer drives cell proliferation 
under the control of the pRb family proteins, pRB, p107 and p130 (Dyson, 1998). The 
hypophosphorylated pRB-bound E2F/DP heterodimer represses transcription of E2F 
target genes in quiescent cells. After stimulation with mitotic signals, the cyclin/cdk 
complex phosphorylates pRB; when hyperphosphorylated, pRB releases E2F and the 
E2F/DP heterodimer induces transcription of the responsive genes (Cayirlioglu and 
Duronio, 2001; Muller and Helin, 2000; Nevins, 2001).   
 
The genes controlled by the E2F/DP complex are involved in DNA repair, 
differentiation, apoptosis and development (Bracken et al., 2004; Cayirlioglu and 
Duronio, 2001; DeGregori and Johnson, 2006; DeGregori et al., 1995a; Duronio et al., 
1995; Ishida et al., 2001; Polager et al., 2002; Stevaux and Dyson, 2002). These genes 
are either the regulators of cell cycle such as cyclin E, cyclin A, B-Myb, E2F1, and 
p107 and the cyclin-dependent kinases (Cdks) or have roles in DNA replication such 
as ribonucleotide reductase, DNA polymerase, the origin recognition complex (ORC), 
thymidine kinase, and dihydrofolate reductase (Cayirlioglu and Duronio, 2001; Ishida 
et al., 2001; Stevaux and Dyson, 2002). 
 
The E2F transcription factors are also important regulators involved in the 
transition from the quiescent state into the cell cycle (DeGregori et al., 1995b; Smith 
et al., 1996). A DNA microarray analysis performed with mouse embryonic 
fibroblasts overexpressing E2F1 or E2F2 revealed that many of the genes induced by 
E2Fs were regulated at the G1/S phase of the cell cycle (Ishida et al., 2001). In 
another study performed with rat fibroblast cells that were made quiescent by serum-
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starvation, overrepression of E2F3 or E2F1 forced cells to re-enter the S phase from 
the G1 phase through upregulation of genes involved in DNA replication, DNA repair 
and mitosis (Polager et al., 2002). These studies strongly emphasized the importance 
of the roles E2Fs play in regulating the transition from the G1 to S phase in cell cycle 
in the context of serum response. 
 
 
1.3.1 pcna 
 
Proliferating cell nuclear antigen (pcna) is a cofactor of DNA polymerase delta 
and an important component of DNA replication in eukaryotic cells. Pcna is also 
involved in DNA repair (Essers et al., 2005).  
 
The relationship between serum starvation/E2F regulation and Pcna expression 
has been shown in many studies; PCNA carries a binding site in its regulatory region 
and is a direct target of E2F1, and this region is transcriptionally activated during the 
transition from G1 to S phase (Lee et al., 1995). In mouse embryonic fibroblast (MEF) 
cells, Pcna expression was increased in the S phase entry after serum stimulation 
following serum starvation (Hurford et al., 1997). In NIH 3T3 (mouse embryonic 
fibroblast) cell line serum starvation caused a cell cycle arrest, while in these cells 
overxpression of Pcna overcame the growth arrest and cells continued to proliferate 
(Fukami-Kobayashi and Mitsui, 1999). The decrease in Pcna mRNA expression after 
40 h serum starvation and following an increase in the expression after serum 
stimulation has also been shown the Chinese hamster ovary cell line (CHOK1) (Liu et 
al., 1995). 
 
PCNA protein has been used as a cell proliferation marker in bovine aortic 
endothelial cells, and PCNA negative cells were addressed as apoptotic after serum 
deprivation and hypoxia (Hogg et al., 1999). In zebrafish embryonic intermediate cell 
mass (ICM) and in adult kidney cells, pcna has also been stated as a cell proliferation 
marker. In 24 hpf zebrafish embryos, pcna expression was observed in the highly 
proliferative sites, such as brain, spinal cord and ICM (Leung et al., 2005). 
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1.3.2 mybl2 
 
MYBL2 (Myeloblastosis oncogene-like 2, B-Myb) belongs to a transcriptional 
factor family consisting of three members named as A-Myb, B-Myb and C-Myb 
(Nomura et al., 1988). 
 
E2F transcription factors have an important role in the regulation of MYBL2 
expression; the promoter region of MYBL2 carries binding sites for E2F1, E2F2, E2F3 
and E2F4. E2F4 negatively regulates the MYBL2 expression in the early G1 phase, 
while E2F1, E2F2 and E2F3 replace the E2F4 at the late G1 and increase the 
expression of MYBL2 as shown in serum starved (synchronized) and then serum 
stimulated T98G human glioblastoma cells and mouse cells (Takahashi et al., 2000). 
Also in normal human bone marrow fibroblast cells, MYBL2 mRNA expression 
increased in serum-stimulated cells that were serum starved for 48 h (Scortechini et 
al., 1999). The serum-stimulated increase in Mybl2 expression has also been shown in 
the quiescent mouse embryonic fibroblast cells, the increase in Mybl2 mRNA was 
detected after serum stimulation in these cells (Tominaga et al., 2004). 
 
 The mybl2 expression is required for zebrafish development, the loss of mybl2 
results in necrosis in central nervous system in the 1 dpf (days post fertilization) 
zebrafish embryo (Amsterdam et al., 2004). The zebrafish mybl2 is also critical for 
G2/M progression; in the zebrafish crash&burn (crb) mutant which carries a loss of 
function mutation in mybl2, the delayed entry to G2/M was observed and 
accompanied with genomic instability and increased cancer susceptibility (Shepard et 
al., 2005).  
 
 
1.3.3 tyms 
 
The TYMS (thymidylate synthase) is an important component of DNA 
synthesis and proliferation. TYMS enzyme generates TTP (thymidine 5’-triphosphate) 
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precursor which is required for DNA replication by converting dUMP (deoxyuridine 
5’-monophosphate) to dTMP (thymidine 5‘-monophosphate) (Conrad, 1971). 
 
The TYMS is a direct target of E2F1. The E2F1 and E2F4 binding sites have 
been detected in the promoter region of human TYMS gene by using ChIP analysis 
(Weinmann et al., 2002). 
 
Long-term serum starvation decreased the Tyms activity in mouse 3T6 
fibroblast cells, which was reversed by serum stimulation, the increased protein 
activity was observed during the S phase of the cell cycle (Navalgund et al., 1980). 
Serum stimulation also increased the Tyms expression in mouse embryonic fibroblast 
cell line, NIH 3T3 (Saxena et al., 2009). 
 
The tyms expression in zebrafish embryo is apparent in the 1-cell stage and 
persists through the 72 hpf (hours post fertilization). The tyms expression is required 
for proper zebrafish development; loss of tyms expression causes an arrest in the 
development of head and tail of the zebrafish embryo (Du et al., 2006). 
 
 
1.3.4 mcm7 
 
Minichromosome maintenance complex component 7, Mcm7, together with 
the other Mcm family proteins (Mcm2-6) is the component of a pre-replicative 
complex (pre-RC), which is required to initiate and elongate the replication during the 
S phase (Blow and Dutta, 2005). 
 
 The MCM7 is a direct target of E2F transcription factors; the promoter region 
of human MCM7 gene carries E2F binding sites (Suzuki et al., 1998). 
 
The serum response and MCM7 relation has previously been shown for human 
cells. In the MCF7 breast cancer cell line, serum stimulation increased the MCM7 
protein levels, peaking after 2, 4 and 6 h of stimulation (Rizwani et al., 2009). In 
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human and mouse cells made quiescent by contact inhibition, the decrease in Mcm7 
protein levels was apparent (Stoeber et al., 2001). 
 
In the developing zebrafish embryo the mcm gene expression was observed in 
the highly proliferative sites (Ryu and Driever, 2006). In the retina of zebrafish 
embryo the decrease in mcm5 caused an aberrant cell cycle progression and increased 
apoptosis (Ryu et al., 2005). Although the role and expression of mcm5 on cell cycle 
progression was investigated in zebrafish, the expression of mcm7 has not been 
previously studied to our knowledge.  
 
 
1.3.5 ctgf  
 
CTGF (Connective tissue growth factor) is a member of the CCN 
(ctgf/cyr61/nov) family. CTGF has important roles in extracellular matrix formation, 
cell proliferation and migration (Moussad and Brigstock, 2000). 
 
The response of Ctgf expression to serum starvation/replenishment may be cell 
type specific. In serum-starved human mesangial cells the Ctgf expression was 
decreased after 24 and 48 h of starvation, while serum stimulation increased the Ctgf 
mRNA expression transiently; the expression of mRNA peaked after 2 h of 
stimulation and gradually decreased as the stimulation continues (Goppelt-Struebe et 
al., 2001). However, according to GEO microarray expresion profile analysis, the 
expression CTGF increased after 3 days of serum starvation in human T98G cancer 
cells (Cam et al., 2004). 
 
CTGF is not a direct target of E2F transcription factors as shown by 
expreriments performed with cycloheximide treatments. The CTGF expression was 
negatively regulated by E2Fs, the mRNA levels of CTGF decreased in the E2F1, 
E2F2 and E2F3 overexpressing human osteosarcoma (U2OS) cells (Muller et al., 
2001). 
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The ctgf expression was shown to be important for zebrafish embryonic 
development, especially of the notochord (Chiou et al., 2006). The requirement of 
Ctgf expression in development was also conserved in the mouse model. In the mouse, 
Ctgf was required for the extracellular matrix production in cartilage, and loss of Ctgf 
caused severe cartilage defects (Ivkovic et al., 2003). 
 
 
1.4 Rapamycin 
 
 
1.4.1 Rapamycin as an inhibitor of cellular signaling  
 
mTOR (mechanistic target of rapamycin) is a serine/threonine kinase which is 
a member of the phosphoinositide 3-kinase related kinase (PIKKs) protein family. The 
PIKKs are regulatory kinases of the cell cycle progression, DNA damage and repair, 
and DNA replication (Sarkaria et al., 1998). 
 
The mTOR regulates cell proliferation and growth in response to nutrients and 
growth factors through regulation of translation. Translation initiation is controlled 
through two pathways by mTOR. In the first pathway, mTOR directly phosphorylates 
Thr389 of S6K1. Activation of S6K1 increases the translation of ribosomal proteins 
and translation factors. In the second pathway mTOR phosphorylates and inactivates 
4E-BP suppressor proteins (Huang et al., 2003; Kim and Novak, 2007). The 4E-BP 
suppressor protein is the inhibitor of eukaryotic translation initiation factor 4E 
(eIF4E). After phosphorylation and inactivation by mTOR binding, 4E-BP dissociates 
from eIF4E and free eIF4E initiate translation (Dufner and Thomas, 1999; Fingar et 
al., 2002; Gingras et al., 1998; Panwalkar et al., 2004).   
 
Nutrients, growth factors, hypoxia and low energy affect the mTOR response 
in human cells (Arsham et al., 2003; Brugarolas et al., 2004; Dennis et al., 2001; 
Edinger and Thompson, 2002; Scott et al., 1998). Growth factors activate mTOR via 
PI3K/Akt pathway. Stress, hypoxia and low energy conditions lead to inactivation of 
mTOR by activating TSC1/TSC2 complex that are the upstream inhibitors of mTOR 
 11 
and are also targets of Akt after growth factor and nutrient stimulation (Hay and 
Sonenberg, 2004; Wullschleger et al., 2006). 
 
Function of tor protein is highly conserved between species from yeast to 
human (Wullschleger et al., 2006). The sequence and the expression of tor in 
zebrafish have been recently identified. The whole-mount in situ hybridization studies 
showed the ubiquitous expression of zebrafish tor from the single cell stage to 24 hpf. 
Between 24 and 48 hpf the expression was detected in the head, brain, eyes and 
brancial arches. After 4 dpf, the expression of zebrafish tor persisted only in head and 
eyes (Makky et al., 2007).  Makky and colleagues also showed that the rapamycin 
treatment arrested the digestive tract development, and caused a weak developmental 
delay overall (Makky et al., 2007).  
 
 
1.4.2 Mechanisms of rapamycin action  
 
Rapamycin is an immunosuppresive, antifungal and antitumor agent; and the 
inhibitor of the mechanistic target of rapamycin (mTOR) (Martel et al., 1977; Vezina 
et al., 1975). Rapamycin inhibits mTOR by forming a complex with FKBP12. The 
rapamycin-FKBP12 complex binds to mTOR and prevents mTOR from initiating 
translation (Sabers et al., 1995; Tsang et al., 2007).  
 
Rapamycin shows its effect on growth inhibition in various cell types, 
including B-cell lymphoma (Wanner et al., 2006), breast cancer (Mosley et al., 2007; 
Yu et al., 2001), leukemia (Mayerhofer et al., 2005), colon adenocarcinoma (Guba et 
al., 2005) and hepatocarcinoma cells (Zhang et al., 2007). 
 
 Rapamycin treatment arrests cell at the G1 phase of the cell cycle from yeast to 
human in various cell types (Albers et al., 1993; Decker et al., 2003; Gorshtein et al., 
2009; Metcalfe et al., 1997; Zhang et al., 2007; Zinzalla et al., 2007). In the 48 h 
serum-starved human osteosarcoma cell line, MG-63, rapamycin treatment arrested 
cells at early G1 phase even after serum stimulation (Albers et al., 1993). 
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Rapamycin exerts its effect on cell cycle progression by inhibiting transcription 
or translation of regulatory genes, such as cyclin D1, pcna, cyclin E 
(Hashemolhosseini et al., 1998; Nelsen et al., 2003). Rapamycin has also been shown 
to prevent the accumulation of cyclin D1 mRNA after serum stimulation of serum-
starved NIH 3T3 fibroblasts and decreased the Cdk4 kinase activity and pRb 
phosphorylation (Hashemolhosseini et al., 1998). In rat pituitary tumor cell line, GH3, 
rapamycin prevented the pRb phosphorylation and following E2F activity, and 
decreased the mRNA and protein levels of cyclin E and cdk2, which are regulated by 
E2F, but did not change the cyclin D1 protein levels (Gorshtein et al., 2009). Also in 
human IL-2-dependent T-cell line, Kit225, rapamycin treatment decreased E2F1 
activity (Brennan et al., 1999). Rapamycin not only affects the activity of E2F/Rb 
pathway by regulating the pRb phosphorylation, it also downregulates the 
transcription of E2F1. The expression of E2F1 was downregulated in primary human 
CASMCs after 100 ng/ml rapamycin treatment for 48 h. In these cells rapamycin 
treatment also decreased the expression E2F target genes; such as cyclin-D3 and 
CDK4, which are the regulators of cell cycle (Zohlnhofer et al., 2004). In addition, 
overexpression of cyclin D1 and E2F1 rescued cells from arresting at G1 and 
stimulates S phase transition in rapamycin treated rat hepatocytes (Nelsen et al., 
2003). 
 
An increase in the number of cells in the G1 phase after rapamycin treatment 
has been shown in many cell types, as explained above. However, for example, in 
OVCAR4 and OVCAR5 ovarian cancer lines, 100 ng/ml rapamycin treatments for 48 
h did not change the cell numbers in G1 phase of the cell cycle (Altomare et al., 
2004). Rapamycin treatment also had no effect on the cell number of the cell cycle 
phases in rapamycin insensitive WB311 rat epithelial cell line, although treatment 
decreased the phosphorylation of S6 and 4E-BP1 as it did in rapamycin sensitive cells 
(Jimenez et al., 2009). The phospho-p70S6 kinase protein levels were decreased after 
rapamycin treatment for 24 h in a dose dependent manner in human malignant glioma 
cell lines U87-MG, T98G, and U373-MG, although the latter one was rapamycin 
insensitive (Takeuchi et al., 2005). These might indicate phosphorylation levels of 
p70S6 kinase and 4E-BP1 may not be indicative of rapamycin sensitivity. 
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Previous studies exemplified the sensitivity of zebrafish to rapamycin. The 
growth of adult caudal fin was negatively affected from rapamycin treatment, whereas 
the juvenile caudal fin was not (Goldsmith et al., 2006).  400 nM rapamycin treatment 
caused an arrest on the digestive tract development at the primitive gut tube stage and 
in general a weak developmental delay up to 72 hpf in zebrafish embryo (Makky et 
al., 2007). The effect of rapamycin on zebrafish model has also been demonstrated 
from the 8-cell stage to 28 hpf zebrafish embryos. Rapamycin treated embryos 
mimicked embryonic growth–associated protein (EGAP) morphants with a 
developmental delay, vessel defects and cardiac failure (Wenzlau et al., 2006). 
However, rapamycin induced cell signaling has not yet been studied at the 
transcriptome level in zebrafish embryos or cell lines. 
 
 
1.4.3 Rapamycin in cell viability and apoptosis, autophagy 
 
The growth arrest at G1 phase induced by rapamycin treatment was explained 
in section 1.4.2. Rapamycin also has outcomes on cell viability and cell death in 
different organisms.  
 
Rapamycin may induce apoptosis or may protect cells from apoptosis by 
inducing autophagy (Ravikumar et al., 2006; Tirado et al., 2005). According to MTT 
assay based cell proliferation analysis, rapamycin treatment decreased cell viability in 
MIN-6 insulinoma cells in a dose-dependent manner starting from 24 h of exposure; 
10 nM and 100 nM rapamycin treatment for 19 h induced apoptosis in those cells 
(Bell et al., 2003).  In JN-DSRCT-1 cell line, a model for desmoplastic small round 
cell tumors, rapamycin induced apoptosis and decreased viable cell number in a dose-
dependent manner via inducing pro-apoptotic Bax and reducing anti-apoptotic Bcl-xL 
protein levels and leading to caspase-3 activation (Tirado et al., 2005). 
 
In human rhabdomyosarcoma cells, rapamycin exposure also induced 
apoptosis which could be rescued by IGF-I treatment (Hosoi et al., 1999). Huang et al. 
proposed that rapamycin induces apoptosis but not G1 arrest under serum starvation in 
p53 deficient human rhabdomyosarcoma cell lines, Rh1 and Rh30 (Huang et al., 2003; 
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Huang et al., 2001). In these cells serum starvation and rapamycin treatment increased 
the number of cells at G1 phase of the cell cycle, however did not change expression 
of the cell cycle regulators; such as cyclin D1, cyclin E and cyclin A, representing 
continuing cell cycle progression. BrdU incorporation also confirmed these results; 
97% of the rapamycin treated cells (100 nM for 24 h) continued to incorporate the 
BrdU, accompanied with the increase in apoptotic cell number. When the cells were 
transfected with p53 carrying plasmid, the number of the apoptotic cells were 
decreased and G1 induced growth arrest increased (Huang et al., 2001). Also in wild 
type mouse embryonic fibroblast cells, MEFs, under serum starvation, rapamycin did 
not induce apoptosis but decreased BrdU incorporated cell number, while in p53-/- 
and p21-/- MEFs, rapamycin induced apoptosis and only slightly decreased the BrdU 
incorporated cell number, proposing in p53 intact cells rapamycin treatment caused a 
G1 arrest but not apoptosis, while in p53-/- and p21-/- MEF cells, rapamycin induced 
apoptosis since cells continued to proliferate  (Huang et al., 2001). 
 
The apoptotic and anti-apoptotic functions of rapamycin may depend on the 
cell type. In vascular smooth muscle cells (VSMCs) of injured rat arteries, rapamycin 
rescued VSMCs from apoptosis by preventing the activity of caspase-3/7 (Reddy et 
al., 2008). In primary human coronary artery smooth muscle cells, CASMCs, 
rapamycin treatment reduced the basal and H2O2-induced apoptosis compared to 
control CASMCs. The activity of caspase-3 was inhibited by rapamycin in these cells, 
suggesting the decrease in apoptosis to some extent was a result of caspase-3 activity 
inhibition (Zohlnhofer et al., 2004).  In the African Green Monkey SV40-transformed 
kidney fibroblast cell line, Cos-7, rapamycin treatment for 48 h before induction of 
apoptosis, protected cells from undergoing apoptosis. This protection was prevented 
when autophagy inhibitor, 3MA was used. Also in a Drosophila model, rapamycin 
treatment prior to apoptotic agent treatment increased the survival ratio of wild type 
Drosophila, but not the Atg1, the gene specific for autophagy, mutants (Ravikumar et 
al., 2006). Rapamycin treatment prior to apoptosis induction decreased the activated 
caspase-3 and caspase-9 in rat pheochromocytoma cell line PC12 (Ravikumar et al., 
2006). In the wild-type yeast model, rapamycin induced autophagy, but not in Atg1 
mutants (Alvers et al., 2009). The upregulation of autophagy has also been observed 
in 3 dpf zebrafish embryos after 24 h rapamycin treatment (He et al., 2009). The 
induction of autophagy was also investigated in human malignant glioma cell lines, 
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e.g., rapamycin sensitive U87-MG, T98G, and rapamycin insensitive U373-MG, 
rapamycin induced autophagy in the rapamycin sensitive cell lines, while had no 
effect on the rapamycin insensitive cell line (Takeuchi et al., 2005). 
 
 
1.4.4 Microarray 
 
1.4.4.1 Brief introduction about microarrays 
 
High-throughput microarray analysis have been used to analyze the expression 
of the genes in various organisms in response to chemical treatments, cancer 
formation and disease (Golub et al., 1999; Kittleson et al., 2004; Lock et al., 2002; 
Martyniuk et al., 2007; Mirnics et al., 2000; Ramaswamy et al., 2001; Ross et al., 
2000; Walker et al., 2006; Xiao et al., 2005). Microarrays are also convenient tools to 
compare the conserved pathways or signatures involved in disease formation or 
cellular functions in different species (Hancock and Lessnick, 2008; Kobayashi et al., 
2010b; Lam et al., 2006; Shepard et al., 2005). Several types of arrays are available 
for different purposes, such as protein microarrays to explore protein-protein 
interactions (MacBeath and Schreiber, 2000), antibody microarrays for detection of 
antigens (Chaga, 2008), tissue microarrays for prognostic and therapeutic approaches 
(Kononen et al., 1998) and DNA microarrays for gene expression, copy number and 
SNP analysis (Hacia et al., 1999; Pollack et al., 1999; Schena et al., 1995). 
 
In principle, DNA microarray chips consist of cDNA or fragmented 
oligonucleotid sequences, specific for the coding or non-coding parts of the DNA 
sequences, attached on a solid surface. The RNA extracted from the subjects are 
reverse transcribed to cDNA and sometimes further transcribed to cRNA which are 
then hybridized to cDNA or oligonucleotid sequences on the microarray chips. The 
hybridization process generates a signal which is detected with special scanners. The 
expression value coming from the intensity of the signal is used for analysis (Lipshutz 
et al., 1999; Schena et al., 1995). In order to compare the expression changes between 
different chips, normalization and preprocessing of the data are required.  
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The preprocessing of the microarray data consists of background correction, 
normalization and summarization (Gautier et al., 2004). In background correction 
step, the background noise is removed from the signal of the probes. Normalization 
removes the chip effects, background noises, or batch effects, thus only biological 
difference is valued (Bolstad et al., 2003). Normalization is performed in order to 
correct the technical differences, thus leaves only the biological differences. The last 
step of preprocessing is summarization. One or more probe sets on the chips 
represents genes, and one probe set consist of 11 to 20 probes in Affymetrix chips. 
Summarization step combines the signal intensities of probes and generates one 
expression value for a probe set (Gautier et al., 2004). Different techniques have been 
used to preprocess and normalize the microarray data, such as MAS 5.0 (Hubbell et 
al., 2002), dChip (Li and Hung Wong, 2001) and RMA (Irizarry et al., 2003). Another 
important subject emerges here is the annotation of probe sets, i.e., associating probe 
sets with their related transcript names, gene information, homology information or 
gene ontology. NetAffx (Liu et al., 2003) and BioMart (Durinck et al., 2005) are 
preferable tools to annotate probe sets.    
 
After preprocessing and normalization, the expression values of DNA 
microarray probe sets can be further analyzed in order to obtain differentially 
expressed genes between treatments/diseases/tumors and their related controls. The 
differentially expressed genes between conditions are filtered according to selected 
criteria, which may be fold change differences, p values according to selected test 
statistics, false discovery rates or combination of them (Chen et al., 2007; Olson, 
2006).  
 
The functional annotations of differentially expressed genes are also performed 
in order to identify the pathways affected and molecular and biological function of the 
genes. Several web-based tools are available to for functional annotations, such as 
DAVID (Dennis et al., 2003; Huang da et al., 2009), FatiGO (Al-Shahrour et al., 
2004) of Babelomics (http://babelomics.bioinfo.cipf.es/functional.html), MGI 
(http://www.informatics.jax.org/function.shtml), WebGestalt 
(http://bioinfo.vanderbilt.edu/webgestalt/) and PathwayMiner 
(http://www.biorag.org/pathway.html). 
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Since microarray data are complex and the information coming from analyses 
is extensive, programs that analyze, store and interpret the data are required. Several 
tools are available to analyze microarray data, such as R programming language 
(http://cran.t-project.org) and Bioconductor packages (Gentleman et al., 2004), 
GeneSpring (http://www.genomics.agilent.com), Ingenuity Pathways Analysis 
(http://www.ingenuity.com/) and BRB Array tools (http://linus.ncbi.nih.gov/BRB-
ArrayTools.html). 
 
 
1.4.4.2 Zebrafish microarrays 
 
Although there are different microarray platforms available for zebrafish 
model (Peterson and Freeman, 2009; Wardle et al., 2006), the most widely used one is 
Affymetrix GeneChip® Zebrafish Genome Array (Santa Clara, CA, USA; 
http:www.affymetrix.com/products/arrays/specific/zebrafish.affx).  
 
Zebrafish microarrays have been used to understand different mechanisms 
effecting the expression of the organism. The effect of chemicals (Carney et al., 2006; 
Henry et al., 2007; Hoffmann et al., 2006; van Boxtel et al., 2008; Xiong et al., 2008), 
diseases, such as cancer (Lam et al., 2006; Langenau et al., 2007; MacInnes et al., 
2008; Ung et al., 2009) or infections (Meijer et al., 2005) on gene expression have 
been surveyed by microarrays in zebrafish. Furthermore, the comparative microarray 
analyses between zebrafish and human tumors helped understand the conserved 
signatures in cancers (Lam et al., 2006; Langenau et al., 2007; Ung et al., 2009).   
 
 
1.4.4.3 Transcriptome studies of rapamycin treatment 
 
The cDNA or tissue microarray analyses contributed to understanding of the 
molecular mechanisms that were affected by the rapamycin treatment (Jimenez et al., 
2010; Mousses et al., 2001). 
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The effect of rapamycin treatment on gene expression has been studied in 
various organisms and cell lines by high-throughput transcriptome analysis. A 
common gene set obtained from meta-analysis of human breast cancer cell line, 
MDA-MB-468, treated with DMSO or 100 nM rapamycin for 24 h, and MDA-MB-
468 xenografts in nude female mice treated with DMSO or 15 mg/kg rapamycin for 
24 h or 3 weeks, has been shown to be important in prognosis of the breast cancer 
(Akcakanat et al., 2009). In xenographs rapamycin treatment affected the genes 
regulating immune response and metabolism (Akcakanat et al., 2009). The effect of 
rapamycin treatment was also investigated in rapamycin sensitive, WB-F344; 
rapamycin insensitive, WB311 and intermediate sensitive, GN5 and H5D, rat 
epithelial cell lines. The genes involved in cell cycle, cell death and energy pathways 
were affected in all cell lines. Aminoacyl-tRNA biosynthesis, ribosome, cell cycle and 
carbohydrate metabolisms were affected in the rapamycin sensitive cell line, WB-
F344, while oxidative phosphorylation, amino acid metabolism and cell 
communication changed in the rapamycin insensitive cell line, WB311 (Jimenez et al., 
2009). In TSC2-/- murine embryonic fibroblast cells 20 nM rapamycin treatment for 
14 h repressed the mitochondrial genes (Cunningham et al., 2007). 
 
Microarray analysis performed with polysome-bound mRNAs is an efficient 
way to assess the effect of rapamycin on translation (Grolleau et al., 2002). In this 
respect, a microarray study performed with rapamycin-treated human E6–1 Jurkat T 
cell line for 4 h searched for the effect of rapamycin on transcription by using poly A 
mRNAs and translation by using only polysome-bound mRNAs. This study showed 
that rapamycin treatment affects both transcription and translation of the genes. 
Rapamycin treatment induced the transcription of negative regulators of cell cycle, 
and repressed the positive regulators of cell proliferation. Translation of ribosomal 
proteins, proteasome subunits and elongation factors were inhibited by rapamycin 
treatment (Grolleau et al., 2002). In another microarray study with human lung 
fibroblast cell line, MRC-5, the effect rapamycin treatment (100 nM for 30 min) had 
on translation initiation was investigated; rapamycin upregulated the mRNAs with 
anti-apoptotic functions, downregulated the ribosomal protein and elongation factor 
mRNAs (Genolet et al., 2008). Also in yeast model the transcriptional and 
translational effects of rapamycin were investigated; the transcription and translation 
of genes involved in oxidative phosphorylation, proteasome subunits, TCA cycle and 
 19 
energy metabolism were upregulated by rapamycin, while transcription and 
translation of ribosomal proteins, rRNA processing, RNA polymerases and translation 
initiation factors were downregulated by rapamycin (Preiss et al., 2003).  
 
Rapamycin treatment repressed the genes coding for cytoplasmic and 
mitochondrial ribosomal proteins, tRNA synthetases and the components of 
translation in Candida albicans (Bastidas et al., 2009). In another study with yeast 
strains showed that genes involved in ribosome and protein synthesis, transcription 
and RNA processing and cell cycle regulation were affected from rapamycin 
treatment (Butcher et al., 2006). 100 nM rapamycin treatment for 2 h in 
Saccharomyces cerevisiae strain BY4741 downregulated genes coding for ribosomal 
proteins and nucleotide synthesis, while upregulated genes coding for energy 
metabolism and autophagy; 4 to 6 h treatment decreased the expression of  lipid 
metabolism genes, while increasing the expression of genes responsible from amino 
acid and vitamin synthesis (Fournier et al., 2010). 
 
 
1.4.5 Selected E2F target orthologs and rapamycin 
 
 
1.4.5.1 pcna 
 
In primary human CASMCs after 100 ng/ml rapamycin treatment for 48 h 
decreased the expression of pcna (Zohlnhofer et al., 2004). In murine T lymphocytes, 
rapamycin decreased IL-2 induced Pcna expression (Feuerstein et al., 1995). 
Rapamycin treatment also decreased the Pcna expression in human keratinocyte stem 
cells (Javier et al., 1997), in rabbit lens epithelium cells (rLECs) (Liu et al., 2010). 
 
 
1.4.5.2 mybl2 
 
There are not many studies showing the response of mybl2 expression to 
rapamycin. However, it has been shown that mybl2 expression was downregulated in 
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primary human CASMCs after 100 ng/ml rapamycin treatment for 48 h (Zohlnhofer et 
al., 2004). Also in mouse mammary epithelium, NMuMG, cells 100 ng/ml rapamycin 
treatment for 24 h decreased the Mybl2 protein levels (Law et al., 2002). 
 
 
1.4.5.3 tyms 
 
48 h rapamycin treatment also decreased the tyms expression in primary human 
CASMCs (Zohlnhofer et al., 2004). In many human gastric cancer cell lines, 
rapamycin and also RAD001 (a rapamycin analogue) downregulated both the mRNA 
and protein levels of tyms (Lee et al., 2010; Shigematsu et al., 2010). 
 
 
1.4.5.4 mcm7 
 
mcm7 expression decreased in primary human CASMCs after 100 ng/ml 
rapamycin treatment (Zohlnhofer et al., 2004). Also in rat aortic smooth muscle cells 
(RASMC), rapamycin treatment decreased the mRNA and protein levels of Mcm7 
(Bruemmer et al., 2003).  
 
 
1.4.5.5 ctgf  
 
The effect of rapamycin on ctgf expression may be cell type dependent. Since, 
different outcomes have been observed in different cell types. Rapamycin treatment 
did not affect the CTGF mRNA expression in bovine mammary epithelial cell line, 
MAC-T (Zhou et al., 2008). However, 50 ng/ml rapamycin treatment starting from 8 h 
increased the CTGF protein levels in rat glomerular mesangial cells (Osman et al., 
2009). In normal keratinocytes (NK) and keloid keratinocytes (KK), rapamycin 
treatment decreased CTGF protein levels (Khoo et al., 2006). 
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Chapter 2. AIMS AND STRATEGY 
 
 
 
 Zebrafish have been used widely as a model organism in molecular biology 
and genetics studies due to its short generation time, easy maintenance, and 
visualization and manipulation of the transparent embryos (Wixon, 2000). Adult and 
embryonic and larval fish have been used to understand and study disease formation, 
such as cancer, organogenesis and embryonic development, and drug screening for 
therapeutic approaches (Driever et al., 1996). ZF4 cell line derived from zebrafish 
embryos (Driever and Rangini, 1993) has been used to explore the regulatory cellular 
signaling components of growth and proliferation in combination with the zebrafish 
adults and embryos (Gruber et al., 2005). Previously zebrafish model has been used to 
explore the components of the regulatory pathways of growth and proliferation, such 
as Wnt, TGF-β, TOR, PTK, and BMP and FGF signaling (Kan et al., 2009; Kim et al., 
1999; Lemeer et al., 2007; Makky et al., 2007; Pyati et al., 2005; Shin et al., 2007). 
E2F and mTOR signaling are two of the main regulatory pathways in cell growth, 
proliferation and disease formation. However, the expression and conserved 
modulation of E2F and mTOR signaling pathway targets have not been studied in 
zebrafish model before.  
 
Our aim in this study has been a) to understand the conservation of E2F 
signaling targets in zebrafish in the context of sequence and expression, which has not 
been studied before in zebrafish and b) to explore the role of mTOR in cell growth 
and development in zebrafish embryos and on global gene expression of the zebrafish 
cell line ZF4.  
 
In order to study the selected pathways in zebrafish, we used the modulators of 
these pathways, serum starvation/replenishment for E2F pathway and rapamycin for 
mTOR pathway. Serum starvation by generating a reversible growth arrest at G0/G1 
phase of the cell cycle is an easy and appropriate model to study the alterations of E2F 
target gene expression (Bettuzzi et al., 1999; Goissis et al., 2007; Khammanit et al., 
2008; Kues et al., 2000; Vackova et al., 2003). Rapamycin is an inhibitor of mTOR 
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pathway; rapamycin forms a complex with FKBP12 and this complex binds and 
prevents mTOR activity (Sabers et al., 1995; Tsang et al., 2007).  
 
First we asked whether ZF4 cells a) were responsive to serum 
starvation/replenishment and also to the rapamycin treatment at the cellular level and 
b) behave as mammalian cells. We performed multiple cellular assays, i.e., cell 
viability assay, MTT; cell proliferation assay, BrdU; cell cycle analysis, propidium 
iodide staining; and apoptosis assay, CDD, to explore the cellular response of ZF4 
cells to serum starvation and rapamycin treatment.  
 
Second we asked whether E2F target genes responded to serum fluctuations in 
the same manner with their mammalian counterparts. In order to answer this question, 
we selected the zebrafish counterparts of five known mammalian E2F target gene 
orthologs, either positively or negatively regulated by E2F in mammals. We searched 
for the sequence and expression conservation of selected genes in zebrafish. For 
sequence conservation, the sequences of selected genes from various species, 
including mammals and fish species were obtained from NCBI and Ensembl data 
bases, aligned by ClustalW and phlygenetic analysis was performed with Mega4. 
Phylogenetic analysis revealed the evolutionary conservation of selected genes in 
several organisms including mammals and fish species. For expression analysis, 
selected gene expressions were investigated in serum starved ZF4 cells, to show the 
dose-dependent gene expression changes and 6 or 24 h serum replenished ZF4 cells, 
to show whether their expression is restored in ZF4 cells as in mammalian cells with 
real-time qRT-PCR. To investigate expression of mTOR pathway components in ZF4 
cells, we used high-throughput microarray analysis. 
 
Rapamycin treatment has been shown to effect the general development and 
organ formation in various organisms (Makky et al., 2007; Moriyama et al., 2010; 
Oldham et al., 2000). Third we asked whether and in which context rapamycin 
treatment affects the zebrafish development in a dose-dependent manner. To explore 
the effect of rapamycin on zebrafish embryo development, we exposed zebrafish 
embryos to varying doses of rapamycin and monitored the general development of 
zebrafish embryos starting from 1 dpf to 5 dpf. 
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Chapter 3. MATERIALS & METHODS 
 
 
3.1 Materials 
 
 
3.1.1 General reagents 
 
The chemicals used in the laboratory were obtained from Sigma-Aldrich (St. 
Louis, MO, U.S.A), Farmitalia Carlo Erba (Milano, Italy), Merck (Schucdarf, 
Germany), Riedel-de Haën (Germany) and Gibco (Carlsbad, CA, USA). Rapamycin 
was purchased from Calbiochem (Darmstald, Germany). BrdU was purchased from 
Sigma (St. Louis, MO, USA). DAPI was obtained from Roche (Germany). 
 
 
3.1.2 Oligonucleotides 
 
The oligonucleotides used in the real-time qRT-PCR were synthesized and 
supplied from Iontek Inc. (Istanbul, Turkey) and from Integrated RNA technologies 
(IDT; Leuven, Belgium). The list of the primers, the expected product sizes and the 
primer efficiencies were given in Table 3.1.  
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Table 3. 1 List of primer pairs and the primer efficiencies of used in the experiments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.3 Antibodies 
 
The phospho-p70S6 kinase (Thr 386) primary antibody, p70S6 kinase primary 
antibody and HRP-conjugated secondary antibody was obtained from Cell Signaling 
Technology (Danvers, MA, USA). Mcm7 primary antibody was purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA) and α -Tubulin was purchased from 
Calbiochem (Darmstadt, Germany). Horseradish peroxidase (HRP)-conjugated goat 
anti-mouse secondary antibody was obtained from Sigma (St. Louis, MO, USA). 
 
3.1.4 Western Blotting materials 
 
The protein transfer materials, Immobilen P transfer (PVDF) membrane was 
from Roche (Germany) and 3mm filter paper was from Whatman International Ltd. 
(Madison, WI, USA). 
Gene 
Name 
Forward primer (5’-3’) Reverse primer (5’-3’) 
Primer 
Efficiency 
mybl2 CCCACACTGAAGGAGGTGAT CTCCTTTACTGCCCTTGCTG 1.89 
pcna AGCCTGTCATCTGTGGGATT TGGTAAAGCTAAGGCCCAAA 1.85 
mcm7 GAGATTTACGGCCATGAGGA GGTGTACTGACTGCGTGGAG 2 
tyms TGCTAACGGCTCCAGAGAGT CATGATGATCCTTCGGTCCT 1.86 
ctgf ACCAATGACAACCGTGAGTG GGTAGTGGTACAGCCGGAAA 1.78 
ef1a CCCTGGACACAGAGACTTCA CAGCCTCAAACTCACCAACA 1.81 
foxm1   GACACATGACCCTGAAGGAGA AGAGTGAGACAGCGGTTTGC 1.9 
pah TGTGGGTATCGTGAGGACAA GGAGCTGTGGCGAATGTACT 1.75 
cyp26b1 CAACACGGGACAAGAGCTG CCCATAAGAACCTTACGCACA 1.92 
tagln2 GCTGGTACAGTGGATCGTCA TGGATCTTCTTCACAGGCTTT 1.98 
ddc CCTGCCTGTACGGAGCTAGA CTGGATCAGCCTGACGATTT 1.85 
bambia TTTGCATGACCTCACACACC CGGAACCACACCTCTTTAGC 1.91 
dkk1b CGCTATTAAAGTCGGTTCAGG TTGCACTGGAGACAGACACC 1.89 
wif1  CAGACTCTGCGTTCTTTGGA GGATGGTCACCTCAAATGCT 1.86 
mmp9 CAAGACATTCGACGGAGACC TGCTTTCCCGAAAGAGATCA 2 
b2m TTCTTTGTCTGCTGTACATCACTG TGCTTGGTGTCCGACATAAC 1.95 
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The protein detection kits, ECL+ Western Blot Detection Kit and SuperSignal 
West Femto were purchased from Amersham GE Healthcare Life and Sciences 
(Buckinghamshire, UK) and Thermo Scientific (Northumberland, UK), respectively. 
Protein size marker, PageRuler Prestained protein ladder was obtained from MBI 
Fermentas (Ontario, Canada).  
 
 
3.1.5 Photography, spectrophotometer and autoradiography  
 
The Kodak (Rochester, NY, USA) films were used for the autoradiography of 
the proteins and were developed by Hyperprocessor (Amsderdam, UK). The protein 
concentration was measured by Beckman Du640 Spectrophotometer from Backman 
Instruments (Fullerton, CA, USA). Nucleic acid concentrations were measured by 
Nanodrop ND-1000 Spectrophotometer from Thermo Fisher Scientific (Wilmington, 
DE, USA). Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) 
was used to assess the RNA quality for microarray analysis. μQuant™ Microplate 
Spectrophotometer was used to measure ELISA based MTT assay (BioTek, 
Winooski, VT, USA). Digital fluorescent microscopy images of BrdU assays were 
obtained from Zeiss, AX10 Imager A1 (Germany). The zebrafish embryo images were 
taken with Leica MZ16FA Stereo microscope (Solms, Germany). 
 
 
3.1.6 Kits 
 
Total RNA was isolated using SV total RNA isolation kit (Promega, Madison, 
WI, USA) and used for both microarray analysis and real time RT-PCR analysis. The 
cDNA synthesized by using RevertAid first strand cDNA synthesis kit (MBI 
Fermentas, Ontario, Canada) and for the cDNA amplification the DyNAmo HS 
SYBR-green kit (Finnzymes, Espoo, Finland) was used. Vybrant MTT Cell 
Proliferation Assay Kit was purchased from Molecular Probes (Darmstadt, Germany). 
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3.1.7 Cell lines and Tissue culture reagents 
 
ZF4, zebrafish embryonic fibroblast cell line was purchased from ATCC 
(Manassas, VA, USA). D-MEM/F-12 (1:1), FBS (fetal bovine serum), 
Penicillin/Streptomycin (10,000 U/mL Penicillin, 10,000 μg/mL Streptomycin) and 
trypsin without EDTA were supplied from HyClone (Logan, UT, USA). 
 
 
3.1.8 Microarray 
Affymetrix zebrafish GeneChips (Affymetrix, Santa Clara, CA) were used for 
microrray analysis. 
 
 
3.2 General Solutions and Media. 
 
 
3.2.1 Cell culture solutions 
 
 
D-MEM/F-12 medium: D-MEM/F-12 (1:1) was supplemented with 10% FBS 
and 1% Penicillin/Streptomycin. Stored at 4ºC, warmed to room temperature prior to 
use. Serum starvation medium was prepared as follows; D-MEM/F-12 (1:1) was 
supplemented with 0%, 0.1%, 1% or 3% FBS with 1% Penicillin/Streptomycin. 
Stored at 4ºC, warmed to room temperature prior to use.  
 
Rapamycin solution: Powder rapamycin was dissolved in DMSO to prepare 5 
mM final concentration of stock solution. For cell culture treatments, 5 mM 
rapamycin was mixed with complete media to make 100 nM working concentration. 
For cell culture expreriments the final concentration of DMSO in culture medium is 
0.002%.  For in vivo rapamycin treatments, 5 mM rapamycin was mixed with embryo 
medium to make 400 nM, 2 µM, 10 µM and 20 µM working concentration and for in 
vivo experiments final concentration of DMSO in embryo medium are 0.008%, 
0.04%, 0.2% and 0.4%, respectively. 
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PBS stock solution (10X): 80g NaCl, 2g KCl, 11.5g Na2HPO4.7H2O, and 2g 
KH2PO4 dissolved in ddH2O to a final concentration of 1 liter.  
 
PBS Working solution (1XPBS): 10X PBS was diluted to 1X with ddH2O. 
pH was adjusted to 7.4. 
 
Freezing solution: 5% DMSO and 95% complete media were mixed and used 
freshly. 
 
 
3.2.2 Cell proliferation solutions 
 
5-bromo-2-deoxyuridine (BrdU) staining stock solution: Powder BrdU was 
dissolved in ddH2O to prepare 10 mg/ml stock concentration.  
 
BrdU staining working solution: 9.2 µl BrdU from stock solution was mixed 
with 10 ml complete media (30 µM). 
 
4',6-diamidino-2-phenylindole (DAPI): Powder DAPI was dissolved in dd 
H2O to prepare 0.1-1 µg/ml working solution. 
 
3-(4,5-dimethylthiazole-2-yl)-2.5-diphenyltetrazolium bromide (MTT) 
solution: Each vial of powder MTT was dissolved in 1 ml 1X PBS to prepare working 
solution.  
 
 
3.2.3 Cell cycle analysis solution 
 
Propidium Iodide (PI) staining solution: 50 µg/ml PI, 0.1 mg/ml RNase A 
and 0.05% TritonX-100 were mixed in 1 ml 1X PBS to prepare working solution. 
 
 
 28 
3.2.4 Western Blotting solutions 
 
NP40 lysis Buffer: 50 mM Tris.Cl pH: 8.0, 150 mM NaCl, 1% NP-40 and 1X 
protease inhibitor mix was mixed in ddH2O. 
 
Bradford Working Solution: 10 mg powder Coomassie brilliant blue was 
dissolved in 10 ml 85% phosphoric acid-5 ml 95% ethanol mix and completed to 1 
liter with ddH2O. Filtered with whatman paper. Stored in dark at +4ºC. 
 
Cracking Buffer (2X protein loading buffer):  50 mM Tris.HCl at pH 6.8, 2 
mM EDTA at pH 6.8, 1% SDS, 10% glycerol and 0.02% Bromophenol blue was 
mixed and 1% Beta-mercaptoethanol was added prior to use. 
 
1.5 M Tris-HCl (PH: 8.8): 54.45 g Tris base was dissolved in 150 ml ddH2O. 
After PH was adjusted with 1N HCl, the volume is completed to 300 ml with ddH2O. 
Stored at +4ºC. 
 
1 M Tris-HCl (PH: 6.8): 12 g Tris base was dissolved in 60 ml ddH2O. After 
PH was adjusted with 1N HCl, the volume is completed to 100 ml with ddH2O. 
Stored at +4ºC. 
 
10% SDS: 10 g SDS was dissolved in 100 ml ddH2O.  
 
30% Acrylamide solution: 145 g acrylamide and 5 g bisacrylamide were 
dissolved in 500 ml ddH2O and filtered. Stored in dark at +4ºC. 
 
10% APS: 0.15 g APS was dissolved in 1 ml of ddH2O to prior to use. 
 
5X Running Buffer: 15 g Tris.base, 95 g glycine and 50 ml 10% SDS were 
mixed in ddH2O to a final volume of 1 liter. 
 
Semi-dry Transfer Buffer: 2.5 gr Glycine, 5.8 gr Tris base, 3.7 ml 10% SDS 
and 200 ml MeOH were mixed in ddH2O to a final volume of 1 liter. 
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TBS stock solution (10XTBS): 12.19 g Tris base, 87.76 g NaCl were 
dissolved in ddH2O to a final volume of 1 liter. pH was adjusted to 8.  
 
TBS working solution (1XTBS):  10X TBS was diluted to 1X with ddH2O.  
TBS-T: 0.1% Tween 20 was dissolved in 1X TBS. 
 
Blocking Solution: 5 g powder non-fat milk was dissolved in 100 ml 0.1% 
TBS-T.  
 
 
3.3 Methods 
 
 
3.3.1 General Methods 
 
 
3.3.1.1 Total RNA extraction 
 
Total RNA were isolated from ZF4 cells for quantitative assessment of gene 
expression, microarray analyses and following confirmatory real-time qRT-PCRs. 
Cells were trypsinized and centrifuged at 1200 rpm for 3 min. The medium was 
aspirated before washing with ice-cold PBS. The PBS was aspirated and cells were 
snap frozen in liquid nitrogen and stored at -80 ºC for later use. Total RNA was 
isolated using SV total RNA isolation kit according to the manufacturer’s 
recommendations (Promega, Madison, WI, USA) and used for both microarray 
analysis and real-time qRT-PCR analysis. The RNA concentration was assessed with 
the NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, 
DE, USA) at a ratio of absorbance at 260 nm to 280 nm. The integrity of the RNA 
samples for microarray analysis was measured by Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA, USA). RNA samples were stored in -80ºC. 
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3.3.1.2 cDNA synthesis 
 
First-stand cDNA synthesis was performed with Revert Aid First strand cDNA 
synthesis kit according to manufacturer’s instructions (MBI Fermentas, Ontario, 
Canada).  
 
 
3.3.1.3 Real-time qRT-PCR analysis 
 
 
3.3.1.3.1 Primer design 
 
Primers used in real-time qRT-PCR experiments were designed by using 
Primer 3 v.0.4.0 (http://frodo.wi.mit.edu) and purchased from Iontek (Istanbul, 
Turkey) and Integrated RNA technologies (IDT; Leuven, Belgium). Intron spanning 
primers were designed from consecutive exons. Gene specificity was assured with 
blasting primer sequences in zebrafish genome by using ENSEMBL 
(http://www.ensembl.org/Multi/blastview). The primer sequences used in serum 
starvation/replenishment and rapamycin microarray confirmation studies was 
presented in Table 3.1. 
 
3.3.1.3.2 Real-time qRT-PCR 
 
The real-time qRT-PCR analysis was performed with primer pairs 
supplemented in Table 3.1 to identify the effect of serum fluctuations or rapamycin 
on the expression of selected gene sets. The real-time qRT-PCR analysis was 
performed using DyNAmo HS SYBR-green kit (Finnzymes, Espoo, Finland) on 
iCycler (Bio-Rad, Hercules, CA, USA) thermocycler. For each amplification 10 μl 
SYBR Green Mix (2X), 20 pmol/μl forward and reverse primers (0.5 μl each) and 8 μl 
autoclaved ddH2O was mixed and completed with 1 μl (1:5 diluted) cDNA template to 
20 μl qPRC mix. For avoiding evaporation 10 μl mineral oil was added to cover the 
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surface of the PCR mix. The amplification conditions were as follows; 10 min at 
95ºC; 45 cycles of 30s of 95 ºC, 30s of 62 ºC (for tyms, mcm7 and mybl2) or 60 ºC 
(for ctgf, pcna, ef1a, b2m, mmp9, cyp26b1, ddc, dkk1b, pah, tagln2, foxm1, bambia, 
wif1), 30s of 72 ºC and final extension at 72 ºC for 10 min. Real-time qRT-PCR runs 
of each gene was performed with biological and technical duplicates for serum 
starvation/replenishment experiments, while three biological replicates and two 
technical duplicates were applied for rapamycin experiment samples. The iCycler iQ 
Optical System Software (version 3.021, BioRad, Hercules, CA, USA) provides the 
melting curves and the threshold cycles of the runs. The melting curves were used to 
assure a single product was obtained for each sample and the threshold cycle (Ct) was 
used to calculate the expression change of the selected genes. The expression changes 
were calculated with an efficiency method; a modified formula of 2
-ΔΔCt  
(Pfaffl, 
2001), in which the expressions of selected genes were normalized according to the 
expression of the housekeeping genes and the mean of the expressions of control 
samples. The following formula was used to calculate the expression change of 
selected genes; 
 
 (Etarget) 
ΔCtTarget (control-sample)
/ (Eref) 
ΔCtReference (control-sample)
 
 
The 10-fold serial cDNA dilutions for each primer pair was used for the 
detection of primer efficiency (E). The formula to calculate the primer efficiencies is; 
 
E=10
 [-1/slope of the dilution curve]
 
 
The reference control genes were observed as the least changed genes from the 
test conditions. For serum fluctuations ef1a and for rapamycin treatments b2m were 
used as reference genes (McCurley and Callard, 2008). 
 
 
3.3.1.4 Protein Extraction, Detection and Western Blotting 
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3.3.1.4.1 Protein extraction from tissue culture cells 
 
The cells were collected in the falcon tubes by trypsinization. After removal of 
culture media, cell pellets washed with ice-cold 1XPBS. 1XPBS were disposed after 
centrifugation at 1200 rpm for 3 min at 4
o
C. The cell pellets were immediately frozen 
by liquid nitrogen and stored at -80
o
C for later use.  
 
For protein extraction cell pellets in falcons were placed in ice. NP40 lysis 
buffer (please see in 3.2.4) was prepared and added, 4-5 volumes of cell pellets, on top 
of the cell pellets in the falcon tubes. The cells were lysed by vortexing at every 5 min 
for half an hour on ice. The lysates were centrifuged at 13000 rpm for 30 min at +4
o
C. 
The supernatant was transferred in a fresh tube and stored at -80
o
C for later use. 
 
 
3.3.1.4.2 Quantification of protein concentrations 
 
The protein concentrations were detected with Bradford assay. Bradford 
solution was prepared as explained in section 3.2.5. The protein concentrations were 
calculated by comparing the absorbance values of cell lysates with the known BSA 
standard curve concentrations (absorbance vs. BSA concentration). The BSA stock 
was prepared fresh by dissolving 1 mg BSA in 1 ml of ddH2O to make 1mg/ml BSA. 
The different BSA concentrations were prepared according to Table 3.2. The OD595 
λm values were obtained and plotted on a standard curve graph. 2 μl of each protein 
sample were mixed with the 900 μl of Bradford working solution and the volume 
completed to 1 ml with the 98 μl of ddH2O. The blank was prepared by mixing 2μl of 
NP40-lysis buffer with the 900 μl of Bradford working solution and 98 μl of ddH2O. 
The protein concentrations were measured at OD595 λm and calculated by using the 
BSA standard curve. 
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Table 3. 2 BSA dilutions for standard curve preparation. 
 
Sample 1 2 3 4 5 6 7 
Bradford  
solution(μl) 
900 900 900 900 900 900 900 
BSA (1mg/ml)  
(μl) 
0 1 2 4 8 16 32 
ddH2O (μl) 100 99 98 96 92 84 68 
 
 
 
3.3.1.4.3 Western Blotting 
 
SDS polyacrylamide gel electrophoresis: 5% Stacking gel and 10% or 15% 
separating gel according to protein size were prepared as follows: 
 
5% stacking gel; 
 
dH2O   5.5 ml 
30% Acrylamide mix 1.3 ml 
1.0 M Tris, pH=6.8 1 ml 
10% SDS   80 μl 
10% APS   80 μl 
TEMED   8 μl 
 
10% separating gel; 
 
dH2O   5.9 ml 
30% Acrylamide mix 5  ml 
1.5 M Tris, pH=8.8 3.8 ml 
10% SDS   150 μl 
10% APS   150 μl 
TEMED   6 μl 
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An equal amount of proteins from each sample was obtained and mixed with 
cracking buffer containing 1% β-mercaptoethanol to complete the volume to 20 μl. 
Proteins were denaturated by boiling in the water for 5 min. Before loading on the 
gel, proteins were centrifuged. Fermentas PageRuler Protein size marker was also 
loaded on the gel to follow the proteins. Proteins were run at 80V during the stacking 
gel and 120V during the separating gel. According to the protein size to be detected, 
runs were terminated.  
 
Transferring proteins to PVDF membrane: The proteins were transferred 
from gel to membrane by a semi-dry transfer process for phospho-p70S6 kinase and 
p70S6 kinase protein level analyses or by wet-transfer for mcm7 and alpha-tubulin. 
PVDF membrane was cut slightly larger than the expected gel size. Before incubation 
in semi-dry transfer buffer, the membrane was placed into 100% methanol for 30 
seconds, then transferred into ddH2O and incubated for 2 min by vigorously shaking. 
4 whatman papers were cut as the same size of the membrane and placed into the 
semi-dry transfer buffer. Before transfer the gel was washed with ddH2O and waited 
in semi-dry transfer buffer. For the transfer a sandwich of 2 whatman papers, the 
membrane and the gel and the rest of the 2 Whatmans were stacked. Transfer was 
performed at 160mA for 30-45 min.  
 
The immunological detection of transferred proteins: After the transfer the 
membrane was washed with 1XTBS-T for 5 min. Membrane was blocked in 5% non-
fat blocking solution for 1 h with gentle agitation. After blocking, the membrane was 
extensively washed for 3X15 min with 1XTBS-T. The primary antibody solutions 
were prepared by adding the recommended antibody concentrations in 5% BSA 
added TBS-T. After overnight primary antibody incubation at 4ºC, the membrane was 
washed for 3X15 min with 1XTBS-T. Secondary antibodies were prepared in 5% 
non-fat blocking solution according to the recommended antibody concentrations. 
After 1h secondary antibody incubation at room temperature, membrane washed for 
3X15 min with 1XTBS-T. Then the membrane was treated with ECL+ western blot 
detection kit for 5 min. To detect the chemiluminescence, the membrane was exposed 
to X-ray films.   
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3.3.2 Cell Culture techniques 
 
 
3.3.2.1 Cell lines 
 
Zebrafish embryonic fibroblast cells, ZF4 (ATCC, CRL-2050), were derived 
from 1-day-old zebrafish embryos (Driever and Rangini, 1993). ZF4 cells are adherent 
fibroblast cells.  
 
 
3.3.2.2 Cell line maintenance  
 
ZF4 cells were grown in D-MEM/F-12 (1:1) including 10% FBS and 1% 
Penicillin/Streptomycin at 28ºC with no air. Medium was changed every 3 to 4 days 
depending on the level of confluency. For subculturing, the growth medium was 
aspirated and the cells were washed with 1XPBS twice before trypsin solution was 
added to the flasks. After the cells were detached from the surface of the flasks, the 
fresh medium was added. The cells were transferred to tubes and centrifuged at 1200 
rpm for 3 min. The medium was aspirated and the cells were dispersed in fresh 
medium and separated into new flasks. The culture media and PBS were kept at 4 ºC; 
trypsin was kept at -20 ºC. All the solutions were warmed to room temperature for 
ZF4 cells before use.   
 
 
3.3.2.3 Cryopreservation of cell lines 
 
The exponentially growing cells were pelleted after trypsinization and re-
suspended with freezing medium. The cryotubes were stored at -80 ºC overnight and 
transferred to the liquid nitrogen tank for long term storage. Freezing medium for ZF4 
cells is a complete growth medium supplemented with 5% (v/v) DMSO as suggested 
by ATCC (http://www.atcc.org). The frozen cells were re-cultured after thawing the 
cells at RT. The incompletely thawed cells were mixed with fresh growth medium in a 
larger tube and centrifuged at 1500 rpm for 5 minutes at room temperature. The 
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medium was aspirated and the cells were re-suspended with fresh complete growth 
medium and plated. 
 
 
3.3.2.4 Serum starvation/replenishment experiments 
 
Serum-starvation experiments were performed by plating 3 X 10
6
 ZF4 cells in 
75-T flasks for 24 h followed by the addition of media containing a pre-determined 
amount of FBS (i.e., 0%, 1%, 3% and 10%). For serum-replenishment experiments, 
ZF4 cells at a density of 3.75 X 10
6 
in 150-T flasks were incubated for 24 and 48 h 
with 0.1% or 10% FBS-containing media and 24 h serum-starved cells were re-
incubated with 10% FBS media for another 24 h. For 6 h serum-replenishment 
experiments, ZF4 cells at a density of 3 X 10
6 
in 75-T flasks were incubated for 24 h 
with 0.1% FBS-containing media and then re-incubated with 0.1% or 10% FBS-
containing media for 6 h. Cells were counted following trypsin (without EDTA; 
HyClone, Logan, UT, USA) treatment with hemocytometer and cell pellets were 
preserved in liquid nitrogen until later use. 
 
 
3.3.2.5 Rapamycin treatment experiments 
 
For microarray experiments, 5.5 X 10
6 
ZF4 cells were cultured in 150-T flasks 
in triplicates. Cells were treated with 100 nM final concentration of rapamycin 
(Calbiochem, Darmstadt, Germany) and DMSO as control for two days before 
collection and counting of cells. 5 X 10
6
 cells were used for RNA isolation for 
microarray studies. To confirm the microarray data by real-time qRT-PCR analysis an 
independent set of rapamycin treatment experiment was used. For rapamycin 
treatment experiments, 5 X 10
6
 ZF4 were seeded in 75-T flasks in triplicates; and cells 
were incubated with 100 nM final concentration of rapamycin or equivalent of DMSO 
for 6 or 48 h before collection for ZF4. Cells were counted following trypsin (without 
EDTA; HyClone, Logan, UT, USA) treatment with hemocytometer and cell pellets 
were preserved in liquid nitrogen until later use.  
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3.3.3 MTT Assay  
 
For different serum levels; 0%, 1%, 3% and 10% FBS treatment, 2 X 104ZF4 cells 
were incubated in triplicates for 24 h in 96-well microplates. For rapamycin experiments 2 
X 104 ZF4 cells were treated with 100 nM rapamycin or equivalent of DMSO for 48 h. 
MTT (3-(4,5-dimethylthiazole-2-yl)-2.5-diphenyltetrazolium bromide) assay was 
performed according to the manufacturer’s protocols (Vybrant MTT Cell Proliferation 
Assay Kit, Molecular Probes, V-13154, Germany). MTT, reduced to an insoluble 
formazan dye by mitochondrial enzymes associated with metabolic activity, provides a 
reliable cellular assay for predicting viable cells (Mosmann, 1983). The MTT experiment 
performed by adding 10 µl MTT solution to 100 µl treatment medium, 4 h before the end 
of the treatment duration. ZF4 cells were incubated in the 28 ºC incubator for 4 h with 
MTT solution. The cell culture medium including MTT solution was removed by 
inverting the plate in order to avoid cell loss. 50 µl DMSO was added to each well. After 
1-2 min DMSO was mixed gently and incubated for 10 min. The absorbancy at 540 nm 
was read with μQuant™ Microplate Spectrophotometer (BioTek, Winooski, VT). The 
results from triplicate measurements were normalized to the blanks and averaged. 
 
 
3.3.4 BrdU Assay 
 
 BrdU (5-bromo-2-deoxyuridine) staining was performed to estimate the effect 
of test conditions on cell proliferation. BrdU is a synthetic analog of tymidine and 
incorporated in DNA of proliferating cells during DNA replication. Therefore, BrdU 
incorporation is used to detect the proliferating cells. For serum 
starvation/replenishment experiments 5 X 10
4 
ZF4 cells were cultured in 6-well plates 
and serum starved for 48 h with 0.1% FBS including media. Serum replenishment was 
performed with treating 24 h serum starved cell with complete media for another 24 h. 
For rapamycin treatments 5 X 10
4 
ZF4 cells were cultured in 6-well plates and treated 
with 100 nM rapamycin or DMSO for 48 h. For BrdU staining cells were incubated 
with 30 µM BrdU for 24h and then fixed with 70% ice cold ethanol for 10 min. After 
fixation, cells were treated with 2N HCl for 20 min. Prior to incubation with an α-
BrdU antibody (1:500 in 2% FBS in PBS; Dako, Denmark) for 1 h, cell were blocked 
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with 10% FBS/PBS for 1 h. After α-BrdU antibody, cells were incubated with α -
mouse secondary antibody (1:750 in 2% FBS; Invitrogen, Carlsbad, CA, USA) for 1 h 
at RT. DAPI staining was used as counterstain to visualize all the nuclei. The digital 
fluorescent microscopy images were taken for all the samples using Zeiss, AX10 
Imager A1 (Germany). Multiple fields were counted, averaged and plotted. 
 
 
3.3.5 Cell Cycle Analysis 
 
The cell cycle analysis of serum starvation/replenishment samples were 
performed by seeding 3 X 10
6
 ZF4 cells in 100 mm petri dishes. For serum starvation 
experiments cells were treated either with 0.1 % or with 10% FBS including media for 
24 and 48 h. For serum replenishment experiments 24 h serum starved cells in 0.1% 
FBS including media were treated with 10% FBS including media for another 24 h. 
The cell cycle analysis of 100 nM rapamycin treated ZF4 cells was performed by 
culturing 5 X 10
5 
ZF4 cells in 6-well petri plates. ZF4 cells were treated with 100 nM 
rapamycin, DMSO including media or culture media for 48 h at 28ºC. After 
treatments, cells were fixed in a 70% EtOH/PBS solution for 15 min on ice. The 
propidum iodide staining was carried out by incubating cells with PI staining solution 
(a final concentration of 50μg/ml PI, and 100μg/ml RnaseA in PBS) at 37ºC in dark 
for 40 min. Propidium iodide staining is used to detect the percent cell numbers at 
each cell cycle stage (Krishan, 1975). For rapamycin experiments attached and non-
attched cells were collected, however for serum starvation/replenishment experiments 
only attached cells were collected for the cell cycle analysis. For serum 
starvation/replenishment samples, 3 X 10
4
 cells and for rapamycin treated samples, 1 X 
10
4
 cells were analyzed by Becton Dickson FACScalibur (USA).  
 
 
3.3.6 Cell Death Detection Analysis 
 
 
The effect of rapamycin on apoptosis was detected with Cell Death Detection 
ELISA
PLUS 
(CDD, Roche, Germany). In principle, CDD assay specifically detects 
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mono and oligonucleasomes (histone-associated DNA fragments) in the cell lysate. 2 
X 10
4
 ZF4 cells were cultured in 96 well plates, treated with 100nM rapamycin or 
equivalent of DMSO or culture media for 48 h at 28ºC. Cell lysates were prepared and 
placed into the streptavidin-coated plates provided with the kit. Cell lysates incubated 
with an immunoreagent composed of anti-histon biotin together with anti-DNA-POD 
(anti-DNA peroxidase) for 2 h at RT. Anti-histone biotin antibody binds to 
streptavidin-coated plates and captures the nucleosomes by their histones, while anti-
DNA-POD binds to DNA in the nucleasomes. The anti-histone recognizes the H1, 
H2A, H2B, H3, and H4 histones from several species. After washing, the ABTS 
solution, the substrate, was added and the absorbancy was assessed with µQuant™ 
Microplate Spectrophotometer (BioTek, Winooski, VT) at 405 nm using 490 nm as 
reference.  
 
 
3.3.7 Microarray Analysis 
 
 
3.3.7.1 The assessment of quantity and quality of RNA 
 
For microarray analysis, 3 rapamycin and 2 DMSO (vehicle control) RNA 
samples were prepared as explained in section 3.3.2.5. Before hybridization on chips, 
the quantity and quality of total RNAs were assessed by using Agilent 2100 
BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). The RIN values and 
rRNA ratios [28s/18s] were supplemented in Table 4.1. After hybridization on chips, 
the quality of RNAs were assessed by using the using the affy (Gautier et al., 2004) 
and affyPLM (Bolstad, 2005; Brettschneider, 2007) packages of Bioconductor 
(Gentleman et al., 2004) in the R 2.10.1 (http://cran.t-project.org). 
 
 
3.3.7.2 Amplification, hybridization and scanning 
 
The Affymetrix zebrafish GeneChips (Affymetrix, Santa Clara, CA, USA; 
http:www.affymetrix.com/products/arrays/specific/zebrafish.affx) were used for 
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microarray analysis. The total RNA conversion to complementary DNA (cDNA) 
(Superscript II kit; Invitrogen, Carlsbad, CA, USA), the in vitro transcription to 
biotin-labeled cRNA (antisense RNA) and the following cRNA fragmentation 
(Ambion, Austin, TX, USA) and lastly hybridization to Affymetrix zebrafish 
GeneChips were performed under the supervision of Dr. Hilal Ozdag from Ankara 
University, Ankara. The results were quantified using a GeneChip scanner 
(Affymetrix, Santa Clara, CA, USA). 
 
 
3.3.7.3 Quality control of the arrays 
 
The quality control of arrays was assessed using the affy (Gautier et al., 2004) 
and affyPLM (Bolstad, 2005; Brettschneider, 2007) packages of Bioconductor 
(Gentleman et al., 2004) in the R 2.10.1 (http://cran.t-project.org). The two methods in 
affyPLM package, Relative Log Expression (RLE) and the Normalized Unscaled 
Standard Error (NUSE) methods were used to evaluate the CEL files. 
 
 
3.3.7.4 Normalization  
 
The CEL files were converted to gene expression values by BRB-Array tools 
version 3.8.0 (http://linus.ncbi.nih.gov/BRB-ArrayTools.html; developed by Dr. 
Richard Simon and the BRB-ArrayTools Development Team). The data were 
normalized using the RMA normalization (Robust multiple array normalization) 
(Bolstad et al., 2003; Irizarry et al., 2003) with background correction, quantile 
normalization and calculating the expression values using median-polish algorithms. 
 
 
3.3.7.5 Obtaining differentially expressed genes 
 
The differentially expressed genes in response to rapamycin treatment were 
identified by using the Class Comparison Tools of BRB-array tools; the significance 
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threshold value was set to p=0.05. Univariate tests were performed to select the 
differentially expressed genes between groups giving the p-values, FDRs and fold 
changes of the significant genes. The upregulated and downregulated probe sets in 
response to rapamycin exposure in the differentially expressed gene set were also 
marked by class comparison tool.  
 
3.3.7.6 Gene Ontology analyses 
 
The gene ontology (GO) terms for biological process (BP), molecular function 
(MF) and cellular component (CC) analysis and KEGG pathway analysis for the 
upregulated and downregulated probesets were performed using Fisher’s exact test in 
DAVID (Dennis et al., 2003; Huang da et al., 2009).  
 
 
3.3.8 Phylogenetic analysis of E2F pathway genes 
 
The evolutionary conservation of selected E2F target genes within different 
species was assessed with phylogenetic analysis. The protein sequences of Pcna, 
Mybl2, Tyms, Mcm7 and Ctgf for different species were extracted from NCBI 
(http://www.ncbi.nlm.nih.gov/) and ENSEMBL (http://www.ensembl.org/index.html) 
databases. The amino acid sequences were aligned using Clustal W (Thompson et al., 
1994). MEGA version 4 (Tamura et al., 2007) was used to generate the bootstrapped 
neighbor-joining phylogenetic trees. The species and their abbreviations used in trees 
were as follows: human (Hs), rat (Rn), mouse (Mm), chicken (Gg), cow (Bt), salmon 
(Ss), stickleback (Ga), green spotted puffer fish (Tn), zebrafish (Dr), western clawed 
frog (Xt), fugu (Tr) and medaka (Ol). The amino acid sequences used in generating 
trees were supplemented in Table 3.3.  
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Table 3. 3 Amino acid sequences used to generate phylogenetic trees 
 
Pcna protein seq.  Accession Number 
rat  NP_071776.1 
mouse  NP_035175.1 
human  NP_002583.1 
chicken  NP_989501.1 
zebrafish  NP_571479.1 
western clawed frog NP_001007921.1 
cow  NP_001029666.1 
fugu  ENSTRUP00000036585 
medaka  ENSORLP00000003669 
stickleback  ENSGACP00000007613 
green spotted puffer fish  ENSTNIP00000018432 
Tyms protein seq.  Accession Number 
human  NP_001062.1 
rat  NP_062052.1 
mouse  NP_067263.1 
zebrafish  NP_571835.1 
western clawed frog  NP_001072852.1 
fugu  ENSTRUP00000004951 
stickleback  ENSGACP00000005414 
medaka, transcript 1  ENSORLP00000013876 
medaka, transcript 2 ENSORLP00000013877 
Mybl2 protein seq.  Accession Number 
mouse  NP_032678.1 
human  NP_002457.1 
rat NP_001100006.1 
zebrafish NP_001003867.2 
chicken  NP_990649.1 
cow  NP_001068916.1 
medaka  ENSORLP00000014540 
stickleback, grXII ENSGACP00000008012 
stickleback, grXVII ENSGACP00000014242 
green spotted puffer fish, ch9 ENSTNIP00000004055 
green spotted puffer fish, ch11 ENSTNIP00000010146 
Mcm7 protein seq. Accession Number 
human isoform 1 NP_005907.3 
human isoform 2 NP_877577.1 
mouse NP_032594.1 
western clawed frog NP_998877.1 
rat  NP_001004203.3 
zebrafish   NP_997734.1 
cow  NP_001020516.2 
fugu  ENSTRUP00000037145 
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medaka  ENSORLP00000000656 
stickleback  ENSGACP00000021654 
green spotted puffer fish  ENSTNIP00000018801 
Ctgf protein seq. Accession Number 
mouse  NP_034347.2 
rat  NP_071602.1 
human  NP_001892.1 
chicken  NP_989605.1 
zebrafish  NP_001015041.1 
western clawed frog NP_001015042.1 
cow  NP_776455.1 
salmon  NP_001133471.1 
fugu  ENSTRUP00000034594 
green spotted puffer fish ENSTNIP00000013889 
medaka, transcript 1 ENSORLP00000022627 
medaka, transcript 2 ENSORLP00000022629 
medaka, transcript 3 ENSORLP00000022630 
 
 
3.3.9 In vivo Zebrafish embryo experiments 
 
 
3.3.9.1 Zebrafish embryo strain 
The in vivo rapamycin experiments were performed with the Tupfel long fin 
(TLF, previous name; Tuebingen long fin), a wild type zebrafish strain, having 
homozygous mutations for leo
t1
 and lof
dt2
. leo
t1
 gene mutation is recessive and cause 
spotting in adult fish. lof
dt2
 mutation is dominant homozygous and results in long fins 
(http://zfin.org). 
 
3.3.9.2 Rapamycin treatment to zebrafish embryo 
 
Shield stage healthy zebrafish embryos were collected and transferred into 96-
well plates, each well contained 3 embryos. At this point, a final concentration of 2 
µM, 10 µM and 20 µM rapamycin or equivalent of DMSO was added to embryo 
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medium. Zebrafish embryos were collected at 1, 2, 3, 4 and 5 dpf (days post 
fertilization) for further examination.  
 
 
3.3.9.3 Morphological measurements  
 
Zebrafish embryos were visualized with Leica MZ16FA Stereo microscope. 
The body length of rapamycin or vehicle (DMSO) treated zebrafish embryos at 
indicated time points were assessed with Image-J (version 1.38) in millimeters.  
 
 
3.3.9.4 Histological examinations of intestinal system 
 
Zebrafish embryos were treated with 400 nM rapamycin or equivalent of 
DMSO for 8 days in 96-well plates. 8 dpf rapamycin or DMSO treated embryos were 
collected and fixed in 4% PFA (paraformaldehyde)/PBS for 1h at RT; washed twice in 
PBS each for 5 min; and incubated in 20% sucrose/PBS overnight at 4ºC.  Zebrafish 
embryos were taken out from the sucrose and placed in plastic molds (Molding Cups, 
Polysciences Inc., Eppelheim, Germany) and the sucrose was cleaned out of the 
embryos. Embryos were covered with Tissue Tek (O.C.T. Compound, Plano, Wetzlar, 
Germany) in sagital orientation. Embryo containing molds were placed on dry ice for 
about 20 min to harden Tissue Tek. The plastic molds were removed and 10-12 µm 
sections were cut. The pieces were placed on to a slide and leaved at RT to dry.  
 
 
3.3.9.5 Hematoxylen-eosin staining 
 
Cryosectioned samples were stained with hematoxylen and eosin to visualize 
the tissues. The slides were stained with Hayer’s hematoxylen (Sigma, St. Louis, MO, 
U.S.A) for 2 min and washed 5 min under the tap water; and stained with eosin 
(Sigma, St. Louis, MO, U.S.A) for 1 min and washed with H2O. Before being 
incubated with 100% EtOH, slides were treated with first 70% EtOH and later 96% 
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EtOH. At last slides were treated with xylol or Poti-histol for 5 min. The sections on 
slides were covered with entalan and coverslips were placed on the sections; left 
overnight to dry; and visualized by Leica DC500 High-resolution Digital Camera 
System (Cambridge, UK). 
 
 
3.3.9.6 Alcian blue staining 
 
Zebrafish embryos were treated with 10 µM rapamycin or DMSO for 5 and 6 
days. Embryos were collected and fixed in 4% PFA overnight at 4ºC. Removed from 
the PFA and transferred to 70% EtOH for 10 min. Embryos were stained overnight 
with 0.1 mg Alcian blue in 0.1 N HCl at RT. After staining, embryos were rinsed in 
H2OT (tap water with 0.1% Tween-20) twice for 5 min. The pigmentation was 
removed by bleaching the embryos in solution containing 10 µl 30% H2O2 and 100 µl 
10% KOH in 890 µl H2OT for 30 min at 37ºC; and washed twice in H2OT for 5 min. 
Embryos were rinsed with 300 µl saturated borate in 600 µl H2OT. The tissues 
covering the cartilage were removed by digestion with 0.25 mg/ml trypsin and 300 µl 
saturated borate in 600 µl H2OT for 30 min; and again washed twice in H2OT for 5 
min. Then they were rinsed in 25% glycerol/75% H2O. Zebrafish were transferred to 
50% glycerol/50% H2O and then to 75% glycerol/25% H2O. Embryos were stored at 
RT or 4ºC.  
 
 
3.3.10 Statistical Analyses 
 
The Minitab software release 13.20 (Minitab Inc., State College, PA, USA) 
was used to analyze the significance of real-time qRT-PCR, MTT, BrdU and PI 
staining results. One-way ANOVA test with Fisher’s pairwise comparisons was 
performed to analyze dose effect in serum starvation or replenishment samples. Two-
way ANOVA test was used to test the significance between dose and time effect in 
serum replenishment (between 24 and 48 h) and rapamycin treatments (between 6 and 
24 h). General linear model was performed to detect the significance of in vivo 
zebrafish experiments; dose and exposure time dependent rapamycin effect on body 
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length was assessed. The graphs were generated by GraphPad Prism 5 software 
(GraphPad Software, San Diego, CA, USA). 
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Chapter 4. RESULTS 
 
4.1 The effect of serum starvation/replenishment on ZF4 cells 
 
 
4.1.1 Cell viability analysis of serum starved/replenished ZF4 cells 
 
The MTT, cell viability assay was performed in order to assess the effect of 24, 
30 and 48 h serum starvation on ZF4 cells. The recovery of the living cell number 
after 6 and 24 h serum replenishment following 24 h serum starvation was also 
investigated with MTT assay. 
 
4.1.1.1 Cell viability analysis of serum-starved ZF4 cells 
 
The effect of serum starvation on viable cell number was assessed by treating 
ZF4 cells with reducing serum concentrations for 24 h. MTT analysis reflected the 
decrease in the number of the living cells as the serum concentration in the media 
decreases (Figure 4.1).  
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Figure 4. 1 MTT analysis of ZF4 cells treated with 0%, 1%, 3% and 10% FBS supplemented media for 
24 h. Pair-wise analysis was performed according to Fisher’s multiple comparisons in One-way 
ANOVA (One-way ANOVA; p≤0.001 for % FBS, a, b, c represents the significance at p≤0.05 from 
10%, 3%, and 1% FBS, respectively). 
 
 
4.1.1.2 Cell number counts of the ZF4 cells used for dose-serum response real-
time qRT-PCRs 
 
 The cell numbers of ZF4 cells used for dose-dependent serum starvation 
experiments were counted after tyrpsinization. As explained in the Materials- Methods 
section of this thesis, 3 X 10
6
 ZF4 cells were treated with pre-determined amount of 
FBS (i.e., 0%, 1%, 3% and 10%) for 24 h, in duplicates, in order to detect the serum 
dose-dependency of ZF4 cells. After treatments, cells were collected and counted to 
observe the concordance with the MTT analysis and attached cell numbers (Figure 
4.2). The numbers of the cells used for serum starvation real-time qRT-PCRs were 
highly correlated with MTT results (Figure 4.1). 
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Figure 4. 2 Cell counts of ZF4 cells used for real-time qRT-PCR analysis. ZF4 cells were treated with 
variying doses (i.e., 0%, 1%, 3% and 10%) of serum including media for 24 h, in duplicates. Cells were 
collected and counted with hemocytometer after trypsinization. The RNA extracts of these cells used 
for real-time qRT-PCR analysis. 
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4.1.1.3 Cell viability analysis of serum replenished ZF4 cells 
 
The decrease in the viable cell number after serum starvation was reversible. 
Serum replenishment gradually increased the living ZF4 cells. The number of the 
viable cells after 6 h serum replenishment increased significantly (Figure 4.3-A). 
After 24 h serum replenishment the viable cell number was reached to the number of 
the control cells that were cultured in the 10% FBS including media (Figure 4.3-B).  
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Figure 4. 3 MTT analyses of 6 and 24 h serum replenished ZF4 cells (A) ZF4 cells were serum 
starved for 30 h with 0.1% FBS including media or serum starved for 24 h and replenished with culture 
media for 6 h. One-way ANOVA was performed to test the significance (One-way ANOVA; p≤0.001). 
(B) ZF4 cells were serum starved with 0.1% FBS including media for 48 h.  24 h serum replenishment 
was performed with culturing 24 h serum starved cells with culture media for another 24 h. One-way 
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ANOVA was performed to test the significance (One-way ANOVA; p≤0.001). * represents the 
significance at p≤0.05 according to Fisher’s multiple comparisons. 
 
 
4.1.1.4 Cell number counts of the ZF4 cells used for 24h serum replenishment 
real-time qRT-PCRs 
 
The cell numbers of ZF4 cells used for 24 h serum replenishment experiments 
were counted after tyrpsinization. The experitmental set up was explained in the 
Materials and Methods section. After treatments, cells were collected and counted to 
observe the concordance with the MTT analysis and attached cell numbers (Figure 
4.4).  
 
 
Figure 4. 4 Cell counts of ZF4 cells used for 24 h serum relplenishment real-time qRT-PCR. ZF4 cells 
were serum starved with 0.1% FBS including media for 24 or 48 h.  24 h serum replenishment was 
performed with culturing 24 h serum starved cells with culture media for another 24 h. Cells were 
collected and counted with hemocytometer after trypsinization. The RNA extracts of these cells used 
for real-time qRT-PCR analysis. 
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4.1.2 Cell proliferation analysis of serum starved/replenished ZF4 cells 
 
The MTT analysis revealed that serum starvation decreased the cell number in 
ZF4 cells, which was reversed after serum replenishment. To assess the proliferative 
capacity of the serum-starved/-replenished cells, BrdU staining was performed with 
the cells that were starved for 48 h, or starved for 24 h and cultured with serum 
containing media for another 24 h. The cells that were proliferating was significantly 
decreased after 48 h serum starvation, however serum replenishment increased the 
proliferating cell number (Figure 4.5-4.6).  
 
 
 
 
Figure 4. 5 Representative presentation of BrdU incorporation of serum replenished ZF4 cells. ZF4 
cells were either serum starved for 48 h in 0.1% FBS supplemented media or serum starved for 24 h 
and then incubated with 10% FBS including culture media for another 24 h; 24 h  serum replenishment 
(24h Rep.) group. BrdU incorporated nuclei were visualized as green stained and DAPI was used to 
stain the nuclei of viable cells. The magnification was 40x for all the figures and the scale bars marks 
the distance of 20 μm. 
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Our results were consistent with the previous reports. In a previous study with 
porcine fetal fibroblasts, serum starvation with 0.2% FCS decreased the percent BrdU 
positive cell number from 90% to 2% after 48 h of starvation. The percent BrdU 
positive cells were decreased as the time of starvation increases (Kues et al., 2000). In 
our study after 48h of starvation, percent BrdU positive cells were decreased from 
99% to 11%, and serum replenishment for 24 h following a 24 h starvation increased 
the proliferating cell number to 72% (Figure 4.6).  
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Figure 4. 6 BrdU incorporation of 24 h serum starved and then 24 h serum replenished (24h rep.) ZF4 
cells. The BrdU positive cells were corrected to DAPI stained nuclei for the multiple areas counted and 
the mean of percent cell number was plotted. One-way ANOVA was performed to test the significance 
with Fisher’s multiple comparisons (One-way ANOVA; p≤0.001). *indicates significance at p ≤ 0.05. 
 
 
4.1.3 Cell cycle analysis of serum starved/replenished ZF4 cells 
 
In order to detect the affect of serum starvation/replenishment in cell cycle 
status of ZF4 cells, we performed PI staining to detect the percentage of the cells at 
different cell cycle stages. Serum starvation causes an increase in G0/G1 phases and a 
decrease in the S and G2/M phases of the cell cycle in mammalian fibroblast cell lines 
(Bettuzzi et al., 1999; Goissis et al., 2007; Khammanit et al., 2008; Kues et al., 2000; 
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Vackova et al., 2003) which recovered by serum addition to culture media (Bettuzzi et 
al., 1999). The percentage of the cells at G0/G1 phase of the cell cycle significantly 
increased in both the 24 h and 48 h serum-starved ZF4 cells, while the percentage of 
the cells at S and G2/M phases decreased. The growth arrest caused by serum 
starvation was reversible; after serum addition to 24 h serum-starved ZF4 cells, the 
cell percentage at the S and G2/M phases increased significantly (Figure 4.7). This 
increase in S phase represents a synchronization event in ZF4 cells. 
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24h 
10% FBS 
24h 
0.1% FBS 
48h 
10% FBS 
48h 
0.1% FBS 
24h Rep. 
G0/G1 85.40 ± 0.12 91.48 ± 0.26*  85.24 ± 0.86 91.22 ± 0.02*  80.66 ± 0.28#*  
S 6.44 ± 0.60 2.25 ± 0.05*  5.90 ± 0.28 2.32 ± 0.42*  8.27 ± 0.24#*  
G2/M 8.35 ± 0.49 6.35 ± 0.21*  8.75 ± 1.04      6.28 ± 0.45   11.25 ± 0.11#  
 
Figure 4. 7 Cell cycle analysis of 24 and 48 h serum starved cells and 24 h serum starved and then 24 h 
serum replenished (24h Rep.) ZF4 cells. 3 X 10
6
 ZF4 cells were cultured in 100 mm petri dishes and 
serum starvation and replenishment was performed as for indicated time points. The mean percentage 
of cells at G0/G1, S, G2/M phases of cell cycle was presented with ± standard deviation. (One-way 
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ANOVA between 24 h 0.1%-10%; G0/G1, p=0.001; S, p=0.01; G2/M, p=0.034; between 48 h 0.1%-
10% and 24h replenishment; G0/G1, p=0.001; S, p=0.001; G2/M, p=0.011). * represents the significant 
difference from 10% FBS at p ≤ 0.05 at corresponding time points. # represents the significant 
difference from 0.1% FBS at 48 h time point. 
 
Since the confluency of the cells also affect the cell percentage at cell cycle 
phases (de Barros et al., 2010), we performed another cell cycle analysis with the ZF4 
cells seeded at low confluency (Figure 4.8). PI staining showed that when cells were 
seeded at a lower confluency, the percentage of the cells at the G0/G1 phase is less 
than cells seeded at higher confluency at 10% FBS group. However in the 24 h 0.1% 
FBS cultured group the difference at cell cycle phases were very similar to the cells 
cultured at a higher confluency (Figure 4.7-4.8).   
 
 
 
 
 24h 10% FBS 24h 0.1% FBS 
G0/G1 78.71 90.34 
S 9.90 1.72 
G2/M 11.58 7.98 
 
Figure 4. 8 Cell cycle analyses of 24 h starved ZF4 cells at low confluency. 1.5 X 10
6 
ZF4 cells were 
cultured in 100 mm petri dishes and serum starved with 0.1% FBS supplemented media for 24 h. The 
mean percentage of cells at G0/G1, S, G2/M phases of cell cycle was presented with ± standard 
deviation. At each event, 1 X 10
4
 cells were analyzed by Becton Dickinson FACScalibur. 
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4.1.4 The effect of serum starvation on translation 
 
 The effect of serum starvation on proteins synthesis was assessed by surveying 
the phospho-p70 S6 kinase protein levels in serum-starved ZF4 cells. Phosphorylation 
of p70 S6 kinase protein on Thr389 is a regulatory step in protein translation (Jefferies 
et al., 1997; Pullen and Thomas, 1997). Serum starvation decreased the 
phosphorylated p70 S6 kinase proteins in ZF4 cells, which represents the negative 
effect of serum starvation on protein translation (Figure 4.9). 
 
 
Figure 4. 9 The activity of phospho-p70S6 kinase in 24 h serum starved ZF4 cells. ZF4 cells were 
serum starved with 0%, 1% and 3% FBS including media. The phospho-p70 S6 kinase (Thr389) protein 
levels were investigated with western blot. The equal loading was tested with total p70 S6 kinase.  
 
 
4.2 The effect of serum starvation/replenishment on E2F target gene 
expression 
 
We selected the zebrafish orthologs of five known mammalian E2F target 
genes to study the molecular and functional conservation in zebrafish (Bracken et al., 
2004). The selected genes; pcna, mybl2, tyms, mcm7 and ctgf expression was 
investigated in serum-starved and -replenished ZF4 cells. The sequence conservation 
of selected genes was surveyed with phylogenetic analysis.  
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4.2.1 Pcna 
 
 The evolutionary conservation of Pcna was searched by comparing the amino 
acid sequences of Pcna in mammalian and fish species. The zebrafish Pcna sequence 
was closer to fish Pcna sequences, while mammalian, chicken and western clawed 
frog PCNA amino acid sequences were more similar (Figure 4.10). 
 
 Hs PCNA
 Bt PCNA
 Rn PCNA
 Mm PCNA
 Gg PCNA
 Xt Pcna
 Dr Pcna
 Ol Pcna
 Ga Pcna
 Tr Pcna
 Tn Pcna98
41
93
99
98
53
60
85
0.01  
 
Figure 4. 10 Phlyogenetic tree of Pcna protein sequence. Species; human (Hs), rat (Rn), mouse (Mm), 
chicken (Gg), cow (Bt), stickleback (Ga), green spotted puffer fish (Tn), zebrafish (Dr), western clawed 
frog (Xt), fugu (Tr) and medaka (Ol). Scale bar =0.01 substitutions per site. 
 
 
 As in their mammalian counterparts (Hurford et al., 1997; Liu et al., 1995), the 
zebrafish pcna expression decreased after 24 h of serum starvation. The gradual 
decrease in the expression was significant at 0% FBS treated cells (Figure 4.11).  
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Figure 4. 11 The real-time qRT-PCR results of pcna expression in serum starved cells for 24 h. ZF4 
cells were serum starved for 24 h with 0%, 1% or 3% FBS containing media. The fold change 
difference from 10% FBS control was calculated. The log2 based fold changes were plotted and used to 
test the significance by one-way ANOVA (pcna, p=0.077). 
a 
indicates the significance to 10% FBS at 
p≤0.05, b indicates the significance to 3% FBS at p≤0.05. 
 
 
 
Serum stimulation reversed the decrease in pcna expression. The expression of 
pcna was rescued starting from the 6 h serum stimulation (Figure 4.12) and after 24 h 
serum replenishment the pcna mRNA levels reached to the mRNA levels of control 
cells (Figure 4.13). 
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Figure 4. 12 The real-time qRT-PCR results of pcna expression in 24 h serum starved and then 6 h 
serum replenished ZF4 cells (6 h rep.). The real-time qRT-PCR results were normalized to the 30 h 
10%-FBS treatment. One-way ANOVA with Fisher’s multiple comparison results showed the 
significant changes between groups (One-way ANOVA; pcna, p=0.014). * represents significance at 
p≤0.05.  
 
 
According to two way ANOVA analysis, the decrease in pcna expression at 
0.1% FBS group was significant and independent of time (Figure 4.13, pcna, Two-
way ANOVA, Pdose = 0.001, Ptime = 0.276). 
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Figure 4. 13 The real-time qRT-PCR results of pcna expression in 24 h serum replenished ZF4 cells. 
The real-time qRT-PCR results were normalized to the 24 h 10%-FBS treatment values. One-way 
ANOVA results showed the significant changes between groups (One-way ANOVA; 24 h serum 
starvation, pcna, p=0.013; 48 h serum starvation and 24 h serum replenishment, pcna, p=0.005).  * 
represents significance at p≤0.05.  
 
 
4.2.2 Mybl2 
 
 The fish Mybl2 amino acid sequences were clustered together in the 
phylogenetic tree, while mammalian and chicken MYBL2 amino acid sequences 
formed another cluster (Figure 4.14). The protein product of the transcripts on 
chromosome 11 in green spotted puffer fish, and on group XVII in stickleback were 
more conserved than the products of the other transcripts (Figure 4.14). 
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 Mm MYBL2
 Rn MYBL2
 Hs MYBL2
 Bt MYBL2
 Gg MYBL2
 Dr Mybl2
 Ol Mybl2
 Ga Mybl2 gXVII
 Tn Mybl2 ch11
 Ga Mybl2 gXII
 Tn Mybl2 ch9
73
98
99
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0.05  
 
Figure 4. 14 Phlyogenetic tree of Mybl2 protein sequence. Species; human (Hs), rat (Rn), mouse 
(Mm), chicken (Gg), cow (Bt), stickleback (Ga), green spotted puffer fish (Tn), zebrafish (Dr) and 
medaka (Ol). Scale bar =0.05 substitutions per site. 
  
 
 Serum starvation caused a significant decrease in mybl2 mRNA expression as 
shown by real-time qRT-PCR analysis. The decrease was significant at both 1% and 
0% FBS treated cells but not in 3% FBS treated cells (Figure 4.15). 
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Figure 4. 15 The real-time qRT-PCR results of mybl2 expression in serum starved cells. The fold 
change difference from 10% FBS control was calculated. One-way ANOVA with Fisher’s multiple 
comparisons was performed to test the significance (mybl2, p≤0.001). a indicates the significance to 
10% FBS at p≤0.05, b indicates the significance to 3% FBS at p≤0.05, c indicates the significance to 1% 
FBS at p≤0.05. 
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 Serum stimulation for 6 and 24 h after 24 h of serum starvation increased the 
mybl2 expression to the basal levels (Figure 4.16-4.17).  
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Figure 4. 16 The real-time qRT-PCR results of mybl2 gene expression in 30 h serum starved and in 24 
h serum starved then 6 h serum replenished cells. The real-time qRT-PCR results were normalized to 
the 30 h 10%-FBS treatment. (One-way ANOVA; mybl2, p=0.001). * represents significance at p≤0.05.  
 
 
 
The decreased expression of mybl2 at 0.1% FBS treatment was significant and 
independent of time (Figure 4.17, Two-way ANOVA, mybl2, Pdose ≤ 0.001, Ptime = 
0.212).  
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Figure 4. 17 The real-time qRT-PCR results of mybl2 gene expression in 24 h serum replenished ZF4 
cells. The real-time qRT-PCR results were normalized to the 24 h 10%-FBS treatment. One-way 
ANOVA results showed the significant changes between groups (One-way ANOVA; 24 h serum 
starvation, mybl2, p=0.031; 24 h serum replenishment, mybl2, p≤0.001).  * represents significance at 
p≤0.05.  
 
 
 
4.2.3 Tyms 
 
 The mammalian TYMS proteins were more similar, thus they clustered 
together, while fish Tyms sequences were formed another branch in the phylogenetic 
tree (Figure 4.18). 
 
 
 Ol Tyms 1
 Ol Tyms 2
 Tr Tyms
 Ga Tyms
 Dr Tyms
 Xt Tyms
 Hs TYMS
 Rn TYMS
 Mm TYMS
100
99
100
99
72
58
0.02  
Figure 4. 18 Phlyogenetic tree of Tyms protein sequence. Species; human (Hs), rat (Rn), mouse (Mm), 
stickleback (Ga), zebrafish (Dr), western clawed frog (Xt), fugu (Tr) and medaka (Ol). Scale bar =0.02 
substitutions per site. 
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 Zebrafish tyms expression was serum responsive as in mouse fibroblast cells 
(Navalgund et al., 1980), serum starvation caused a significant decrease in tyms 
mRNA expression (Figure 4.19). Serum replenishment for 6 and 24 h increased the 
tyms mRNA expression in ZF4 cells (Figure 4.20-4.21) as in mouse cells (Saxena et 
al., 2009). The decrease in expression of tyms for 24 and 48 serum starved cells were 
significant and independent of time (Figure 4.21, Two-way ANOVA, tyms, Pdose = 
0.001, Ptime = 0.558). 
 
tyms
10% 3% 1% 0%
-6
-4
-2
0
2
ab
FBS treatment
F
o
ld
 c
h
a
n
g
e
 (
L
o
g
2
)
 
Figure 4. 19 The real-time qRT-PCR results of tyms expression in serum starved cells. The fold change 
difference from 10% FBS control was calculated (One-way ANOVA, tyms, p=0.024). 
a 
indicates the 
significance to 10% FBS at p≤0.05, b indicates the significance to 3% FBS at p≤0.05. 
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Figure 4. 20 The real-time qRT-PCR results of tyms gene expression in 6 h serum replenished ZF4 
cells.The real-time qRT-PCR results were normalized to the 30 h 10% FBS (One-way ANOVA; 6 h 
replenishment, tyms, p=0.011). * represents significance at p≤0.05.  
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Figure 4. 21 The real-time qRT-PCR results of tyms gene expression 24 h serum replenished ZF4 cells. 
The real-time qRT-PCR results were normalized to the 24 h 10% FBS treatment. The log2 based fold 
changes were calculated and plotted. One-way ANOVA results showed the significant changes between 
groups (24 h serum starvation, tyms, p=0.002; 24 h serum replenishment, tyms, p=0.03).  * represents 
significance at p≤0.05.  
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4.2.4 Mcm7  
 
The amino acid sequence of zebrafish Mcm7 was clustered together with fish 
counterparts (Figure 4.22).   
 
 Hs MCM7 1
 Hs MCM7 2
 Bt MCM7
 Mm MCM7
 Rn MCM7
 Xt Mcm7
 Dr Mcm7
 Ga Mcm7
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 Tr Mcm7
 Tn Mcm7
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Figure 4. 22 Phlyogenetic tree of Mcm7 protein sequence. Species; human (Hs), rat (Rn), mouse 
(Mm), cow (Bt), stickleback (Ga), green spotted puffer fish (Tn), zebrafish (Dr), western clawed frog 
(Xt), fugu (Tr) and medaka (Ol). Scale bar =0.02 substitutions per site. 
 
 
 Serum starvation caused a significant decrease in mcm7 mRNA expression. 
The decrease was significant at both 1% and 0% FBS treatment groups (Figure 4.23).   
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Figure 4. 23 The real-time qRT-PCR results of mcm7 expression in serum starved cells. The fold 
change difference from 10% FBS control was calculated (One-way ANOVA, mcm7, p=0.001). 
a 
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indicates the significance to 10% FBS at p≤0.05, b indicates the significance to 3% FBS at p≤0.05, c 
indicates the significance to 1% FBS at p≤0.05. 
 
 
 
 6 h serum stimulation following 24 h serum starvation did not rescue the mcm7 
expression according to the real-time qRT-PCR analysis, yet an increase in the mRNA 
levels was observed (Figure 4.24). 24 h serum stimulation significantly increased the 
mcm7 mRNA levels; the mcm7 expression after serum stimulation significantly 
exceeded the mcm7 expression in the 48 h 10% FBS treated control cells (Figure 
4.25).  
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Figure 4. 24 The real-time qRT-PCR results of mcm7 gene expression in 6 h serum replenished ZF4 
cells. The real-time qRT-PCR results were normalized to the 30 h 10% FBS treatment (One-way 
ANOVA; 6 h replenishment, mcm7, p=0.095). * represents significance at p≤0.05. 
 
 
 
According to two-way ANOVA analysis the decreased expression of mcm7 in 
24 and 48 h serum starved cells was significant and independent of time (Figure 4.25, 
Two-way ANOVA, mcm7,Pdose ≤ 0.001,Ptime = 0.576). 
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Figure 4. 25 The real-time qRT-PCR results of mcm7 gene expression in 24 h serum replenished ZF4 
cells.The real-time qRT-PCR results were normalized to the 24 h 10% FBS treatment values in 24 h 
replenishment samples. One-way ANOVA results showed the significant changes between groups (24 h 
serum starvation, mcm7, p=0.015; 24 h serum replenishment, mcm7, p≤0.001).  * represents 
significance at p≤0.05.  
   
 
 
 The serum response trend observed in mRNA levels was conserved also in the 
protein levels. Serum starvation decreased the Mcm7 protein, while serum 
replenishment increased the Mcm7 protein levels starting from the 6 h (Figure 4.26). 
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Figure 4. 26 Western Blot analysis of Mcm7 protein in response to serum starvation or replenishment. 
(A) Mcm7 protein levels in 24 h serum starved ZF4 cells. (B) Mcm7 protein in 24 and 48 h serum 
starved or 24 h serum starved and then 6 or 24 h serum replenished ZF4 cells.  
 
 
4.2.5 Ctgf 
 
The zebrafish Ctgf amino acid sequence was closer to salmon, and this group 
was clustered together with fish Ctgf amino acid sequences as the other selected E2F 
target genes (Figure 4.27). 
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Figure 4. 27 Phylogenetic tree of Ctgf protein sequence. Species; human (Hs), rat (Rn), mouse (Mm), 
chicken (Gg), cow (Bt), salmon (Ss), green spotted puffer fish (Tn), zebrafish (Dr), western clawed frog 
(Xt), fugu (Tr) and medaka (Ol). Scale bar =0.02 substitutions per site. 
 
 
 According to Fisher’s pair-wise comparisons ctgf expression gradually 
increased in cells cultured with 1% and 3% FBS including media in ZF4 cells (Figure 
4.28) as in human cells (Cam et al., 2004). A significant decrease in expression was 
observed at 0% FBS treated cells, yet the decrease was not significant between 0% 
FBS and 10% FBS treated cells (Figure 4.28). The response to serum starvation was 
time-dependent according to two-way ANOVA analysis, but significant at both 24 
and 48 h serum starved cells (Figure 4.30, ctgf, Pdose ≤ 0.001, Ptime = 0.01).  
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Figure 4. 28 The real-time qRT-PCR results of ctgf expression in serum starved cells.The fold change 
difference from 10% FBS control was calculated (One-way ANOVA, ctgf, p=0.013). 
a 
indicates the 
significance to 10% FBS at p≤0.05, b indicates the significance to 3% FBS at p≤0.05, c indicates the 
significance to 1% FBS at p≤0.05. 
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Figure 4. 29 The real-time qRT-PCR results of ctgf expression in 6 h serum replenished ZF4 cells. The 
real-time qRT-PCR results were normalized to the 30 h 10%-FBS treatment values in 6 h replenishment 
samples (One-way ANOVA; 6 h replenishment, ctgf, p=0.053). * represents significance in dose 
comparisons at p≤0.05. 
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Figure 4. 30 The real-time qRT-PCR results of ctgf gene expression in 24 h serum replenished ZF4 
cells. The real-time qRT-PCR results were normalized to the 24 h 10%-FBS treatment values in 24 h 
replenishment samples. The log2 based fold changes were calculated and plotted. One-way ANOVA 
results showed the significant changes between groups (24 h serum starvation, ctgf, p=0.028; 24 h 
serum replenishment, ctgf, p=0.007).  * represents significance in dose comparisons at p≤0.05. 
 
 
4.3 The effect of rapamycin treatment on ZF4 cells 
 
 
Previously, the effects of rapamycin on cell cycle, cell proliferation, cell 
viability and death have been searched in different organisms (Albers et al., 1993; 
Altomare et al., 2004; Decker et al., 2003; Gorshtein et al., 2009; Jimenez et al., 2009; 
Metcalfe et al., 1997; Ravikumar et al., 2006; Zinzalla et al., 2007). However, 
characterization of rapamycin effect on zebrafish cell lines has not been performed 
previously. Before analyzing the gene expression response by qRT-PCR to rapamycin 
exposure in ZF4 cells, we investigated the cellular response of ZF4 cells to rapamycin 
treatment. Cell viability after rapamycin treatment was assessed by MTT analysis. 
BrdU incorporation assay and PI staining were performed to test whether rapamycin 
caused cell cycle arrest in ZF4 cells. Rapamycin may arrest cells at G1 phase of the 
cell cycle, and cause a growth arrest, or cells may continue proliferating after 
rapamycin treatment (Altomare et al., 2004; Bell et al., 2003; Jimenez et al., 2009; 
Tirado et al., 2005). Previous studies also state the role of rapamycin on cell death and 
autophagy (Ravikumar et al., 2006; Tirado et al., 2005); we also detected a decrease in 
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apoptosis in rapamycin treated cells by CDD analysis and the cell number in subG1 
phase of cell cycle was lower as compared to DMSO (vehicle control).  
 
 
4.3.1 Cell viability analysis of rapamycin treated ZF4 cells 
 
According to MTT analysis, rapamycin treatment did not change the living cell 
number in ZF4 cells as compared to DMSO (vehicle) and culture media controls 
(Figure 4.31). 
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Figure 4. 31 MTT analyses of 100 nM rapamycin treated or control ZF4 cells. ZF4 cells were treated 
with 100 nM rapamycin or equivalent of DMSO (vehicle control) or 10% FBS including plain culture 
media for 48 h. One-way ANOVA was performed to test the significance (p=0.470). 
 
 
4.3.2 Cell proliferation analysis of rapamycin treated ZF4 cells 
 
 Rapamycin treatment has also no statistically significant effect on proliferating 
cell number in ZF4 cells although a decreasing trend was recorded (p = 0.141). After 
rapamycin treatment ZF4 cells continued entering S phase (Figure 4.32). 
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Figure 4. 32 BrdU staining of 100 nM rapamycin treated ZF4 cells. ZF4 cells were treated with 100 
nM rapamycin or equivalent of DMSO for 48 h. Percent BrdU positive cells were calculated by 
correcting BrdU positive cells to DAPI stained nuclei. One-way ANOVA was performed to test the 
significance (p=0.141). 
 
 
4.3.3 Cell Death Analysis of Rapamycin Treated ZF4 cells 
 
 In ZF4 cells, rapamycin treatment did not decrease the cell viability and 
proliferation (Figure 4.31-4.32). Interestingly, cell death detection analysis showed 
that rapamycin significantly decreased the basal apoptosis in ZF4 cells (Figure 4.33).  
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Figure 4. 33 Cell Death Detection (CDD) of rapamycin treated ZF4 cells. ZF4 cells were treated with 
100 nM rapamycin, DMSO or culture media for 48 h. One-way ANOVA with Fisher’s multiple 
comparisons were performed to test the significance (p=0.01). * represents significance at p≤0.05. 
 
 
4.3.4 Cell cycle analysis of rapamycin treated ZF4 cells 
 
Cell cycle analysis confirmed that rapamycin did not cause cell cycle arrest in 
ZF4 cells, since no significant increase was observed in G0/G1 phase as in BrdU 
analysis. Rapamycin treated cells entered S phase as in DMSO control. A decreasing 
trend in subG1 phase, indicating apoptotic cell population, was also detected in 
rapamycin treated samples (p = 0.394), although this decrease seemed statistically 
insignificant as a result of high variation in the rapamycin samples. As previously 
reported, rapamycin may reduce the basal apoptosis in cells (Zohlnhofer et al., 2004). 
CDD and cell cycle analysis of ZF4 cells in response to rapamycin treatment were 
also in the same direction with that previous report (Figure 4.33-4.34).  
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            DMSO      Rapamycin 
subG1 8.43 ± 1.97 5.67 ± 3.47  
G0/G1 79.22 ± 1.48 81.07 ± 3.05  
S 5.06 ± 0.81 5.03 ± 1.56  
G2/M 7.47 ± 1.19 8.41 ± 0.53  
 
Figure 4. 34 Cell cycle analyses of 48 h 100 nM rapamycin or equivalent of DMSO treated ZF4 cells. 
The mean percentage of cells at subG1, G0/G1, S and G2/M phases of cell cycle was presented with ± 
standard deviation. One-way ANOVA with Fisher’s multiple comparisons were made to test the 
significance. 
 
4.3.5 Cell number counts of ZF4 cells used in the microarray study 
 
Before performing the microarray study with ZF4 cells, ZF4 cells were treated 
with decreasing concentrations of rapamycin for 48 h and attached cells were counted 
with hemocytometer (Figure 4.35). The cells we used for counting were from the 
same passage lineage with the cells used in the microarray (passage15 for cell counts 
and passage 16 for microarray analysis); however, no MTT, BrdU, or PI analyses 
were performed with these ZF4 cells used in the microarray study. On the other hand, 
the assays reported in 4.3.1-4.3.4 in the above sections were performed on ZF4 cells 
from a later lineage.  
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Figure 4. 35 Attached cell number counts of rapamycin treated cells. 3 x 10
4 
ZF4 cells were seeded in 
24-well plates. After 24 h of culturing ZF4 cells were treated with 100, 10, 1 and 0.1 nM of rapamycin 
or equivalent of DMSO for 48 h.  
 
 
4.4 Transcriptome analysis of rapamycin exposed ZF4 cells 
 
 
The global gene expression response to rapamycin treatment was detected with 
high-throughput microarray analysis. ZF4 cells were treated with 100 nM rapamycin 
for 48 h and extracted RNA samples were used for microarray analysis.  
 
 
4.4.1The quality control of RNA samples 
 
 
The RNA integrity, rRNA Ratio (28s / 18s) and RNA concentrations were 
measured by using Agilent 2100 BioAnalyzer before hybridization. The high integrity 
of RNA is essential for proper analysis of gene expression in both microarray analysis 
and RT-PCR experiments and Agilent 2100 BioAnalyzer provides the RIN (RNA 
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integrity numbers) for the RNA samples. RIN values closer to 10 mean the RNA is 
intact for that sample (Schroeder et al., 2006). The RIN values of RNA samples for 
rapamycin and DMSO controls ranged between 8.7-9.1 and rRNA Ratio (28s / 18s) 
between 1.7-2, representing the high integrity of RNAs (Table 4.1). 
 
Table 4. 1 The experimental conditions, concentrations and RIN values of RNA 
samples used in the microarray experiments 
Sample Name Treatment 
Duration of 
Treatment 
Concentration 
of RNA 
rRNA Ratio 
[28s / 18s] 
RIN 
value 
1-1 rap rapamycin 48h 238 ng/μl 1.9 8.7 
2-1 rap rapamycin 48h 246 ng/μl 1.8 8.8 
1-3 rap rapamycin 48h 379 ng/μl 1.8 8.9 
1-2 dmso DMSO 48h 215 ng/μl 2.0 9.1 
1-4 dmso DMSO 48h 449 ng/μl 1.7 8.9 
 
 
 
After hybridization on chips, the quality of RNA and arrays were assessed by 
using affy and affyPLM packages of Bioconductor in R 2.10.1. 
 
Since RNA degradation starts at the 5’ end of the mRNA, the mean intensities 
of the probes at the 5’ end is lower. If the slope of the degradation plot is high, it 
means there is high degradation in mRNAs of that chip. If the ends of 5’ and 3’ are 
close, the slope of the plot is lower, meaning lower rate of degradation (Gautier et al., 
2004; Wilson et al., 2004). The slopes and appearance of the lines also should be 
similar among the experiments (Archer et al., 2006; Gautier et al., 2004). The RNA 
degradation plot for DMSO and rapamycin treated samples represented that there was 
no outlier among the chips, the pattern and the slopes of the chips were similar, and 
thus all the chips could further be analyzed (Figure 4.36). 
 
 77 
 
Figure 4. 36 The RNA degradation plot of the RNA samples used for the microarrays. This plot shows 
the mean intensities (shifted and scaled) from 5' to the 3' of the mRNA and each blue line represents a 
chip.  
 
 
4.4.2 The quality control of arrays 
 
The quality of the arrays was surveyed by using affyPLM package of 
Bioconductor. AffyPLM package was used to detect whether any chip in the 
experiment was problematic and should not be used for further analysis.  
 
RLE and NUSE are the two quality assessment tools of affyPLM package. In 
the microarray analysis, it is expected that only a small proportion of genes are 
affected by treatments and the rest of the genes remains unaffected. In the RLE plot, 
the RLE values are expected to be 0 or close to be 0. They indicate that any probe in 
any chip does not significantly deviate from the median value of that particular probe 
calculated based on all chips. 
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NUSE (Normalized Unscaled Standard Error) is another quality control 
measure found in affyPLM package. It is expected that median values of standard 
errors to be 1. If any chip is aberrant (median values, 1.05 or higher); then that chip 
might be excluded from the analysis (Jones et al., 2006).  
 
The RLE and NUSE plots of the chips used in the rapamycin microarray 
fulfilled the required criteria (Figure 4.37). 
 
 
Figure 4. 37 Relative Log Expression (RLE) and Normalized Unscaled Standard Error (NUSE) plots of 
the chips used in the experiment. 
 
 
4.4.3 Normalization 
 
The raw data were normalized in order to avoid the differences that arise from 
array handling, batches, labeling, rather than the biological ones. The expression 
values of each probe id were obtained upon RMA normalization (Irizarry et al., 2003). 
The medians of each array lined up similarly after normalization (Figure 4.38-4.40). 
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MVA plots before and after normalization also indicated that normalization helped 
standardize medians and the distribution of differences along the 0 midline (Figure 
4.39-4.41). 
 
 
 
Figure 4. 38 Boxplot presentation of the arrays before normalization (raw data). Each red box 
represents the range of the values from 50% of the probes in an array. The x axis shows the array 
numbers and the y axis is the log2 intensities of the arrays. 
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Figure 4. 39 MVA plots of the arrays before normalization. The log2 intensities of each array were 
compared to the median of log2 intensities of all arrays. It is expected that the distribution of the log 2 
intensities to be around 0 at M axis. 
 
 
 
Figure 4. 40 Boxplot presentation of the arrays after normalization. 
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Figure 4. 41 MVA plots of the arrays after normalization. 
 
 
 
4.4.4 Identification of differentially expressed genes after rapamycin exposure 
 
The differentially expressed genes between rapamycin and DMSO control 
were obtained with class comparison function of BRB array tools (p=0.05), which 
uses a random variance model for univariate tests and computes a p-value for each 
probe set (Wright and Simon, 2003). 2185 probe ids (i.e., 904 probe ids upregulated 
and 1281 probe ids downregulated, among 15.600 probe ids) were detected as 
significantly modulated between rapamycin and DMSO groups (Figure 4.39). We did 
not perform multiple test correction so that more genes could be included to identify 
functional clusters more efficiently. At a level p<0.05, a high number of probesets 
were identified as being affected by rapamycin, thus some of which are likely to be 
false posivites. However, in the literature, it states that high FDRs might be used for 
identification of pathways since strict p-values will lead to shrinkage of the gene lists 
(Gold et al., 2009). Furthermore, we plan on comparing differentially expressed genes 
from multiple studies for determining core pathways affected by rapamycin. However, 
we demonstrate herein that applying different parameters to detect significant gene 
lists provided different numbers of significant genes (Table 4.2). 
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Table 4. 2 The number of probe ids in different significance parameters 
 
Selected parameters 
Total number of 
probe ids 
The number of 
upregulated  
probe ids 
The number of 
downregulated 
probe ids 
p value= 0.05 2185 904 1281 
p value= 0.001 210 76 134 
max. proportion of 
FDRs=0.3 
CI%= 70% 
 
432 150 282 
max. proportion of 
FDRs=0.3 
CI%= 80% 
 
30 12 18 
max. proportion of 
FDRs=0.5 
CI%= 70% 
 
432 150 282 
max. proportion of 
FDRs=0.5 
CI%= 80% 
 
156 59 97 
fold change=2 48 25 23 
fold change=1.5 353 174 179 
CI, confidence interval which gives the confidence level of false discovery rates; max. allowed 
proportion of FDRs, maximum allowed proportion of false-positive genes. 
 
A cluster analysis performed with Cluster program (Eisen et al., 1998) and 
visualized by JavaTreeview (Saldanha, 2004) showed that rapamycin and DMSO 
samples were grouped together within their class although there existed more 
variability among the rapamycin treated samples (Figure 4.42). 
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Figure 4. 42 Cluster presentation of the differentially expressed genes. According to class comparison 
analysis of BRB array tools, 2185 genes were identified as differentially expressed between rapamycin 
and DMSO groups (p=0.05).  
 
 
4.4.5 KEGG pathway analysis of differentially expressed genes 
 
 The functional analysis of the differentially expressed genes was performed 
with DAVID (Dennis et al., 2003; Huang da et al., 2009). According to KEGG 
pathway results, along with other genes, upregulated genes coded for the ribosomal 
proteins, while downregulated genes coded for the subunits of proteasome (Table 4.3-
4.4). The downregulation of the genes coding for proteasomal subunits were 
consistent with the previous reports showing a similar pattern (Grolleau et al., 2002). 
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Table 4. 3 The KEGG results from DAVID of upregulated genes with rapamycin 
treatment 
 
Term p-value Benjamini Zebrafish Array  
Affy id 
Gene Name 
Ribosome 1,8E-5 2,6E-2 Dr.4091.1.S1_at ribosomal protein l8 
   Dr.17536.2.S1_a_at ribosomal protein l3 
   Dr.876.1.S1_at ribosomal protein l5a 
   Dr.15443.2.S1_at ribosomal protein l10a 
   Dr.1338.1.S1_at ribosomal protein l28-like 
   Dr.14110.1.A1_at zgc:73262 
   Dr.1208.1.S1_at chromosome 15 open reading frame 15 (h. 
sapiens) 
   Dr.1324.1.S1_at ribosomal protein s5 
   Dr.24671.1.S1_at ribosomal protein l27 
   Dr.18282.2.S1_at ribosomal protein s7 
 
Table 4. 4 The KEGG results from DAVID of downregulated genes with rapamycin 
treatment 
 
Term p-value Benjamini Zebrafish Array  
Affy id 
Gene Name 
Proteasome 4,7E-4 5,2E-2 Dr.11843.1.S1_at proteasome (prosome, macropain) subunit, 
beta type, 6 
   Dr.3054.1.A1_at proteasome (prosome, macropain) 26s 
subunit, atpase, 4 
   Dr.15385.1.S1_at zgc:110330 
   Dr.10120.1.S1_at proteasome (prosome, macropain) subunit, 
alpha type, 6b 
   Dr.786.1.S1_at proteasome (prosome, macropain) subunit, 
alpha type, 2 
   Dr.10596.1.S1_at proteasome (prosome, macropain) subunit, 
alpha type, 4 
   Dr.1375.1.S1_at proteasome (prosome, macropain) 26s 
subunit, atpase, 1a 
   Dr.20627.1.S1_at proteasome (prosome, macropain) subunit, 
beta type, 5 
   Dr.15038.1.S1_at proteasome (prosome, macropain) subunit, 
beta type, 1 
   Dr.20156.1.S1_at proteasome (prosome, macropain) subunit, 
alpha type,5 
   Dr.5594.1.S1_at proteasome (prosome, macropain) subunit, 
beta type, 3 
   Dr.9622.1.S1_at zgc:92726 
   Dr.3143.1.S1_at proteasome (prosome, macropain) 26s 
subunit, atpase, 3 
 
 
 
4.4.6 Gene Ontology analysis of differentially expressed genes 
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The upregulated genes were predominantly located in the intracellular non-
membrane-bound organelles and ribosome (according to CC), and were involved in 
gene expression and translation, regionalization and pattern specification (according to 
BP), and functioned in nucleic acid binding and as structural constituents of ribosome 
(according to MF) (Table 4.5-4.6-4.7).  
 
The downregulated genes by rapamycin were mainly located in the cytoplasm, 
chromosome, endoplasmic reticulum, proteasome and mitochondrion (according to 
CC), had roles in catabolic and metabolic processes, DNA damage and repair 
response (according to BP), and functioned in oxidoreductase and ion- or cation-
transporter activity (according to MF) (Table 4.5-4.6-4.7). 
 
 
 
Table 4. 5 The Gene Ontology (GO) results for cellular component (CC) category of 
up and down genes after rapamycin treatment (DAVID). 
 
 
Category  
(for up genes 
in rapamycin) 
Term Gene Count P-Value  Benjamini 
CC intracellular non-membrane-bound organelle 40 3,3E-6 6,9E-4 
CC non-membrane-bound organelle 40 3,3E-6 6,9E-4 
CC ribosome 17 2.0E-5 2.7E-3 
     
Category (for 
down genes in 
rapa) 
Term Gene Count P-Value  Benjamini 
CC cytoplasmic part 102 8,7E-11 3,6E-8 
CC cytoplasm 136 4,9E-10 1,0E-7 
CC intracellular part 236 3,3E-9 4,6E-7 
CC cytosol 22 9,1E-8 9,4E-6 
CC intracellular organelle part 67 4,9E-7 3,4E-5 
CC organelle part 67 4,9E-7 3,4E-5 
CC proteasome core complex (sensu Eukaryota) 11 8,0E-7 4,7E-5 
CC proteasome complex (sensu Eukaryota) 11 1,9E-6 1,0E-4 
CC intracellular 257 2,3E-6 1,1E-4 
CC endoplasmic reticulum 25 2,3E-6 1,1E-4 
CC intracellular organelle 178 2,7E-5 1,0E-3 
CC organelle 178 2,8E-5 9,8E-4 
CC intracellular membrane-bound organelle 153 1,9E-4 6,0E-3 
CC membrane-bound organelle 153 1,9E-4 6,0E-3 
CC intracellular non-membrane-bound organelle 48 2,4E-4 6,6E-3 
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CC non-membrane-bound organelle 48 2,4E-4 6,6E-3 
CC mitochondrion 25 4,7E-4 1,1E-2 
CC chromosome 17 1,1E-3 2,6E-2 
CC envelope 17 1,5E-3 3,3E-2 
 
 
 
 
 
Table 4. 6 The Gene Ontology (GO) results for biological process (BP) category of up 
and down genes after rapamycin treatment (DAVID). 
 
 
Category  
(for up genes 
in rapamycin) 
Term Gene Count P-Value  Benjamini 
BP regionalization 19 1,2E-6 2,6E-3 
BP gene expression 84 1,6E-6 1,8E-3 
BP translation 23 3,1E-5 2,3E-2 
BP pattern specification process 19 5,8E-5 3,2E-2 
BP regulation of biological process 85 8,4E-5 3,7E-2 
     
Category  
(for down 
genes in 
rapamycin) 
Term Gene Count P-Value  Benjamini 
BP catabolic process   48 3,4E-11 7,8E-8 
BP macromolecule catabolic process 38 2,8E-10 3,2E-7 
BP cellular catabolic process 38 4,0E-10 3,0E-7 
BP cellular macromolecule catabolic process 28 3,6E-9 2,0E-6 
BP metabolic process 346 6,2E-8 2,8E-5 
BP intracellular transport 38 1,2E-6 4,4E-4 
BP protein catabolic process   23 1,6E-6 5,2E-4 
BP cellular localization 41 2,2E-6 6,4E-4 
BP coenzyme metabolic process 24 6,1E-6 1,5E-3 
BP biopolymer catabolic process 24 6,1E-6 1,5E-3 
BP alcohol catabolic process 15 8,7E-6 1,8E-3 
BP hexose metabolic process 17 1,2E-5 2,2E-3 
BP monosaccharide metabolic process 17 1,4E-5 2,5E-3 
BP glucose metabolic process 15 1,4E-5 2,3E-3 
BP hexose catabolic process 14 1,7E-5 2,5E-3 
BP monosaccharide catabolic process 14 1,7E-5 2,5E-3 
BP glucose catabolic process 14 1,7E-5 2,5E-3 
BP cellular carbohydrate catabolic process 15 1,8E-5 2,3E-3 
BP DNA metabolic process 35 1,9E-5 2,3E-3 
BP establishment of cellular localization 38 2,1E-5 2,4E-3 
BP carbohydrate catabolic process 15 3,5E-5 3,8E-3 
BP carboxylic acid metabolic process 28 6,8E-5 7,0E-3 
BP organic acid metabolic process 28 6,8E-5 7,0E-3 
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BP response to stress 30 9,3E-5 8,8E-3 
BP modification-dependent protein catabolic 
process 
13 1,0E-4 9,1E-3 
BP ubiquitin-dependent protein catabolic process 13 1,0E-4 9,1E-3 
BP cellular protein catabolic process 13 1,0E-4 9,1E-3 
BP modification-dependent macromolecule 
catabolic process 
13 1,0E-4 9,1E-3 
BP proteolysis involved in cellular protein 
catabolic process 
13 1,0E-4 9,1E-3 
BP cellular carbohydrate metabolic process 21 1,3E-4 1,0E-2 
BP cofactor metabolic process 31 1,7E-4 1,2E-2 
BP response to DNA damage stimulus 16 2,0E-4 1,4E-2 
BP coenzyme biosynthetic process 18 2,1E-4 1,5E-2 
BP protein localization 36 2,3E-4 1,5E-2 
BP generation of precursor metabolites and 
energy 
38 2,4E-4 1,5E-2 
BP alcohol metabolic process 18 2,4E-4 1,5E-2 
BP macromolecule localization 36 2,5E-4 1,5E-2 
BP glycolysis 11 3,2E-4 1,9E-2 
BP microtubule-based movement 11 3,9E-4 2,3E-2 
BP cytoskeleton-dependent intracellular 
transport 
11 3,9E-4 2,3E-2 
BP DNA repair 15 4,3E-4 2,3E-2 
BP carbohydrate metabolic process 29 4,9E-4 2,6E-2 
  
 
 
 
 
 
 
Table 4. 7 The Gene Ontology (GO) results for molecular function (MF) category of 
up and down genes after rapamycin treatment (DAVID).   
 
Category (for 
up genes in 
rapa) 
Term Gene Count P-Value  Benjamini 
MF nucleic acid binding 103 3,5E-6 4,7E-3 
MF structural constituent of ribosome 17 1,1E-5 7,3E-3 
     
Category (for 
down genes in 
rapa) 
Term Gene Count P-Value  Benjamini 
MF catalytic activity 300 2,4E-17 3,3E-14 
MF oxidoreductase activity 77 2,7E-10 1,8E-7 
MF threonine endopeptidase activity 11 1,4E-6 6,3E-4 
MF hydrogen ion transmembrane transporter 
activity 
17 4,9E-6 1,7E-3 
MF carbon-carbon lyase activity 12 1,9E-5 5,2E-3 
MF monovalent inorganic cation transmembrane 
transporter activity 
17 3,3E-5 7,7E-3 
 
MF inorganic cation transmembrane transporter 
activity 
21 4,0E-5 7,7E-3 
MF lyase activity 19 9,8E-5 1,6E-2 
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4.4.7 Confirmation of microarray results 
 
4.4.7.1 Selection of genes 
 
In order to confirm microarray results we prepared another experimental set-up 
with ZF4 cells, in which ZF4 cells were treated with 100 nM rapamycin or DMSO for 
48 h as in the microarray analysis and we added an additional treatment time point, 6 
h, to visualize time dependent response of the genes to rapamycin. In this experiment, 
ZF4 cells were from a later passage than those used for the rapamycin microarray 
experiment. We selected 9 genes, 7 of them were upregulated and 2 of them were 
downregulated by rapamycin treatment, for real-time qRT-PCR confirmations (Table 
4.8). The genes that were selected for confirmation were among the genes which have 
high fold change differences, low p-values and FDRs. 
 
 
4.4.7.2 Real-time qRT-PCR confirmation 
 
Of the 9 genes, we confirmed five; among these four were upregulated (Figure 
4.44) and one was downregulated (Figure 4.46-A). These genes were ddc, cyp26b1, 
dkk1b, wif1, and pah, respectively. Although, only 5 genes were confirmed by real-
time qRT-PCR analysis, the log2 fold changes of all the selected genes were highly 
correlated and tend to behave in the same direction given the high Pearson correlation 
coefficient (0.791) (Figure 4.43). Since the qRT-PCR experiment was performed with 
a different batch of ZF4 cells from a later passage than those used for microarray 
studies, the inability to detect significant differential expression for bambia, foxm1, 
tagln2, and mmp9 suggests that there might be batch effects. 
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Table 4. 8 Log2 fold change ratios of microarray and real-time qRT-PCR results of 
selected genes. 
Gene 
Symbol 
Microarray Real-time qRT-PCR 
  
Probe id 
Log2 fold 
change 
p-
value 
FDR 
Log2 fold 
change at 48 
hours 
p-value 
One-way 
ANOVA 
ddc 
Dr.26319.1.A1_at 1.11 ≤0.001 0.01 
0.93 0.004 
Dr.861.1.S1_at 0.81 ≤0.001 0.03 
cyp26b1 
 
Dr.180.1.A1_at 1.05 ≤0.001 0.03 
1.62 0.001 
DrAffx.2.62.S1_at 0.83 ≤0.001 0.03 
Dr.26342.1.A1_at 1.09 ≤0.001 0.06 
Dr.180.2.A1_at 0.69 0.01 0.2 
pah Dr.4171.1.A1_at -1.34 ≤0.001 0.01 -1.08 0.004 
dkk1b Dr.8056.1.S1_at 1.98 ≤0.001 0.01 3.40 ≤0.001 
wif1 Dr.3690.1.S1_at 0.98 ≤0.001 0.01 0.92 0.003 
bambia Dr.7919.1.S1_at 1.18 ≤0.001 0.03 0.55 0.153 
foxm1 Dr.17623.1.S1_at -1.14 ≤0.001 0.01 -0.45 0.129 
tagln2 Dr.2363.1.S1_at 0.62 ≤0.001 0.04 0.43 0.166 
mmp9 Dr.967.1.S1_at 1.46 ≤0.001 0.01 0.20 0.412 
 
 
 
Figure 4. 43 The correlation between microarray and real-time qRT-PCR results for selected genes. 
The Pearson correlation coefficient was calculated in Minitab (The Pearson correlation coefficient= 
0.791 and P Value = 0.011). 
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Figure 4. 44 The selected genes for confirmation that were significantly upregulated by rapamycin in 
real-time qRT-PCR analysis. (A-D) ZF4 cells treated with 100 nM rapamycin or equivalent of DMSO 
either for 6 or 48 h. The data was normalized to 48 h DMSO treatment. The log2 based fold changes 
were plotted and used to test the significance by two-way ANOVA to test the significance between 
treatment and time (Two-way ANOVA, ddc, ptreatment= 0.022, ptime≤0.001; dkk1b, ptreatment≤0.001, 
ptime=0.004; cyp26b1, ptreatment=0.008, ptime=0.039; wif1, ptreatment=0.004, ptime=0.039). * represents the 
significant response to rapamycin and 
# 
represents the significant difference between 6-48h.  
 91 
 
 
Figure 4. 45 The genes whose expressions were detected as upregulated by microarray analysis, but 
cannot be confirmed by real-time qRT-PCR analysis. (A-C) ZF4 cells treated with 100 nM rapamycin 
or equivalent of DMSO either for 6 or 48 h. The data was normalized to 48h DMSO treatment. The 
log2 based fold changes were plotted and used to test the significance by two-way ANOVA to test the 
significance between treatment and time (Two-way ANOVA, bambia, ptreatment= 0.420, ptime=0.362; 
tagln2, ptreatment=0.482, ptime=0.972; mmp9, ptreatment=0.765, ptime≤0.001). 
# 
represents the significant 
difference between 6-48 h. 
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Figure 4. 46 The selected genes for confirmation that were downregulated by rapamycin in real-time 
qRT-PCR analysis. (A-B) ZF4 cells treated with 100 nM rapamycin or equivalent of DMSO either for 6 
or 48 h. The data was normalized to 48 h DMSO treatment. The log2 based fold changes were plotted 
and used to test the significance by two-way ANOVA to test the significance between treatment and 
time (Two-way ANOVA, pah, ptreatment≤0.001, ptime=0.884; foxm1, ptreatment=0.098, ptime=0.010). * 
represents the significant response to rapamycin and 
# 
represents the significant difference between 6-48 
h. 
 
 
 
4.4.8 The effect of rapamycin on E2F target genes 
 
We have shown that E2F target genes, pcna, mybl2, tyms, mcm7 and ctgf were 
behaved in the similar direction to serum fluctuations as the mammalian homologs. In 
order to investigate whether pcna, mybl2, tyms, mcm7 and ctgf expressions also 
behave similarly with the mammalian counterparts in response to rapamycin, we 
extracted the expression profiles from our microarray analysis. According to 
microarray data only pcna and mybl2 expression seemed to be affected from 
rapamycin, while the others were not responsive (Table 4.9). Previous studies showed 
that rapamycin treatment decreases the expression of mybl2 and pcna in mammalian 
cells (Javier et al., 1997; Law et al., 2002; Zohlnhofer et al., 2004) as in ZF4 cells.  
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Table 4. 9 The effect of rapamycin on E2F target gene expression based on ZF4 
microarray analysis. 
 
Gene 
Symbol 
Probe id 
Log2 fold 
change 
p-value FDR 
pcna Dr.1348.1.S1_at -0.36 ≤0.001 0.13 
mybl2 Dr.17421.1.A1_at -0.70 0.002 0.11 
tyms Dr.1047.1.S1_at -0.04 0.75 0.92 
mcm7 Dr.1055.1.S1_at -0.11 0.40 0.74 
ctgf Dr.10431.1.S1_at 0.53 0.11 0.48 
 
 
 
4.5 The effect of rapamycin on zebrafish embryo: in vivo studies 
 
 
4.5.1 Effect of rapamycin on zebrafish body development 
 
In order to observe the effect of rapamycin treatment on the development of 
zebrafish embryo, we treated zebrafish embryos with increasing doses of rapamycin 
for different time points. Our results suggested that rapamycin caused a significant 
delay in the development of the zebrafish embryo in a dose- and time- dependent 
manner (Figure 4.47-4.48). Rapamycin treated embryos morphologically had bigger 
yolks and shorter body size. The effect of rapamycin on body size was more apparent 
at 10 and 20 µM treatments, although 2 µM treatment also had significant effect on 
the body size (Figure 4.48).  
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Figure 4. 47 The effect of rapamycin treatment on zebrafish embryo development. (A-E) Shield stage 
zebrafish embryos were treated with 2 µM, 10 µM and 20 µM rapamycin or equivalent of DMSO and 
collected with indicated time points. All the treatments were performed with duplicates or triplicates. 
Scale bars marks the distance of 100 μm for all the pictures. 
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Figure 4. 48 The graphical presentation of time- and dose- dependent treatments. The lengths of the 
fish were measured from the tip of the head to the end of notochord in milimetres, averaged and plotted 
against the time of development. Whiskers represent the standard deviation among embryos. The 
ANOVA analysis for dose- and time- dependent response to rapamycin was performed to test the 
significance (General Linear Model; pdose≤0.001; ptime≤0.001, prapamycin≤0.001). 
 
 
 
Figure 4. 49 Representative presentation of measurements. The body length of the zebrafish was 
measured as shown in figures above from 2 to 5 dpf. The meaurements were performed using Image-J 
software. Since embryos at 1dpf were not completely flexed they were not used for analyzing the trend 
for body size. The start and end point of measurements were shown with a red line. Measurements were 
made from diencephalon to the tip of notochord at 2dpf; and from the tip of the snout to the tip of  
notochord at 3 dpf, 4 dpf  and 5 dpf.  
 
 
(A) (B) (C) 
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4.5.2 Effect of rapamycin on intestinal system 
 
Previously, Makky and colleagues have shown that rapamycin treatment 
caused a weak general developmental delay but mainly arrested digestive tract 
development at 400 nM (Makky et al., 2007). We also confirmed these results; 
zebrafish embryos were treated with 400 nM rapamycin, and at 8 dpf we observed an 
arrest in the digestive tract development (Figure 4.50). 
 
 
 
Figure 4. 50 The effect of rapamycin on digestive tract development. (A) DMSO embryos at 8 dpf 
cryosectioned and hematoxylin-eosin stained. The digestive tract formed properly. (B) 400 nM 
rapamycin treated 8 dpf embryos. Digestive tract formation was arrested. sb, swim bladder; g, gut; y, 
yolk. 
 
 
4.5.3 Effect of rapamycin on pigmentation 
 
 Rapamycin not only arrested general development, it also affected the 
pigmentation and cartilage development of zebrafish embryos. Neural crest cells give 
rise to cartilage components (Yelick and Schilling, 2002) and pigment cells in 
zebrafish (Parichy, 2006). 
 
The zebrafish have 3 kinds of pigments; black melanophores, yellow 
xanthophores and silver iridophores (Hirata et al., 2003; Parichy, 2006). Rapamycin 
particularly affected melanophores and iridophores. 
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4.5.3.1 Melanophore pigmentation delay in response to rapamycin treatment 
 
We observed an apparent reduction in the melanophore pigmentation of 
rapamycin treated embryos starting from 24 hpf to 5 dpf (Figure 4.47-51). 
Melanocytes seemed to fail migrating ventrally and slowed migration laterally. In 24 
hpf embryos treated with rapamycin, almost no pigmentation was observed for all the 
doses tested (Figure 4.47). The pigmentation was fainter from head to tail in the 
rapamycin treated embryos and the migration of melanocytes to the yolk and 
horizontal myoseptum was apparently delayed in the 2 and 3 dpf treatment groups. 
The delay of melanocyte migration to yolk and horizontal myoseptum persisted 
through the 4 and 5 dpf larvae (Figure 4.47). 
 
 
 
Figure 4. 51 The effect of rapamycin treatment on melanophore pigmentation at 4 dpf. Scale bars 
represent the distance of 100 μm for all the pictures. 
 
 
4.5.3.2 Iridophores in response to rapamycin treatment 
 
The iridophore pigmentation was also responsive to rapamycin treatment in the 
zebrafish embryo. In the 5 dpf zebrafish embryo, rapamycin treatment arrested the 
iridophore migration to the yolk of the embryo (Figure 4.52).  
 
 
 98 
 
 
Figure 4. 52 The iridophores on the yolk of the 5 dpf rapamycin or DMSO treated zebrafish embryo. 
The silver light pigments are the iridophores accompanied with the black melanophores.  
 
 
4.5.4 Effect of rapamycin on cartilage development 
 
The cartilage components were shorter in the rapamycin treated embryos for 
both 5 and 6 dpf. The branchial arches were barely stained in the 5 dpf rapamycin 
treated embryos as compared to their control counterparts. In the 6 dpf rapamycin 
treated embryos the alcian blue staining of the branchial arches were more apparent 
(Figure 4.53).  
 
 
 
 
Figure 4. 53 5 and 6 dpf 10 µM rapamycin treated embryos strained with alcian blue. The ventral view 
of alcian blue stained embryos were presented. m, meckel’s cartilage; pq, palatoquadrate; ch, 
ceratohyal; hs, hyosymplectic; ba, branchial arches. 
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Chapter 5. DISCUSSION 
 
 
 
Comparing the conserved expression patterns between species, such as human 
and zebrafish, helps us understand and explore the role of a particular signaling 
pathway with roles in cell proliferation and cancer formation (Lam et al., 2006; Ung et 
al., 2009). 
 
 Zebrafish is an emerging model for cell signaling, cancer and development 
studies. In this study, we surveyed the expression changes of zebrafish orthologs of 
the known mammalian E2F transcription factor targets and of the mTOR pathway 
target genes in zebrafish model for the first time. We have shown that cell 
proliferation and cell cycle stages of ZF4 cells were significantly affected by the 
serum starvation and replenishment treatments, as in mammalian cells as well as that 
the rapamycin treatment diminished the basal apoptosis in ZF4 cells, although cell 
proliferation remained unaffected. We also reported on for the first time the global 
gene expression change that includes significant modulations in ribosomal and 
proteaosomal components. The delay rapamycin caused on the development of organs 
with a neural crest origin, i.e., cranial cartilage elements and pigmentation, are also 
intriguing aspects of our findings and require further expoloration both in vitro and in 
vivo. 
 
 
5.1 Serum response of E2F target genes in zebrafish 
 
 Serum starvation/replenishment is an effective way to study the cell cycle and 
mitogen dependency of cancer cells (DeGregori et al., 1995b; Nakashima et al., 2005; 
Porter et al., 2003; Smith et al., 1996). The genes whose expressions were regulated 
by serum response in fibroblast cells have also been shown to be regulated in various 
epithelial cancer types. Therefore, the conserved serum response signatures in 
fibroblast cells are important for epithelial cancer prognosis (Chang et al., 2004). 
Microarray studies have been used to characterize the conserved serum response 
signatures in human cancers and zebrafish cell lines (Cam et al., 2004; He et al., 
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2006). In various cell types from different species serum starvation causes a reversible 
cell cycle arrest at G0/G1 phase of the cell cycle, which may be reversed by serum 
replenishment (Bettuzzi et al., 1999; Goissis et al., 2007; Khammanit et al., 2008; 
Kues et al., 2000; Vackova et al., 2003). Serum depletion as an inducer of cell cycle 
arrest is also an appropriate model to study the gene expression changes of cell cycle 
regulatory proteins (Brunn et al., 1997; Hidalgo and Rowinsky, 2000). E2F 
transcription factor family regulates the expression of genes involved in the G1 to S 
phase of the cell cycle progression (Linhart et al., 2005). Accordingly, the serum 
starvation/replenishment model was chosen to investigate the regulation of E2F target 
gene expressions in ZF4 cell line.  
 
Before the gene expression was surveyed in zebrafish cells, the cellular 
response of ZF4 cells to serum fluctuations was investigated. After serum starvation, 
we found that the viable cell number decreased in ZF4 cells in a dose-dependent 
manner. The decrease in viable cell number persisted up to 30 and 48 h exposure; 
Serum starvation also decreased the proliferating cell number in ZF4 cells. After 48 h 
of serum starvation the cell number entering S phase significantly decreased in ZF4 
cells as observed by BrdU and PI staining. 24 and 48 h serum starvation caused a 
growth arrest at G1 phase of the cell cycle; the percent cell number significantly 
increased in G0/G1 phase, while it significantly decreased in S and G2/M phases 
according to PI staining. Serum stimulation for 24 h reversed the effects of serum 
starvation. The viable cell number significantly increased upon 6 and 24 h serum 
stimulation. Also the percent cell number entering S phase was restored with 24 h 
serum stimulation as shown by the BrdU and PI analysis. Our results were consistent 
with previous studies performed with mammalian fibroblast cell lines, in which serum 
starvation caused an increase the cell number at G0/G1 phase, and a decrease at S and 
G2/ phases, which may be reversed by serum stimulation (Bettuzzi et al., 1999; 
Goissis et al., 2007; Khammanit et al., 2008; Kues et al., 2000; Vackova et al., 2003). 
Our results clearly showed that serum starvation caused G0/G1 arrest in ZF4 cells. 
However according to 24 h dose dependent serum starvation MTT assay results; 
serum starvation may induce cell death in ZF4 cells as the level of serum decrease in 
the media. The cell number counts were highly correlated with MTT results for the 24 
h serum starved cells under differing doses of serum treatment (0, 1, 3% FBS). Since 
only attached cells were used for MTT, BrdU and cell cycle analysis, the effect of 
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serum starvation on different types of cell death in ZF4 cells remains unknown and 
need to be futher studied. However, it is apparent that the most of the remaining cells 
after serum starvation for 24 hours go into a state of G1 arrest, and then recover to the 
original levels with the addition of serum within 24 hours based on the MTT, BrdU 
and PI analyses from the serum replenishment experiments.  Furthermore, the amount 
of cell death may depend on the passage number the ZF4 cells in and/or the duration 
of the serum starvation (48 h). 
 
The zebrafish orthologs of mcm7, pcna, mybl2, tyms, and ctgf whose 
expressions known to be  directly or indirectly regulated by E2F transcription factors 
in mammals have been selected to study whether the E2F target gene response is 
conserved in zebrafish (Lee et al., 1995). The selected genes are also important 
components of DNA repair, replication and cell cycle progression (Essers et al., 
2005).  
 
The phylogenetic analysis showed the evolutionary conservation of the 
selected genes in several species. Our phylogenetic analysis with protein sequences of 
selected genes confirmed that they were orthologous genes and showed sequence 
conservation between species. As expected the zebrafish orthologs of selected E2F 
target genes clustered with their fish counterparts, while the mammalian homologs 
clustered together. The expression of mcm7, pcna, mybl2, tyms, and ctgf were 
investigated in 24 h serum-starved ZF4 cells with 0%, 1%, and 3% FBS including 
media. Our results showed that serum starvation caused a significant decrease in gene 
expressions of mcm7, pcna, mybl2 and tyms in a dose-dependent manner as in the 
mammalian cells. ctgf expression significantly increased at 1% FBS treated cells, 
although 0% FBS treated cells were not different from 10% FBS.  
 
The effect of serum replenishment also was surveyed in 24, 30 and 48 h serum-
starved ZF4 cells. Following a 24 h serum starvation, ZF4 cells were serum 
replenished either for 6 or 24 h and the changes in gene expression were observed 
with real-time qRT-PCR. pcna and mybl2 expressions significantly decreased in 24, 
30 and 48 h serum-starved ZF4 cells. After 6 and 24 h replenishment, the expressions 
of pcna and mybl2 were back to basal levels. tyms expression significantly decreased 
in 24 and 30 h serum-starved ZF4 cells according to Fisher’s multiple comparisons. In 
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6 and 24 h serum replenished ZF4 cells, the expression of tyms significantly increased. 
The mcm7 expression significantly decreased at 24 and 48 h serum-starved ZF4 cells. 
mcm7 expression completely recovered, also overtopped the basal levels after 24 h 
serum replenishment. Previously the change in MCM7 protein levels in response to 
serum starvation and replenishment have been shown in human and mouse cells 
(Rizwani et al., 2009). We also investigated the change in Mcm7 protein levels in 
response to serum starvation for 24 and 48 h and serum replenishment for 6 and 24 h 
following 24 h serum starvation. Consistent with real-time qRT-PCR results, 24 and 
48 h serum starvation decreased, and not 6 h but 24 h of serum replenishment restored 
the Mcm7 protein levels, although both at 6 and 24 h of replenishment an increase in 
protein levels have been observed. The ctgf expression significantly increased in 24 
and 48 h serum-starved ZF4 cells, however 24 h serum replenishment was not enough 
to decrease the ctgf expression to basal levels.  
 
Previously, the serum responsiveness of the selected genes has been shown in 
higher organisms. The increase in Pcna expression has been shown in quiescent 
mouse embryonic fibroblast cells, MEFs, and Chinese hamster ovary cell line, 
CHOK1s, after serum stimulation (Hurford et al., 1997). The Mybl2 expression 
decreased in serum-starved T98G human glioblastoma cells, mouse embryonic 
fibroblast cells and in normal human bone marrow fibroblast cells and increased after 
serum stimulation (Takahashi et al., 2000). Serum stimulation increased the Tyms 
expression in serum-starved mouse 3T6 fibroblast cells and mouse embryonic 
fibroblast cells, NIH 3T3 (Saxena et al., 2009). MCM7 has also been shown to be 
serum modulated; in breast cancer and mouse cells, serum starvation decreased and 
serum stimulation increased MCM7 protein levels (Rizwani et al., 2009). The Ctgf 
expression in response to serum fluctuations varied; in human mesangial cells Ctgf 
expression behaved like the other selected genes, while in human T98G cancer cells, 
serum starvation increased the Ctgf expression (Goppelt-Struebe et al., 2001). 
 
In conclusion, the expression of selected E2F target gene orthologs, responded 
to serum fluctuations as they did in the mammalian cells.  
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5.2 The effect of rapamycin treatment on gene expression of ZF4 cells and on 
zebrafish embryo 
 
 
5.2.1 The effect of rapamycin treatment on gene expression of ZF4 cells  
 
 
5.2.1.1 The effect of rapamycin treatment on ZF4 cell cycle progression 
 
mTOR (mechanistic target of rapamycin) is a serine/threonine kinase and a 
member of phosphoinositide 3-kinase related kinase (PIKKs) protein family, which 
are the regulators of cell cycle progression, DNA damage and repair, and DNA 
replication (Sarkaria et al., 1998). In human cells, mTOR pathway is responsive to 
changes in nutrients, growth factors, hypoxia and energy (Arsham et al., 2003; 
Brugarolas et al., 2004; Dennis et al., 2001; Edinger and Thompson, 2002; Scott et al., 
1998). 
 
mTOR activity is negatively regulated by rapamycin, which is naturally an 
immunosuppressive, antifungal and antitumor reagent (Martel et al., 1977; Vezina et 
al., 1975). Rapamycin by blocking mTOR pathway, one of the major regulatory 
pathways in the cells, interferes with the cell cycle progression in different cell lines 
(Albers et al., 1993; Decker et al., 2003; Gorshtein et al., 2009; Metcalfe et al., 1997; 
Zhang et al., 2007; Zinzalla et al., 2007). Rapamycin treatment has important 
outcomes in the cell proliferation, viability, apoptosis and autophagy. As in serum 
starvation, rapamycin treatment induces a growth arrest at the G0/G1 phase of the cell 
cycle in human, rat, murine and yeast cells (Albers et al., 1993; Decker et al., 2003; 
Gorshtein et al., 2009; Metcalfe et al., 1997; Zhang et al., 2007; Zinzalla et al., 2007). 
However, in some cell lines rapamycin treatment may not induce a cell cycle arrest at 
G0/G1 phase thus they are rapamycin insensitive; and cells continue to proliferate 
(Altomare et al., 2004). Rapamycin has both apoptotic and anti-apoptotic functions 
probably regulating anti-apoptotic and pro-apoptotic genes and caspase activity 
(Ravikumar et al., 2006; Tirado et al., 2005). Rapamycin induced apoptosis and 
decreased cell viability has been observed in human and mouse cell lines (Tirado et 
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al., 2005). On the contrary, rapamycin has been shown to be protective against 
apoptosis induction in some human, monkey, rat cell line models and in fruitfly 
(Reddy et al., 2008).  
 
In ZF4 cells, we did not observe any significant difference in cell cycle 
progression after rapamycin treatment. 100 nM rapamycin treatment for 48 h did not 
change the viable cell number according to MTT analysis. Rapamycin had also no 
effect on proliferating cell number according toBrdU and PI staining; we could not 
detect a significant difference in the cell number entering S phase. Interestingly, 
rapamycin treatment decreased the basal apoptosis in ZF4 cells. Cell death detection 
analysis (CDD) showed that rapamycin treated cells were less apoptotic than both 
DMSO (vehicle) and control cells cultured with 10% FBS including media. As in ZF4 
cells, in primary human coronary artery smooth muscle cells, rapamycin treatment 
decreased the basal and also H2O2-induced apoptosis as compared to control cells 
(Zohlnhofer et al., 2004). However, we could not confirm the effect of rapamycin on 
cell death in the cell cycle analysis performed with PI staining. Although the percent 
cell number at subG1 phase in rapamycin treated cells were lower when compared to 
DMSO treated cells, the decrease was insignificant because of the high variation 
observed for rapamycin samples at the subG1 phase. Our results showed that 
rapamycin has no quantifiable effect on cell cycle progression of ZF4 cells based on 
BrdU and PI analyses, and yet is likely to be anti-apoptotic. However, in order to 
show the effect of rapamycin on apoptosis more effectively apoptosis should be 
induced in ZF4 cells and the apoptotic cell number in the rapamycin treated and 
control cells should be quantified. Furthermore, it should be considered that ZF4 cells 
might develop resistance to rapamycin over time. Thus the ability of ZF4 cells also to 
undergo G1 arrest or to become apoptotic/antiapoptotic might depend on their source, 
and passage duration and number. 
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5.2.1.2 The effect of rapamycin treatment on gene expression in ZF4 cells, 
microarray analysis 
 
Rapamycin treatment affects cellular growth by regulating the transcription 
and translation of the cell cycle regulatory genes, such as cyclin D1, cyclin D3, pcna, 
cyclin E, E2F1 and cdk2 (Hashemolhosseini et al., 1998; Nelsen et al., 2003). In 
addition to studying single gene expressions in response to rapamycin treatment, the 
high-throughput microarray analyses have been performed to understand the effect of 
rapamycin treatment on global gene expression. The differentially expressed genes do 
not only help researchers to understand conserved regulatory pathway between 
different species, can also be used for prognostic approaches (Akcakanat et al., 2009).  
 
According to microarray analysis with yeast strains Candida albicans and 
Saccharomyces cerevisiae strain BY4741, rapamycin treatment downregulated the 
genes coding for ribosomal proteins, tRNA synthetases and the components of 
translation (Fournier et al., 2010), and upregulated the genes coding for energy 
metabolism and autophagy (Fournier et al., 2010). 
 
Rapamycin might affect expression of certain genes independent or dependent 
of the sensitivity status of cells to rapamycin. According to a microarray study 
performed with different rat cell lines, the genes encoding for the energy metabolism, 
cell cycle progression and death have been observed to be responsive to rapamycin 
treatment in the rapamycin sensitive (WB-F344), insensitive (WB311) and 
intermediate sensitive (GN5 and H5D) cell lines. On the other hand, in the rapamycin 
sensitive cell line, aminoacyl-tRNA biosynthesis, ribosome, cell cycle and 
carbohydrate metabolism were affected from rapamycin treatment, while in 
rapamycin insensitive cell lines, oxidative phosphorylation, amino acid metabolism 
and cell communication were affected from rapamycin treatment (Jimenez et al., 
2009).  
 
In addition to analysis of gene transcription, the effect of rapamycin treatment 
on gene translation has also been studied with a microarray approach via polysome-
bound mRNAs (Grolleau et al., 2002). Rapamycin treatment respressed the translation 
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of ribosomal proteins, proteasome subunits and elongation factors in human E6–1 
Jurkat T cells (Grolleau et al., 2002). In human lung fibroblast cells, MRC-5, mRNAs 
with anti-apoptotic functions were upregulated and mRNAs of ribosomal proteins and 
elongation factors were downregulated with rapamycin treatment (Genolet et al., 
2008). 
 
The effect of rapamycin on gene expression has not been investigated 
previously in zebrafish thus we used Affymetrix GeneChip® Zebrafish Genome Array 
to profile ZF4 cells that were treated with 100 nM rapamycin treatment or equivalent 
of DMSO for 48 h. The quality of arrays also fulfilled the required criteria and there 
was not any aberrant chip in the experiments according to NUSE and RLE graphs. By 
using BRB Array tools, the raw data was normalized and the differentially expressed 
genes were identified. Differentially expressed genes were selected with a random 
variance model for univariate tests (Wright and Simon, 2003). Among 15,610 probes, 
2185 of them were differentially expressed between rapamycin and DMSO (p=0.05). 
The KEGG pathway and functional analysis of the differentially expressed genes were 
performed by DAVID.  
 
The genes encoding for the ribosomal proteins, and components of gene 
expression and translation, regionalization and pattern specification were upregulated 
by rapamycin. The genes involved in proteasome structure, catabolic and metabolic 
processes, DNA damage and repair responses were downregulated by rapamycin. 
Consistent with our results, the transcriptional and translational downregulation of 
protesome subunits by rapamycin has been shown in human E6–1 Jurkat T cells 
(Grolleau et al., 2002). We also observed consistent but mild downregulation of close 
to 90% of the mitochondrial ribosomal proteins in rapamycin treated cells; this result 
is also in accord with previous studies showing the downregulation of mitochondrial 
ribosomes (Bastidas et al., 2009; Cunningham et al., 2007). Although in yeast model 
and some human cell lines (Fournier et al., 2010) rapamycin treatment downregulates 
ribosomal proteins, in ZF4 cells rapamycin treatment upregulated ribosomal proteins. 
According to our analysis, the increase in the ribosomal proteins was mild; the 
increase ranged between 0.2-0.4 log2 fold change, but was consistent. The observed 
increase in ribosomal protein expression might be related with the inhibition of their 
translation, thus accumulation of mRNAs.  
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The increased ribosomal protein expression might be related with the 
secondary roles of ribosomal proteins. In addition to their conserved roles in protein 
synthesis, ribosomal proteins have been shown to involved in the cell survival and 
apoptosis (Chen and Ioannou, 1999). In adult zebrafish, heterozygous mutations in 
ribosomal proteins increased the rate of tumor formation, and ribosomal subunits have 
been proposed as haploinsufficient tumor suppressor genes (Amsterdam et al., 2004). 
Human 23K ribosomal protein also functions as an inhibitor of cell proliferation 
(Chen et al., 1998). In Jurkat cells constitutively active RPL7 (ribosomal protein L7) 
caused a cell cycle arrest at G1 phase and induced apoptosis (Neumann and 
Krawinkel, 1997). In human WI38 both overexpression and inhibition of RPL23 
(ribosomal protein L23), stabilized p53 and induced growth arrest (Jin et al., 2004). 
Ribosomal subunits may also be involved in cell cycle progression; the 
overexpression of ribosomal protein L35a in Jurkat cells protected from indution of 
apoptosis (Lopez et al., 2002); over-expression of another ribosomal protein L36a 
increased cell proliferation, also L36a has been found to be overexpressed in 
hepatocellular carcinoma cases and cell lines (Kim et al., 2004). 
 
As shown previously, types of ribosomal subunits may induce or repress cell 
growth in different cells. In ZF4 cells, slight but consistent increase in ribosomal 
protein expression might serve as a protector of apoptosis. 
 
 
5.2.1.3 Confirmation of microarray results by real-time qRT-PCR 
 
In order to confirm the microarray results with real-time qRT-PCR, 9 genes; 
either significantly upregulated or downregulated by rapamycin treatment according 
to microarray analysis, have been selected. The selected genes were wif1, dkk1b, 
bambia, ddc, cyp26b1, pah, mmp9, tagln2 and foxm1. For confirmation analysis an 
independent rapamycin experimental setup was performed, in which ZF4 cells were 
treated with 100 nM rapamycin for 6 and 48 h. As a result, we confirmed the increase 
in ddc, cyp26b1, dkk1b, and wif1 expressions and the decrease in pah expression in 
response rapamycin treatment by real-time qRT-PCR; however we could not detect a 
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significant change in other four selected genes in response to rapamycin treatment. 
Yet, the log2 fold changes for all the selected genes were in the same direction and 
were signficantly correlated between the microarray and real-time qRT-PCR results 
(Pearson correlation coefficient=0.791, P-Value = 0.011).  
 
Validation of microarray results with real-time qRT-PCR is reliable (Dallas et 
al., 2005). Thus, there might be several reasons why some of the genes identified in 
the microarray study were not confirmed in the following qRT-PCR study (i.e., the 
expression changes observed for the bambia, foxm1, tagln2, and mmp9 were not 
significant in qRT-PCR study while they were significant according to the microarray 
analysis). One such reason might be that ZF4 cells used for the microarray and those 
used for the qRT-PCR experiments were from different passages thus might have 
displayed different levels of sensitivity to rapamycin. Another possibility could be that 
the exact amount of change in the gene expression from the microarray study may not 
be reflected in real-time qRT-PCR analyses. It is also possible that the correlation of 
microarray results with real-time qRT-PCR results may be poorer for the genes 
exhibiting low fold change differences (<1.5) while the correlation is expected to be 
higher in the genes with high fold change differences (>1.5) (Dallas et al., 2005). In 
our study, we selected our microarray validation genes among the genes with 
significantly high fold changes. However, even among these genes, the fold change 
differences do not exceed 2/-1.8 log2 fold, since rapamycin affected the degree of 
expression moderately, according to our study. Indeed, the log2 fold changes of the 
genes that could not be confirmed by real-time qRT-PCR were 1.46/-1.14 between 
rapamycin and DMSO samples. Although real-time qRT-PCR analysis is known to be 
more sensitive than the microarray analyses, around a 70% match with real-time qRT-
PCR and microarray results has been frequently reported (Morey et al., 2006; 
Rajeevan et al., 2001).  
 
The p-value of selected genes also plays an important role in the high 
correlation of the microarray and real-time qRT-PCR results. Genes with low p-
values, such as 0.0001 showed higher correlation than the genes with high p-values 
(Morey et al., 2006). However, the discrepancies between our microarray and real-
time qRT-PCR results probably have not emerged from the selected p-value criteria, 
since all our selected genes have significantly low p-values (<0.001). Discrepancies 
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might also result from the false positive microarray results due to differential 
hybridization or probeset specificity or alternative splicing. It has been reported in the 
literature that although the selected genes seem to be highly differentially expressed 
genes, they may be still false positive and not differentially expressed (Wright and 
Simon, 2003).  
 
 
Among the genes confirmed by qRT-PCR, only DKK1 was shown to be a 
target for rapamycin previously in human cells to our knowledge thus we show for the 
first time the effect of rapamycin on dkk1b, wif1, ddc, cyp26b1, and pah expression in 
zebrafish. Further studies are needed to generalize whether these genes are common 
targets of rapamycint treatment. Below, information on function and expression of 
genes significantly affected by rapamycin in zebrafish are provided.  
 
WIF1 (WNT inhibitory factor 1) is a Wnt antagonist protein. Wif1 inhibits 
Wnt signaling by directly binding to Wnt proteins and preventing their binding to Wnt 
receptors (Hsieh et al., 1999). WIF1 expression was downregulated in human prostate, 
breast, non-small cell lung and bladder tumors (Wissmann et al., 2003). The sequence 
of wif1 is also highly conserved between zebrafish, Xenopus and human. wif1 was 
expressed in zebrafish embryo in the notochord at the 15-somite-stage, the epiphysis 
and ventral midbrain at the 24 hpf zebrafish (Hsieh et al., 1999). Wif1 involved in 
CNS and limb development in mouse model (Hu et al., 2008; Witte et al., 2009). The 
effect of rapamycin on WIF-1 expression has not been shown previously. 
 
DKK1 (dickkopf homolog 1) is a member of the dickkopf family (Krupnik et 
al., 1999). Dkk1 is secreted protein and inhibits Wnt signaling by preventing the 
formation LRP5/6–Wnt–Frizzled complex (Brott and Sokol, 2002; Kawano and 
Kypta, 2003). Dkk1 has a conserved function in various species as a Wnt signaling 
inhibitor including zebrafish (Fedi et al., 1999; Glinka et al., 1998; Krupnik et al., 
1999; Shinya et al., 2000; Wu et al., 2000). dkk1b expression is observed in zebrafish 
embryos starting from blastula stage and persisted. Zebrafish dkk1 protein has a major 
role in the anterior nervous system and axial mesondoderm formation (Hashimoto et 
al., 2000). dkk1 regulates and required for head formation in Xenopus (Glinka et al., 
1998). In human keratinocytes, DKK1 was involved in pigmentation and thickness of 
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skin (Yamaguchi et al., 2008). The role of DKK1 in cancer formation has also been 
shown in various human cancers, such as Wilms’ tumors, lung cancers, hepatocellular 
carcinomas, hepatoblastomas, esophageal squamous cell carcinomas and myelomas, 
in which DKK1 was upregulated, and colorectal cancers, in which DKK1 was 
downregulated (Gonzalez-Sancho et al., 2005; Patil et al., 2005; Tian et al., 2003; 
Wirths et al., 2003; Yamabuki et al., 2007). Recently, the effect of rapamycin 
treatment on DKK1 expression was shown in human cells; rapamycin treatment or 
silencing mTOR by shRNA treatment increased the DKK1 expression in primary 
human endothelial cells (Kobayashi et al., 2010a). 
 
DDC (dopa decarboxylase) is an enzyme, which is involved in catecholamine 
biosynthesis (Blaschko, 1942). In human cells DDC decarboxylates L-DOPA to 
dopamine, and L-5-hydroxytryptophan to serotonin (Lovenberg et al., 1962). DDC 
has been found to be overexpressed in prostate cancer (Avgeris et al., 2008). The 
relation of DDC with Parkinsons’ Disease has also been shown; the combination of 
DDC inhibitors and L-Dopa has been used in the treatment of Parkinsons’ Disease. 
The ddc expression was detected in the dopaminergic neurons of the juvenile 
zebrafish brains (Filippi et al., 2010). The effect of rapamycin on DDC expression has 
not been shown. 
 
The CYP26B1 (cytochrome P450, family 26, subfamily B, polypeptide 1) is 
involved in retinoic acid metabolism; this enzyme converts all-trans-Retinoic acid 
into 4-oxo-RA, 4-OH-RA, and 18-OH-RA. CYP26B1 is expressed in various normal 
human tissues according to multi-tissue RNA dot blot analysis (White et al., 2000). 
But the higher expression is detected in the cerebellum of the brain tissue (Trofimova-
Griffin and Juchau, 2002; White et al., 2000). The expression of mouse Cyp26B1 is 
detected in many developing tissues such as, limbs, spinal cord, spleen, kidney and 
cartilage elements (Abu-Abed et al., 2002). Zebrafish cyp26b1 also functions in 
metabolizing retinoic RA and is expressed in zebrafish embryo from 8-10 hpf. 
Cyp26b1 expression was observed in developing zebrafish embryo in the neural 
tissues, such as eyes and some parts of brain including cerebellum and diencephalon, 
pectoral fin which is the homolog of forelimbs, pharyngeal arches and otic vesicle 
until 48 hpf (Zhao et al., 2005).  The expression profiles in different organisms 
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highlight the importance of Cyp26b1 in embryonic development. The effect of 
rapamycin on CYP26B1 expression has not been shown previously. 
 
PAH (phenylalanine hydroxylase) gene encodes for a protein involved in 
phenylalanine catabolism, the enzyme is responsible for conversion of phenylalanine 
to tyrosine (Kobe et al., 1999). The deficiency of metabolizing phenylalanine causes 
the genetic disorder, phenylketonuria and one of the factors of this disease is 
deficiency of PAH enzyme (Folling, 1934; Jervis, 1947; Parker, 1979). The role of 
this enzyme in melanogenesis has been shown (Schallreuter and Wood, 1999). In 
developing zebrafish embryo, pah expression was observed in the central nervous 
system and kidney at 18 and 24 hpf (Song et al., 2004). The effect of rapamycin on 
PAH expression has not been shown previously. 
 
 
5.2.2 The effect of rapamycin treatment on zebrafish embryogenesis and larval 
development 
 
Zebrafish is a preferable and widely used model organism in molecular 
biology, organ development, cancerogenesis, drug screening, and developmental 
studies (Chen et al., 1996; Drummond et al., 1998). 
 
Previously, the sensitivity of zebrafish model to rapamycin has been shown in 
the zebrafish embryos and adults (Goldsmith et al., 2006). A mild developmental 
delay in embryonic development and arrest in the digestive tract development were 
observed up to 72 hpf in zebrafish embryo, after 400 nM rapamycin treatment (Makky 
et al., 2007). The developmental delay induced by rapamycin was accompanied with 
vessel defects and cardiac failure in zebrafish embryos from the 8-cell-stage to 26 hpf 
(Wenzlau et al., 2006). Rapamycin treatment (400 nM for 2 days) suppressed 
lymphangiogenesis, formation of the growth of lymphatic vessels, also in 26 hpf 
zebrafish embryo as in mammalian models (Flores et al., 2010). phospho-p70S6 
kinase protein levels were responsive to rapamycin treatment in zebrafish embryos as 
in mammals; phospho-p70S6 kinase protein levels were decreased in 500 nM 
rapamycin treated zebrafish embryos (DiBella et al., 2009). Rapamycin-induced 
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autophagy has been detected in 3 dpf zebrafish embryos (He et al., 2009), the 
induction of autophagy by rapamycin has previously been shown in mammals and 
fruitfly (Ravikumar et al., 2006).  However, the dose-dependent effect of rapamycin 
on the development of zebrafish neural crest derived tissues such as melanocytes and 
cranial cartilage has not been studied.  
 
In order to explore the effects of rapamycin on zebrafish embryo development, 
shield stage embryos were treated with 2, 10 and 20 µM rapamycin provided in the 
embryo medium, for a duration of 1 day to 5 day. We observed that 400 nM 
rapamycin treatment arrested the development of digestive tract as previously shown 
(Makky et al., 2007). According to our results rapamycin caused a general delay in 
zebrafish developmental in a dose-dependent manner starting from 1 dpf to 5 dpf. 
Interestingly, rapamycin treatment caused a detention in pigmentation and cartilage 
development in larvae. We observed a delay in both the melanophore and iridophore 
pigmentation in the rapamycin treated group. Recently, the negative effect of 
rapamycin on melanocyte pigmentation has been shown in Xenopus model (Moriyama 
et al., 2010) supporting our findings in zebrafish embryos. We demonstrated that the 
cartilage elements were also shorter and pharyngeal arches stained less in the 
rapamycin treated embryos as compared to the control fish. These defects in cartilage 
elements accompanied with reduced pigmentation have previously been shown in 
different zebrafish mutants (Neuhauss et al., 1996), but not in rapamycin treated 
zebrafish. Previously, the inhibitory effect of rapamycin treatment on the general 
development and developing bone and cartilage has been reported in rat and chicken 
models and mouse embryonic carcinoma cells, ATDC5 (Alvarez-Garcia et al., 2007; 
Alvarez-Garcia et al., 2010; Nishigaki et al., 2002; Oh et al., 2001; Sanchez and He, 
2009). Rapamycin treatment inhibited the chondrogenic differentiation of chick bud 
mesenchymal cells by repressing the formation of cartilage nodules (Oh et al., 2001). 
In rat model, rapamycin treatment repressed chondrocyte proliferation in the growth-
plate, caused aberrant chondrocyte growth (Alvarez-Garcia et al., 2007). In 
conclusion, rapamycin treatment might interfere with chondrogenic differentiation in 
vertebrates, the dose-dependent delay we reported in cartilage element formation in 
zebrafish model, might also be a result of a delay in chondrogenic differentiation. 
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Although the inhibitory effects of rapamycin treatment in pigment formation or 
migration have not been shown previously in zebrafish, the link between S6 kinase 
and pigment cells was shown in Drosophila. As explained in the introduction part of 
this thesis, rapamycin treatment is known to cause a decrease in S6 kinase 
phosphorylation, hence a decrease in S6 kinase activity (Demidenko and 
Blagosklonny, 2008). Particularly interesting is that in Drosophila S6 kinase mutants, 
the absence of red pigments has been observed (Montagne1999). However, in 
senescent retinal pigment epithelium (RPE) cells, rapamycin treatment inhibited 
senescence markers (Chen et al., 2010). Our results suggest that rapamycin might 
affect formation and/or migration of pigment cells and restricts them dorsally to the 
yolk; and these effects might involve changes in the S6 kinase activity. These results 
require further study yet implicate rapamycin as a possible teratogen and point to a 
need for further assessment in use during pregnancy.  
 
In our study, we observed an increase in dkk1b expression and a decrease in 
pah and ddc expressions in the rapamycin treated ZF4 cells. The involvement of these 
genes in pigmentation has been shown in different organisms. Overexpression of 
DKK1 has been shown to supress the melanocyte growth and proliferation in human 
keratinocytes (Yamaguchi et al., 2004; Yamaguchi et al., 2008; Yamaguchi et al., 
2007). DDC provides dopamine by conversion from dopa, which in turn can be used 
for melanin formation and thus is involved in the color formation (e.g., butterfly 
wings  (Koch et al., 1998)). PAH supplies tyrosine for melanin production and 
contributes to melanogenesis (Schallreuter and Wood, 1999). In our study, we 
detected upregulation of dkk1b and downregulation of pah in ZF4 cells, which were 
modulated in the expected direction for observing a defect in pigmentation patterns. 
However, our results were obtained in ZF4 cells thus the expression of these genes 
also should be investigated in rapamycin treated embryos to confirm these initial 
findings. 
 
Cartilage and pigment cells are derived from the neural crest cells (Yelick and 
Schilling, 2002). Our results suggest that rapamycin might negatively affect 
particulary the neural crest cell derivatives, namely cranial cartilages and pigment 
cells. In zebrafish, the neural crest cells are formed at the border of the neural plate 
during gastrulation and give rise to pigment cells, cartilage components and cells of 
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the peripheral nervous system (Lister, 2002). However, the pigment cells in the retinal 
epithelium are derived from the neural epithelium not from the neural crest cells 
(Dupin and Le Douarin, 2003). The delayed melanophore and iridophore 
pigmentation in the horizontal myoseptum and yolk, but not in the eye of the 
rapamycin treated embryos may also indicate that the effect of rapamycin might be 
specific to neural crest derivatives. A similar situation with pigmentation was 
observed in Xenopus embryos treated with rapamycin further supporting our findings 
(Moriyama et al., 2010). 
 
In further support of our findings in relationship to the interaction between 
neural crest cells and rapamycin treatment, we searched the literature for rapamycin 
and neural crest derived tumor related studies. Malignant peripheral nerve sheath 
tumors (MPNST) derived from NF1 (Neurofibromatosis type 1) patients have also 
been thought to derive from the neural crest cells. Peviously, rapamycin derivative, 
RAD001 were shown to be protective for the tumor formation in MPNST xenografts 
in mice. RAD001 treatment also decreased the growth of several MPNST cell lines 
(Johansson et al., 2008). These suggest that rapamycin might be particularly beneficial 
for neural crest derived tumor regression and warrant further study. 
 
 
5.3  Zebrafish as a model for conserved gene expression signal profiling 
 
We have established ZF4 cell line in zebrafish as a quiescence model. Two 
types of potential quiescent inducing stimuli were used: serum deprivation and 
rapamycin exposure. Both of these agents were shown to be potent growth inhibitors 
in mammals. Our findings showed that serum starvation in zebrafish indeed has 
similar consequences in terms of G1/S arrest while rapamycin did not seem to have an 
effect on cell proliferation. On the other hand, ZF4 cells exhibited anti-apoptotic 
response when treated with rapamycin and this might compensate for a potential delay 
in cell growth/proliferation. These findings are novel and set ZF4 as a potentially 
phylogenetically conserved vertebrate cell line model for expression signaling 
pathway comparisons across taxa. We have used b2m and ef1a as reference genes and 
performed a series of qRT-PCR experiments to demonstrate serum responsiveness and 
rapamycin sensisitivity of ZF4 cells. Our findings revealed conserved expression 
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patterns for pcna, mybl2, tyms, mcm7 and ctgf in zebrafish as observed for mammals. 
We have identified several novel genes that were affected by rapamycin exposure, 
namely, dkk1b, pah, dcc, wif1 and cyp26b1 which were not previously studied in 
zebrafish in this context and/or associated with rapamycin sensitivity. Furthermore, 
exposure of zebrafish embryos to different doses of rapamycin revealed novel 
phenotypes not previously shown in zebrafish. Among these were reductions and 
delays in pigmentation and cartilage development. These neural crest derivatives have 
been identified as affected by rapamycin dose-dependently for the first time in the 
zebrafish model, although general growth retardation has been observed in 
invertebrates and in vertebrates including zebrafish when exposed to rapamycin.  
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Chapter 6. FUTURE PERSPECTIVES 
 
 
6.1 E2F target gene regulation in zebrafish 
 
 In our study, we have shown that ZF4 cell line is an appropriate model to study 
E2F target gene expression in response to serum fluctuations as in mammalian cells 
(Takahashi et al., 2000). 
 
 However, in order to show that selected E2F target genes are also regulated by 
E2F1, the zebrafish E2F1 gene needs to be cloned and sequenced. The E2F1 gene 
sequence has not been identified in zebrafish. We performed preliminary studies to 
find a possible ortholog of human E2F1 gene in zebrafish. The sequencing of the 
putative E2F1 sequence and its overexpression or depletion studies would be helpful 
to search for the E2F1 regulation in zebrafish cells. Indeed, in mammalian fibroblast 
cell lines, overexpression of E2F1 mediated the progression to S phase in quiescent 
cells (Ishida et al., 2001). The overexpression of E2F1 in serum-starved ZF4 cells, and 
monitoring cell cycle progression and selected E2F1 target gene expression could be 
performed in ZF4 cells to explore a conservatory role for E2F1 between species. Also 
the function of E2F1 in zebrafish development can be investigated by silencing E2F1 
in zebrafish embryos. The role on E2F1 in regeneration of tissues, such as liver and 
fin can be easily applied in zebrafish models. 
 
Furthermore, mammalian mcm7, pcna, mybl2 and tyms genes have binding 
sites to E2F1 in their promoter regions (Lee et al., 1995). However, there is no 
detailed information about regulation of these genes in zebrafish by E2F1. Our future 
studies will include searching of the promoter regions of zebrafish mcm7, pcna, mybl2 
and tyms for E2F binding sites.  
 
We also have shown that in zebrafish model the selected E2F target genes 
behave in the same manner as their mammalian counterparts which may indicate the 
conserved role of the selected genes in cell cycle regulation also in zebrafish. As being 
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crucial regulator of cell cycle, the deregulation of E2F signaling pathway components 
has been observed in various cancers. The overexpression of MCM7 have been 
observed in prostate cancer and associated with reoccurrence of the cancer after the 
treatment (Ren et al., 2006). High expression of MCM proteins have been detected in 
different carcinomas, including kidney, bladder and colon (Freeman et al., 1999). 
PCNA expression has been shown to be predictive in the metastasis of breast cancers 
(Schonborn et al., 1995). The high expression of TYMS has been associated with the 
decrease in overall survival in colorectal cancer (Popat et al., 2004). Loss of mybl2 
expression increased cancer susceptibility in zebrafish (Shepard et al., 2005). The high 
CTGF expression has been shown to be correlated with extended survival in lung 
cancers (Chen et al., 2007).The overexpression of these genes can easily be applied to 
zebrafish embryo model, the formation of tumors could be monitored and therapeutic 
approaches can be tested in vivo, since using zebrafish model for drug screening is an 
emerging and promising field (Taylor et al., 2010; Wang et al., 2010). 
 
 
6.2 Identification of conserved signatures in response to rapamycin in different 
species 
 
 We have shown that rapamycin significantly affected a large number of 
transcripts; among these rapamycin upregulated ribosomal protein expressions, while 
downregulated the genes encoding proteasome subunits according to our microarray 
results. The observation of increase in ribosomal protein expression is a novel finding 
to our knowledge. It is known that mutations, causing the loss of ribosomal proteins 
contribute to tumor formation in zebrafish (Amsterdam et al., 2004) thus upregulation 
of ribosomal proteins by rapamycin might be a coping mechanism for tumor 
formation. Currently, we are performing a meta-analysis to assess whether expression 
profile upon rapamycin exposure is conserved from invertebrates to vertebrates based 
on existing microarray studies in flies, mice, rats, and humans.  
 
 
6.3 In vivo rapamycin experiments with zebrafish embryos 
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In rapamycin treated embryos, we observed a delay in general embryonic 
development, cartilage formation and pigmentation. Further studies are planned for 
the morphometric analysis of zebrafish embryos using multivariate techniques and 
automated image analysis. In the near future we also plan on further studying the 
expression of known markers of cartilage formation and neural crest cells, e.g., dlx2, 
sox9a and sox9b in 10 and 36 hpf rapamycin treated and control embryos by in situ 
hybridization (Chiang et al., 2001; Li et al., 2002). Sox9 expression is crucial for 
cartilage development as shown in mouse and zebrafish (Bi et al., 1999; Chiang et al., 
2001; Yan et al., 2002) and zebrafish has two sox9 genes, which are the orthologs of 
human SOX9; sox9a and sox9b (Chiang et al., 2001). Although both sox9a and sox9b 
are important for cartilage formation, their expression patterns overlap or differ in 
adult and embryos of zebrafish (Chiang et al., 2001). In 24 hpf zebrafish embryo both 
genes are expressed in parts of the brain, and in the head region. At this point only 
sox9a is expressed in the cranial mesenchyme, at the time of hatching sox9b is also 
expressed. Both genes are expressed during chondrogenesis of the head and pectoral 
fin. In the tissues of adult zebrafish, sox9a is expressed in brain, pectoral fin, kidney, 
muscle and testis, while sox9b expression is restricted only in ovary tissue (Chiang et 
al., 2001). sox9b is a neural crest marker of the developing zebrafish. The expression 
of sox9b is observed in the midbrain, hidbrain and trunk neural crest precursors at the 
11-12 hpf zebrafish embryo and proposed as a marker of cranial and trunk neural crest 
precursor cells (Li et al., 2002). In the 14 hpf embryos sox9a is expressed in the otic 
placode, while sox9b is expressed in the cranial and trunk premigratory neural crest, 
eye and ear. sox9b expression in cranial neural crest cells is higher than sox9a 
expression. sox9b mutation causes a reduction in the pharyngeal arches and cranial 
cartilages, while in sox9a mutants the cartilage elements are more affected in 4 dpf 
zebrfish embryos (Yan et al., 2005). The pigmentation is also effected by sox9b 
mutation. Only in sox9b mutants but not in sox9a mutants, iridophore pigmentation is 
decreased, and melanocytes become less condensed (Yan et al., 2005). Our 
preliminary results show that sox9b expression might be reduced or delayed in 
rapamycin treated zebrafish embryos (data not shown) is in accord with the phenotype 
observed in rapamycin treated embryos, i.e., a delay but not a severe effect on 
cartilage development and reduction in melanocyte and iridophore pigmentation. 
Studies are in progress to confirm these preliminary results. 
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Abstract Targets of E2F transcription factors effectively
regulate the cell cycle from worms to humans. Further-
more, the dysregulation of E2F transcription modules plays
a highly conserved role in cancers of human and zebrafish.
Studying E2F target expression under a given cellular state,
such as quiescence, might lead to a better understanding of
the conserved patterns of expression in different taxa. In
the present study, we used literature searches and phylog-
eny to identify several targets of E2F transcription factors
that are known to be serum-responsive; namely, PCNA,
MYBL2, MCM7, TYMS, and CTGF. The transcriptional
serum response of zebrafish orthologs of these genes were
quantified under different doses (i.e., 0, 0.1, 1, 3, and 10%
FBS) and time points (i.e., 6, 24 and 48 hours, h) using
quantitative RT-PCR (qRT-PCR) in the zebrafish fibroblast
cells (ZF4). Our results indicated that mRNA expression of
zebrafish pcna, mybl2, mcm7 and tyms drastically
decreased while that of ctgf increased with decreasing
serum levels as observed in mammals. These genes
responded to serum starvation at 24 and 48 h and to the
mitogenic stimuli as early as 6 h except for ctgf whose
expression was significantly altered at 24 h. The zebrafish
Mcm7 protein levels also were modulated by serum star-
vation/replenishment. The present study provides a
foundation for the comparative analysis of quantitative
expression patterns for genes involved in regulation of cell
cycle using a zebrafish serum response model.
Keywords Cell cycle analysis  MTT analysis 
Phylogenetics  Real-time qRT-PCR 
Serum/wound response  ZF4
Abbreviations
ZF4 Zebrafish embryonic cell line
FBS Fetal bovine serum
tyms Thymidylate synthetase
mybl2 Myeloblastosis oncogene-like 2
pcna Proliferating cell nuclear antigen
ctgf Connective tissue growth factor
mcm7 Minichromosome maintenance deficient 7
ef1a Elongation factor 1-alpha
Introduction
The comparison of expression patterns across different taxa
helps to identify the extent of the contribution by a par-
ticular signaling/transcription module into the regulation of
cell cycle and tumor progression [1]. E2F transcription
factors are crucially important in cell cycle regulation and
share conserved regulatory motifs in worms, insects, fish
and mammals [2]. The dysregulation of E2F transcription
modules might promote tumors as revealed by the highly
conserved signatures obtained from functional gene-set
enrichment analyses of the zebrafish and human cancer
microarray datasets [1, 3]. Indeed, the zebrafish has
recently emerged as a preferable vertebrate model
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organism for demonstrating the striking conservation of
liver cancer expression profiles between zebrafish and
human [1, 4]. Furthermore, zebrafish were used as a
promising xenotransplantation model for human malignant
cell lines [5, 6].
The quiescent state induced by serum starvation repre-
sents a powerful model for studying the mitogen depen-
dency of cancer cells [7, 8]. An increased wound/serum
response has already been associated with a worse prog-
nosis in multiple epithelial cancers [9] while microarray
studies of human cancer cells and zebrafish cell lines have
helped to characterize the global transcriptional signature
for serum response [10, 11]. The strong association
between the cell cycle, E2F transcription factors and
mitogen levels has been well-established for mammals:
The reduced serum conditions result in decreased rates of
proliferation followed by an arrest in the G1 phase of the
cell cycle [12]; and E2F1, among other transcriptional
regulators, drives quiescent cells into the S phase [13, 14].
In serum-replenished human cell lines, an increase in E2F1
at the G1 to S phase transition also has been detected [15].
However, the cellular aspects of the quiescent state induced
by serum starvation are not well characterized in zebrafish.
Similarly, the expression response of E2F targets to serum
starvation/replenishment has been investigated using large
scale transcriptional factor binding site and expression
studies in mammals [16, 17]. For instance, among others,
PCNA, TYMS, MCM2-7, MYBL2 were shown to be readily
induced in mammals by growth-inducing mitogenic stimuli,
such as increased serum concentrations and/or by E2F sig-
naling while CTGF was repressed by E2F signaling [16–22].
In zebrafish, pcna, tyms, mybl2 and ctgf were studied previ-
ously, yet mostly in the context of embryonic development
and tissue expression. pcna has been shown as a cell prolif-
eration marker in zebrafish embryonic intermediate cell mass
and in the highly proliferating cell subgroup of adult kidney
cells [23]. The zebrafish ctgf is expressed in the zebrafish
embryonic stages [24, 25], while mybl2 has been shown to be
involved in cancer progression as well as cell proliferation,
similar to human homolog [26, 27]. Previous studies have
shown the importance of Pcna as well as Mcm proteins in
zebrafish cell proliferation in zebrafish retina [28, 29]. The
expression of pcna and mcm5 were shown to be correlated,
and proposed as the markers of cell proliferation also in
zebrafish models [28]. Although several components of the
minichromosome maintenance (Mcm) complex including
mcm7 have been identified in an insertional mutagenesis
screen in zebrafish, only the expression of mcm5 has been
characterized in detail [28, 30]. Accordingly, the time- and
dose-dependent serum responses for the abovementioned
genes have not been analyzed quantitatively in the literature.
In the present study, we hypothesized that serum star-
vation might lead to quiescence in zebrafish fibroblasts and
thus modulate the strength and magnitude of expression
response of E2F target orthologs in a dose- and time-
dependent manner [16, 18, 19, 21, 31]. Therefore, we first
demonstrated the phylogenetic conservation of the selected
orthologs of mammalian E2F targets in zebrafish. Next, we
established a serum-response model using zebrafish
embryonic fibroblast cells (ZF4) based on cell viability
assays. Moreover, the levels of cell proliferation and cell
cycle progression were determined when ZF4 cells were
serum-replenished based on BrdU incorporation measure-
ments and flow cytometric analyses, respectively. We then
performed real-time qRT-PCR analysis of these selected
genes under different dose- and time-dependent serum
starvation and serum replenishment conditions. Our find-
ings indicated that ZF4 cells went into a reversible state of
quiescence upon serum depletion as evidenced by multiple
cellular parameters, and thus could be used as a quiescence
model for comparative expression studies among verte-
brates. In addition, mRNA expression of mybl2, tyms,
pcna, mcm7 and ctgf responded to serum starvation/
replenishment in a manner comparable to that observed in
mammals based on the information from existing literature.
This study provides a foundation for the comparative
analysis of expression patterns for genes involved in cell
cycle regulation using the ZF4 cell line serum response
model.
Materials and methods
Selection of the gene set and primer design
To obtain a more comprehensive understanding of the
zebrafish serum-dependent cell signaling, we strategically
selected a set of genes known to be repressed under serum
deprivation and/or upregulated by E2F1 [16, 18, 19, 21, 31,
32]. Accordingly, zebrafish orthologs of TYMS, MYBL2,
PCNA and MCM7 were selected for phylogenetics and
qRT-PCR studies. In addition, CTGF, a likely secondary
target repressed by E2F also was selected. The decrease in
CTGF mRNA levels by E2Fs was confirmed with Northern
Blot analyses, and the regulation of CTGF transcription
was likely to be indirect shown by cycloheximide treatment
[32]. Primers were designed for real-time qRT-PCR anal-
ysis using Primer 3 v.0.4.0 (http://frodo.wi.mit.edu)
(Table 1) [33].
Amino acid sequence alignments and phylogenetic
analysis
The protein sequences extracted from NCBI (http://www.
ncbi.nlm.nih.gov/) and ENSEMBL (http://www.ensembl.
org/index.html) databases were aligned using ClustalW
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[34] and the percent amino acid identity was calculated.
The amino acid sequences provided in Table S1 for the
Tyms, Mybl2, Pcna, Ctgf and Mcm7 proteins were used for
generating the bootstrapped neighbor-joining phylogenetic
trees using MEGA version 4 [35] for the following species:
human (Hs), rat (Rn), mouse (Mm), chicken (Gg), cow
(Bt), salmon (Ss), stickleback (Ga), green spotted puffer
fish (Tn), zebrafish (Dr), western clawed frog (Xt), fugu
(Tr) and medaka (Ol).
Cell culture
The zebrafish embryonic fibroblast (ZF4; ATCC, CRL-
2050) [36] cells were cultured in D-MEM/F-12 (1:1) with
10% FBS and 1% Penicillin/Streptomycin (10,000 U/ml
Penicillin, 10,000 lg/ml Streptomycin; HyClone,
SH30023, CH30160, and SV30010, respectively; Logan,
UT, USA) at 28C.
Three different experimental designs were used for
qRT-PCR analyses; each group contained two biological
replicates. Treatment groups at each time point were
compared with their time-specific control groups (10%
FBS). Accordingly, (1) dose-dependent serum starvation
experiments were performed using 3 9 106 ZF4 cells
(passage number, 13) in T75 flasks incubated with 10%
FBS for 24 h followed by the addition of media containing
a dose series of FBS (i.e., 0, 1, 3 and 10%) for another
24 h. (2) For the 24 h serum replenishment experiments,
3.75 9 106 ZF4 cells (passage number, 16) in T150 flasks
were incubated for 24 h (i.e., time 0) and 48 h with 0.1 or
10% FBS-containing media after an initial seeding period
of 24 h; the 24 h serum-starved cells were re-incubated
with 10% FBS for another 24 h (serum replenishment). (3)
Similarly, for the 6 h serum replenishment experiments, 3
9 106 ZF4 cells (passage number, 20) were incubated in
T75 flasks for 24 h with media containing 0.1% FBS and
then re-incubated with 0.1 or 10% FBS for 6 h. A 30 h
10% FBS control group also was included. Cells were
counted following trypsin (without EDTA; HyClone,
SV30037, Logan, UT, USA) treatment and cell pellets
were preserved in liquid nitrogen until later use.
MTT analyses were performed at different serum levels,
with 2 9 104 ZF4 cells (passage number, 22) cultured in
triplicates for 24 h in 96-well microplates. Similarly MTT
assays for serum replenishment were performed with
2 9 104 ZF4 cells (passage number, 19) that were starved
for 24 h in 96-well plates before replenishment with 10%
FBS for the indicated time points. For PI staining, 3 9 106
ZF4 cells (passage numbers, 20–23) were seeded in
100 mm petri dishes and cultured in 0.1 or 10% FBS
supplemented media. All samples were prepared in dupli-
cates for testing significance. For BrdU analysis 5 9 105
ZF4 cells (passage number, 22) were cultured in 6-well
plates in triplicates and serum starved in 0.1% FBS for
48 h. Effects of 24 h serum replenishment also were tested.
Assays for cell cycle, viability and proliferation
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), reduced to an insoluble formazan dye by
mitochondrial enzymes, provides a reliable cellular assay
for detecting viable cells. The MTT assay was performed
according to the manufacturer’s protocols (Vybrant MTT
Cell Proliferation Assay Kit, Molecular Probes, V-13154,
Germany). The absorbancy at 540 nm was read with a
lQuantTM Microplate Spectrophotometer (BioTek, Wi-
nooski, VT, USA). The results from triplicate measure-
ments were normalized to the blanks and averaged.
The cell cycle analysis of 24–48 h serum-starved or that
of 24 h starved and then replenished ZF4 cells was per-
formed with propidium iodide (PI) staining to assess the
percentages of cells at each cell cycle stage [37, 38]. The PI
staining was performed as previously described [39]. At
each sampling, 3 9 104 cells were analyzed by Becton
Dickinson FACScalibur (USA).
The effect of serum starvation on cell proliferation was
investigated with 5-bromo-2-deoxyuridine (BrdU) staining
as previously described [39]. Briefly, cells were incubated
with BrdU adjusted to a final concentration of 0.92 lg/ml
for 24 h (Sigma, B9285, St. Louis, MO, USA). Fixed cells
were blocked in 10% FBS in PBS for 1 h before incubation
with an a-BrdU antibody (1:500 in 2% FBS in PBS; Dako,
M0744, Denmark) and a-mouse secondary antibody (1:750
Table 1 List of primer pairs and the amplification efficiencies of the primers
Gene name Forward primer Reverse primer Primer efficiency
mybl2 50-CCCACACTGAAGGAGGTGAT-30 50-CTCCTTTACTGCCCTTGCTG-30 1.89
pcna 50-AGCCTGTCATCTGTGGGATT-30 50-TGGTAAAGCTAAGGCCCAAA-30 1.85
mcm7 50-GAGATTTACGGCCATGAGGA-30 50-GGTGTACTGACTGCGTGGAG-30 2
tyms 50-TGCTAACGGCTCCAGAGAGT-30 50-CATGATGATCCTTCGGTCCT-30 1.86
ctgf 50-ACCAATGACAACCGTGAGTG-30 50-GGTAGTGGTACAGCCGGAAA-30 1.78
ef1a 50-CCCTGGACACAGAGACTTCA-30 50-CAGCCTCAAACTCACCAACA-30 1.81
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in 2% FBS; Invitrogen, A11029, USA). DAPI was used for
counterstaining nuclei. The number of BrdU incorporated
cell nuclei was determined by counting multiple fields per
group (i.e., approximately 1100–1500 DAPI stained nuclei)
on digital fluorescent microscopy images (Zeiss, AX10
Imager A1, Germany).
Real-time qRT-PCR analysis
Total RNA was isolated from 0, 1, 3 and 10% FBS-treated
samples as well as those from the serum replenishment
experiments (0.1 and 10% FBS samples at 6, 24, 30 and
48 h) using SV total RNA isolation kit (Promega, Z3100,
Madison, WI, USA). Reverse-transcription into cDNA was
performed by RevertAid First Strand cDNA synthesis kit
(Fermentas, K1622, Lithuania). Real-time qRT-PCR anal-
ysis was conducted with iCycler (Bio-Rad, Hercules, CA,
USA) thermocycler using DyNAmo HS SYBR-green kit
(Finnzymes, F-410L, Espoo, Finland). Each cDNA sample
was amplified in duplicate by using 20 lM gene-specific
primers (Table 1). Amplification conditions were 10 min at
95C followed by 45 cycles of 30 s at 95C, 30 s at 62C
(for tyms, mcm7 and mybl2) or 60C (for ctgf, pcna and
ef1a). The primer efficiencies (E) were calculated using 10-
fold serial dilutions of cDNA where E equals to 10 [-1/slope
of the dilution curve] (Table 1). The relative expression ratio of
target genes were calculated using a modified delta-delta Ct
method [40] based on primer pair-specific amplification
efficiencies and ef1a as the reference gene [41, 42]. The
log2 transformed fold change values were plotted in the
figures and were used for testing significant differences.
For each gene, the real-time qRT-PCR reactions were
performed in the same run using biological and technical
duplicates.
Western blot
Western blots were performed in order to analyze the
serum response of the Mcm7 protein expression. Briefly,
cells were lysed with NP-40 lysis buffer containing 50 mM
Tris–HCl, pH 8, 150 mM NaCl, 1% NP40 and 1X protease
inhibitor complex (Roche, Mannheim, Germany). Protein
quantification was performed using Bradford solution
(Sigma, B6916, St. Louis, MO, USA). 20 lg of total pro-
tein lysate was subjected to gel electrophoresis and trans-
ferred (Invitrogen, Carlsbad, USA) as previously described
[39]. Western blotting was performed using the primary
antibodies, Mcm7 (Santa Cruz Biotechnology, sc9966,
Santa Cruz, CA, USA) or a-Tubulin (Calbiochem, CP06,
Darmstadt, Germany), following 1 h incubation with the
horseradish peroxidase (HRP)-conjugated goat anti-mouse
secondary antibody (Sigma, St. Louis, MO, USA). Proteins
were detected using ECLplus (Amersham, rpn 2132,
Buckinghamshire, UK). Mcm7 protein expression was
compared against that of a-Tubulin for the same set of
samples.
Statistical analyses
The MTT, BrdU and PI staining results were analyzed by
One-way ANOVAs to test for the dose dependency and/or
effects of serum replenishment in response to serum in ZF4
cells. The log2 transformed real-time qRT-PCR expression
results for dose-dependent serum starvation for tyms,
mybl2, pcna, ctgf, and mcm7 and were compared among
groups using a One-way ANOVA. The time-dependent
serum replenishment data for the same genes were ana-
lyzed using a Two-way ANOVA to test for effects of time
and dose, simultaneously. For both the starvation and
replenishment experiments, pairwise analyses between
dose treatments within an ortholog were then performed
using Fisher’s pairwise comparisons following use of a
One-way ANOVA. All analyses were performed in Minitab
and plotted with GraphPad Prism 5.0 (USA).
Results
Phylogenetic conservation of PCNA, MYBL2, TYMS,
MCM7, and CTGF
Phylogenetic analyses of selected genes showed variable
degrees of conservation of the zebrafish homologs with
their vertebrate orthologs, yet expectedly the mammalian
proteins clustered together while the zebrafish orthologs
were closer to fish counterparts (Fig. 1a–e).
The zebrafish and mammalian comparisons based on
ClustalW indicated that the sequence similarity ranged
from low to high depending on the gene under consider-
ation. For example, the zebrafish Mybl2 amino acid
sequence was very weakly conserved among taxa (53%
between human and zebrafish) whereas Pcna protein
sequence identity among species was relatively higher
(90% between human and zebrafish). The Tyms, Ctgf and
Mcm7 protein sequence similarities between human and
zebrafish ranged between 75 and 80% (Table S2).
Analysis of cell cycle and proliferation in serum-
starved/replenished ZF4 cells
The cell cycle analysis of 24–48 h serum-starved ZF4 cells
was performed with PI staining. Our results revealed that a
large fraction of the control ZF4 cells were found at the G0/
G1 phase of the cell cycle (Fig. 2). However, serum star-
vation caused a significant increase in cells at the G0/G1
phase, while decreasing the number of cells entering the S
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and to a lesser degree the G2/M phases for both the 24 and
48 h serum starvation experiments. The treatment with
serum for 24 h increased the number of cells entering the S
phase, when compared with the serum-starved and non-
starved cells; this increase might have reflected a syn-
chronization event induced by serum starvation for cells at
the G1 phase of the cell cycle (Fig. 2). When cells were
cultured at a lower confluency, a similar trend was
observed such that serum starvation resulted in an increase
in G0/G1 and a decrease in S phases (Fig. S1). However,
our findings suggest that the number of 10% FBS-treated
cells at G0/G1 might be influenced by the level of con-
fluency while the serum-starved cell numbers did not vary
with confluency levels (Fig. 2 vs. Fig. S1).
Our results also showed that serum starvation caused a
significant decrease in cell proliferation such that the rate
of BrdU incorporation was 99% in the control ZF4 cells
cultured with 10% FBS for 48 h, while only 11% of the
cells incorporated BrdU upon 48 h serum starvation
(Fig. 3). The ZF4 cells that were serum-starved and then
replenished for 24 h reentered a state of proliferation. This
indicated that the effect of 24 h serum starvation on DNA
synthesis was reversible.
Dose-dependent response to serum starvation
The increase in cell viability of ZF4 cells was directly
correlated with the increased serum levels. The pairwise
comparisons showed that the 0, 1 and 3% FBS groups
responded to reduced serum levels by a significant decrease
in cell viability (Fig. 4a, One-way ANOVA; P B 0.001 for
% FBS).
One-way ANOVA performed on real-time qRT-PCR
results showed that mybl2, mcm7 and tyms expression
levels decreased significantly under serum starvation in a
dose-dependent manner while the level of change
approached significance in pcna (Fig. 4b). Pairwise tests
based on Fisher’s multiple comparisons indicated that the
expressions of mybl2, mcm7, tyms and pcna genes were
significantly down regulated at the 0% FBS treatment but
only for mybl2 and mcm7, the change in expression was
significant also at the 1% FBS level when compared to
control levels. ctgf showed a significant dose-dependent
response to serum starvation; ctgf expression steadily
increased at the 3 and 1% FBS treatments, while there
was no significant difference between the 10 and 0% FBS
treatments (Fig. 4b).
(a)
(b)
(c)
(d)
(e)
 Ol Ctgf 1
 Ol Ctgf 2
 Ol Ctgf 3
 Tr Ctgf
 Tn Ctgf
 Dr Ctgf
 Ss Ctgf
 Xt Ctgf
 Gg CTGF
 Mm CTGF
 Rn CTGF
 Hs CTGF
 Bt CTFG
100
97
93
100
65
100
100
93
100
76
0.02
 Mm MYBL2
 Rn MYBL2
 Hs MYBL2
 Bt MYBL2
 Gg MYBL2
 Dr Mybl2
 Ol Mybl2
 Ga Mybl2 gXVII
 Tn Mybl2 ch11
 Ga Mybl2 gXII
 Tn Mybl2 ch9
73
98
99
100
100
91
73
97
0.05
 Hs PCNA
 Bt PCNA
 Rn PCNA
 Mm PCNA
 Gg PCNA
 Xt Pcna
 Dr Pcna
 Ol Pcna
 Ga Pcna
 Tr Pcna
 Tn Pcna98
41
93
99
98
53
60
85
0.01
 Ol Tyms 1
 Ol Tyms 2
 Tr Tyms
 Ga Tyms
 Dr Tyms
 Xt Tyms
 Hs TYMS
 Rn TYMS
 Mm TYMS
100
99
100
99
72
58
0.02
 Hs MCM7 1
 Hs MCM7 2
 Bt MCM7
 Mm MCM7
 Rn MCM7
 Xt Mcm7
 Dr Mcm7
 Ga Mcm7
 Ol Mcm7
 Tr Mcm7
 Tn Mcm7
100
99
69
100
100
92
79
75
0.02
Fig. 1 The phylogenetic
analyses of selected E2F target
ortholog protein sequences in
different species (Table S1).
a Ctgf; b Mybl2; c Tyms;
d Mcm7; e Pcna. The
bootstrapped neighbor-joining
phylogenetic tree was generated
using MEGA4. Species: Human
(Hs), rat (Rn), mouse (Mm),
chicken (Gg), western clawed
frog (Xt), zebrafish (Dr), fugu
(Tr), medaka (Ol), cow (Bt),
salmon (Ss), stickleback (Ga),
green spotted puffer fish (Tn).
Scale bar refers to substitutions
per site
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Time-dependent response to serum replenishment
Serum replenishment for 6 h was adequate for recovery of
the cells from reduced cell viability caused by serum star-
vation (Fig. 5a, One-way ANOVA; P B 0.001), while the
24 h serum replenishment allowed for complete recovery of
cell viability (Fig. 5b, One-way ANOVA; P B 0.001).
The expressions of tyms, mybl2, mcm7 and pcna were
significantly different in at least one of the groups tested (i.e.,
24 or 48 h serum-starved (0.1% FBS) or control (10% FBS)
groups). A Two-way ANOVA showed that the starvation
associated decrease observed in the expression of these genes
was significant and independent of time (Fig. 6a, Two-way
ANOVA according to log2 transformed fold change differ-
ence; tyms, Pdose = 0.001, Ptime = 0.558; mybl2, Pdose B
0.001, Ptime = 0.212; pcna, Pdose = 0.001, Ptime = 0.276;
mcm7, Pdose B 0.001, Ptime = 0.576). Serum-starved cells at
both the 24 and 48 h showed significant decreases in the
mRNA levels of mybl2, mcm7 and pcna whereas that of tyms
was only significantly different from the 24 h 10% FBS
24h
10% FBS
24h
0.1% FBS
48h
10% FBS
48h
0.1% FBS
24h
Replenishment
G0/G1 85.40 ± 0.12 91.48 ± 0.26* 85.24 ± 0.86 91.22 ± 0.02* 80.66 ± 0.28#*
S 6.44 ± 0.60 2.25 ± 0.05* 5.90 ± 0.28 2.32 ± 0.42* 8.27 ± 0.24#*
G2/M 8.35 ± 0.49 6.35 ± 0.21* 8.75 ± 1.04 6.28 ± 0.45 11.25 ± 0.11#
24h 10% FBS 24h 10% FBS
48h 10% FBS 48h 0.1% FBS
24h Rep.
Fig. 2 Cell cycle analysis of
ZF4 cells in response to serum
fluctuations. The mean
percentage of cells at the G0/
G1, S, G2/M for the 24 h and
48 h serum starvation and 24 h
serum replenishment (24 h
0.1% FBS following 24 h 10%
FBS) experiments were shown
along with ± standard
deviation. *indicates a
significant difference from the
10% FBS group while # refers
to a significant difference
between the 48 h 0.1% FBS and
24 h replenishment groups at
P B 0.05
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treatment. Strikingly, the serum replenishment restored
expression to the original levels (Fig. 6a). The transcriptional
change in ctgf, on the other hand, was time-dependent, yet
highly significant at both the 24 and 48 h time-points
(Fig. 6a, Two-way ANOVA according to log2 transformed
fold change difference; ctgf, Pdose B 0.001, Ptime = 0.01).
The level of protein expression of Mcm7 also exhibited a
significant decrease under the 24 h serum starvation regime
(Fig. 6b) suggesting that changes observed at the mRNA
levels also were reflected in the protein synthesis.
We also quantitatively analyzed the change in mRNA
levels for cells replenished with 10% FBS for 6 h upon
serum starvation (Fig. 7a). The expression levels of tyms,
mybl2 and pcna increased significantly with serum at 6 h as
they did at 24 h, while the expression of ctgf was unaf-
fected. The change in mcm7 mRNA expression approached
significance at 6 h while it was highly significant at 24 h.
mcm7 gene expression was also studied at the protein level.
There was a consistent decrease in the Mcm7 protein levels
by serum starvation at the 24 and 48 h treatments. The
serum replenishment, particularly for the 24 h, was highly
effective in restoring the original level of protein expres-
sion for Mcm7 (Fig. 7b).
Discussion
In the present study, we investigated the expression pat-
terns of the zebrafish orthologs of the known mammalian
direct or secondary targets of E2F transcription factors;
tyms, mybl2, pcna, ctgf and mcm7 in serum-starved/
replenished ZF4 cells using real-time qRT-PCR analyses.
Moreover, we demonstrated for the first time that in ZF4
cells serum starvation and replenishment treatments
BrdU DAPI Merge
48h
10% FBS
48h
0.1 % FBS
24h rep.
100
*
50
*Pe
rc
en
t c
el
l n
u
m
be
r
48
h 1
0%
48
h 0
.
1%
24
h r
ep
.
0
FBS treatment
Fig. 3 BrdU incorporation in
serum-starved/replenished ZF4
cells. ZF4 cells treated with
0.1% FBS for 48 h were
compared with those in control
group cultured in 10% FBS for
48 h. In the replenishment
group, cells recovered from
starvation for 24 h (24 h rep.).
Nuclei were stained by DAPI
where BrdU incorporating cell
nuclei were observed using the
green filter. Scale bars
represented a distance of 20 lm
and the magnification was set at
940. The mean number of BrdU
positive nuclei corrected against
the total number of nuclei per
group was plotted, whiskers
correspond to ± std. *indicates
significance at P B 0.05
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significantly affected cells at different cell cycle phases in
ZF4 cells. In the literature, there are a few examples
showing that the serum response might be dose- and time-
dependent [20, 43–46]. Herein we showed that the effects
of serum starvation/replenishment on gene expression of
E2F target orthologs were dose- and time-dependent in
Fig. 4 Dose-dependency of
ZF4 serum response a MTT
assay results of ZF4 grown
under different serum
concentrations, i.e., 0, 1, 3 or
10% FBS-supplemented media,
for 24 h, b The real-time qRT-
PCR results of selected genes in
response to serum starvation.
The ZF4 cells were grown in 0,
1, 3 or 10% FBS-supplemented
media for 24 h. Data were
normalized to the 10% FBS
treatment. (One-way ANOVA
according to log2 transformed
fold change difference; tyms,
P = 0.024; mybl2, P B 0.001;
pcna, P = 0.077; ctgf,
P = 0.013; mcm7, P = 0.001).
a, b, c refers to significance at
P B 0.05 from 10, 3, and 1%
FBS, respectively, based on
Fisher’s multiple comparisons
Fig. 5 MTT assay results of
serum-replenished cells a 6 h
serum replenishment with 10%
FBS (6 h rep.), b 24 h serum
replenishment with 10% FBS
(24 h rep.). * refers to
significance at P B 0.05 where
only a two-group comparison
was made
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ZF4 cells. In the present study, ZF4 cells arrested at G0/G1
upon serum starvation served as a model for quiescence.
The transcriptional serum responses of the selected genes
were in accord with findings from studies performed with
mammalian cells.
The characterization of proliferative properties
of ZF4 cells in response to serum
The asynchronized mammalian fibroblasts accumulate in
G0/G1 phase of the cell cycle after serum starvation and
reenter the S phase upon serum stimulation [47]. Herein,
we described the cellular serum response of the ZF4
fibroblast cell line, a frequently used in vitro model in
zebrafish [48–52]. Our results showed that (a) the serum
starvation significantly decreased the viable cell numbers,
which were later on rescued by serum replenishment; and
(b) the viable ZF4 cells that have survived the serum
starvation stopped proliferating and became arrested at the
G0/G1 phase of cell cycle as previously shown in the
mammalian fibroblast cells [47, 53–56]. Most strikingly,
the serum-replenished cells reentered the S phase of cell
cycle and commenced proliferation as the mammalian
fibroblasts [57]. The high percentage of ZF4 cells entering
the S phase after serum stimulation represented a likely
synchronization process caused by serum starvation.
The expression response to serum fluctuations
in ZF4 cells in comparison to that in mammals
Recent studies emphasize the role of comparative models
in understanding the functional conservation of important
cell signaling components. Our findings indicated that the
zebrafish pcna, tyms, mcm7 and mybl2 genes were highly
responsive to serum in the direction observed in mamma-
lian cells [18, 20, 21].
The real-time qRT-PCR results showed that the zebra-
fish pcna expression was highly responsive to serum star-
vation and replenishment as previously shown for mouse
embryonic fibroblast (MEF) [21, 58] and in the Chinese
Fig. 6 a The real-time qRT-
PCR results of selected genes
under 24 h serum replenishment
regime. The real-time qRT-PCR
results were normalized to the
24 h 10% FBS-treatment. One-
way ANOVA results were, for
24 h: tyms, P = 0.002; mybl2,
P = 0.031; pcna, P = 0.013,
ctgf, P = 0.028; mcm7,
P = 0.015 for 48 h: tyms,
P = 0.03; mybl2, P B 0.001;
pcna, P = 0.005; ctgf,
P = 0.007; mcm7, P B 0.001.
* refers to a group significantly
different from the 10% control
at the given time point. 10%
rep. refers to the treatment of
24 h serum starvation followed
by 24 h serum replenishment.
b Protein expression of Mcm7
gene for the 24 h starved versus
asynchronized ZF4 cells
Mol Biol Rep
123
hamster ovary cell line (CHOK1) [59]. Serum starvation
resulted in a highly significant decrease in the expression of
the zebrafish mybl2 in our study as in the normal human
bone marrow fibroblasts [19]. We observed an increase in
mybl2 expression starting from 6 h of serum stimulation. In
quiescent mouse embryonic fibroblast cells the Mybl2
mRNA increased gradually after serum stimulation starting
at the 12 h of serum replenishment [60].
We detected a significant increase in the tyms expression
even within 6 h of serum replenishment. A similar increase
in the Tyms expression following serum stimulation also
was observed in NIH 3T3 cells between the 8 h-10 h of
serum treatment [61] yet in mouse 3T6 fibroblasts, the
Tyms activity showed a decrease under long-term serum
starvation [31].
We have found that ctgf expression was serum-respon-
sive in a time-dependent manner and most drastically
increased at the 24 h 0.1% FBS treatment; the expression
was reduced following serum recovery between the
6–24 h. Human CTGF expression also responded to serum
in the same direction based on the GEO microarray
expression profile analysis of human T98G cells [11].
Stimulatory effects of serum starvation on zebrafish ctgf
thus suggest significant functional conservation across
vertebrate taxa. However, the direction of the effects might
be species as well as cell-type specific, as in contrast to our
findings, a decrease in the CTGF mRNA was detected after
serum stimulation in a human mesangial cell line [22].
In mouse and human cells, the prolonged quiescent state
caused the downregulation of all the mcm proteins
Fig. 7 a The real-time qRT-
PCR results for 6 h serum-
replenished cells. The real-time
qRT-PCR results were
normalized to the 30 h 10%
FBS-treatment. One-way
ANOVA results were: tyms,
P = 0.011; mybl2, P = 0.001;
pcna, P = 0.014; ctgf,
P = 0.053; mcm7, P = 0.095.
The significance at P B 0.05
was represented as * b Protein
expression of Mcm7 under
serum starvation and
replenishment
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(MCM2-7), while reentering into the G1 phase led to
upregulation of Mcm transcripts and proteins [18]. We
have shown that mcm7 expression in ZF4 cells was serum-
responsive, while the changes observed at the mRNA
levels were linearly reflected at the protein level; similar
changes were observed in the serum-stimulated MCF7
breast cancer cells [62]. The mRNA and protein expression
of the mcm7 gene have been characterized in zebrafish
model for the first time in the present study. However, to
better assess the correlation between mRNA and protein
levels under serum starvation, further studies focusing on
other genes are needed.
In conclusion, our findings indicated that the level of
serum incorporated into the media has been reflected in the
cellular characteristics as well as the transcriptional
response the ZF4 cells displayed, suggesting a significant
dose- and time-dependency in serum response. Further-
more, we showed that the fibroblast serum response in
zebrafish was highly similar to that in mammals with
respect to the genes under investigation. Serum starvation
was as effective at the 48th h as at the 24th h for pcna,
tyms, mcm7, mybl2, and ctgf. 6 h serum replenishment
experiments on the other hand showed that only the
expression of tyms, mybl2 and pcna returned to near normal
levels while the mcm7 and ctgf responded to increased
serum levels relatively later. Moreover, the mammalian
orthologs of the selected genes examined in the present
study are known to be regulated by different transcription
factors in addition to E2F family members, i.e., c-myc,
p53, and/or TFG-b2 [16, 63–68]. It will be interesting to
further test whether these zebrafish orthologs also share
common transcriptional regulatory signatures.
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